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ABSTRACT
Spotted fever group (SFG) Rickettsia are obligate intracellular bacteria that are
transmitted by ticks during a bloodmeal to a mammalian host. Interestingly, the SFG pathogen,
Rickettsia conorii, has been shown to infect and grow in macrophages with a similar efficiency
as the target endothelial cell, whereas a non-human pathogenic counterpart, Rickettsia
montanensis, is unable to grow within macrophages. We have since determine that this
phenotype applies to other pathogenic and non-human pathogenic Rickettsia, showing a
correlation with growth in macrophages and rickettsial virulence. Recently, our lab has also
defined host proteins that are altered during macrophage infection with R. conorii compared to R.
montanensis to define alterations in host processes that may be essential for pathogen survival
and replication. Among the proteins altered during macrophage infection with R. conorii are
those involved in lipid metabolism. Therefore, we hypothesize that if pathogenic Rickettsia
species, such as R. conorii, require host lipid metabolic processes, then inhibition of these
pathways will negatively impact rickettsial survival and host modulation during infection of
macrophages. Here, the requirement of central processes important for lipid metabolism, such as
lipid droplet modification and catabolism, and fatty acid β-oxidation, for R. conorii survival in
macrophages was elucidated. Conversely, a common way bacteria manipulate the host is through
employment of effector proteins that are able to interact with host proteins to drive processes
favorable for efficient bacterial infection. Herein we develop tools required for investigation of a
putative Rickettsia rickettsii effector protein, RARP3. In summary, the findings presented within
this thesis are necessary for further understanding the mammalian host:pathogen interaction in
hopes to develop alternative therapeutics against spotted fever group Rickettsia.
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CHAPTER I. INTRODUCTION AND LITERATURE REVIEW
1.1. Rickettsia
Microorganisms within the genus Rickettsia are small (0.3-0.5µM x 0.8-1.0µM)
coccobacilli, Gram-negative α-proteobacteria, that are obligate intracellular organisms
transmitted by hematophagous arthropods to mammalian hosts (Walker 2007). Due to the
discrete nature of arthropod bites and initial presentation of a non-specific febrile illness,
rickettsial diseases are commonly left untreated or misdiagnosed, leading to severe morbidity
and frequently mortality. Along with misdiagnosis and untreated cases being cause for concern,
treatments for those diagnosed rickettsial diseases are limited to a repertoire of antibiotics,
including tetracycline, doxycycline and chloramphenicol, with doxycycline being used to treat
80% of rickettsial disease cases (Rolain et al. 1998; Raoult et al. 1987a). Even with the
effectiveness of doxycycline to treat rickettsial diseases, morbidity and mortality caused by these
microorganisms remain high (McQuiston and Paddock 2012). Therefore, understanding the hostpathogen dynamic is necessary for defining novel targets for development of new preventative
and treatment therapeutics.
1.1.1. History of Rickettsia
As early as the 1500s, rickettsial diseases wreaked havoc across the world. However, it
was not until the early 1900s that Rickettsia species were credited for major outbreaks
throughout history. The first known rickettsial outbreak occurred in Siege of Naples in 1529,
______________________________________________________________________________
Section 1.4 of this chapter was published as PE Allen and JJ Martinez, "Modulations of Host
Lipid Pathways by Pathogenic Intracellular Bacteria" in MDPI: Pathogens, July 2020, Volume 9:
Issue 8 (Special Issue Virulence Mechanisms of Rickettsiae). Copyright Information for Chapter
I, Section 1.4.
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which was later determined to be caused by R. prowazekii, the causative agent of endemic typhus
(Walker and Ismail 2008). Throughout history endemic typhus has continued to cause significant
morbidity and mortality predominantly in human populations closely grouped together, with
major ties to soldier deaths in the war of Spanish succession (1710-1712) and the Napoleonic
war (McQuiston and Paddock 2012; Angelakis, Bechah, and Raoult 2016). As recent as the early
1900s, during World War I, 3 million people in Russia died of what is suspected to be endemic
typhus, with around 30 million people contracting the disease (Walker and Ismail 2008;
Angelakis, Bechah, and Raoult 2016; Bavaro et al. 2005; Kelly et al. 2002).
In comparison to R. prowazekii, the more severe disease-causing SFG species, including
R. rickettsii and R. conorii, were not credited for high morbidity and mortality until the late
1800s, with the first clinical case of spotted fever described in 1899. Soon after, in 1906, a
disease initially termed “black measles”, now more commonly known as Rocky Mountain
spotted fever, was deemed the cause of drastic mortality in the Bitterroot Valley in Montana
(Burgdorfer 1977). This major health crisis became the focus of Howard T. Ricketts studies. His
team determined the tick-borne origin of the “black measles” with the causative agent being R.
rickettsii (Ricketts 1904). This discovery is what ultimately led to the emergence of the Rickettsia
genera in honor of Ricketts pioneering work with R. rickettsii and other rickettsial species.
Unfortunately, Ricketts curiosity about Rickettsia’s led to his passing presumable due to
epidemic typhus acquired during his studies in Mexico (Wolbach 1919; Gross and Schafer
2011). Various other scientists would continue throughout the early 1900s, to investigate
Rickettsia and rickettsial diseases some of which would also succumb to severe and sometimes
deadly rickettsial infections.
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With the discovery of antibiotics in late 1920s and their increased use in 1940-1950s, the
1950-1970s was falsely perceived as the end of infectious disease burdens; however, in terms of
rickettsial and various other diseases, this abolishment was not the case. For example, SFG
Rickettsia’s, such as R. rickettsii and R. conorii, have exhibited a drastic increase in cases, with a
peak in R. rickettsii cases as recent as 2008 (Chapman et al. 2006; Openshaw et al. 2010;
McQuiston and Paddock 2012). Although, morbidity is on the rise, the mortality rate has
decreased. This can be attributed largely to the application of doxycycline in diagnosed cases.
Since rickettsial diseases are predominantly associated with a general febrile illness commonly
seen in a variety of infections, there is the question of whether the increase in rickettsial cases is
correlated to an increase in bacterial prevalence due to changes in ecology and human-vector
overlap, or if this can be attributed to an increase in vector surveillance and increased disease
diagnostics (McQuiston and Paddock 2012; Openshaw et al. 2010).
1.1.2. Clinical Aspects of Rickettsial Infections
As mentioned previously, a common initial presentation of a rickettsial infection includes
a fever, headache, anorexia, and myalgia, characteristic of a general febrile illness. More rare
symptoms can vary among groups and even species within groups but include a maculopapular
rash as the infection disseminates throughout the body and to various organs ultimately causing a
systemic infection and sometimes death in more serious cases (Drexler et al. 2016; Dumler and
Walker 2005). Some species, such as R. conorii and R. rickettsii, can also present with a small
lesion, called an eschar, at the site of inoculation which is characterized by a gathering of
bacteria and innate immune cells comprising of the wound. The presentation of the eschar varies.
However, in SFG cases, eschars are seen in approximately 70-80% of documented cases
(Paddock et al. 2004; Oteo and Portillo 2012). The incubation time from infected vector bite to
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onset of symptoms ranges from 2 to 14 days, with the maculopapular rash, if presented,
occurring approximately 3 to 5 days after onset of fever (Lin and Deckler 2012). The
discrepancies in rickettsial disease presentation and similarities to other general febrile illnesses
contributes to the increased potential for misdiagnosis likely causing a misrepresentation in cases
and mistreatment adding to increased morbidity, and some cases death (Drexler et al. 2016).
Clinically, Rickettsia are associated with a predominantly vasculotropic infection that
causes signs of vascular permeability throughout the organism (Dumler 2012). Upon host
inoculation, infection and dissemination throughout vascular endothelial cells triggers
disruptions of tight junctions within the vasculature causing leaks and dysregulation of the host
circulatory system, typically associated with more severe and complicated cases that can
ultimately lead to death (Walker and Ismail 2008). However, Rickettsia interact with other cell
types, including resident macrophages and dendritic cells at the site of inoculation, due to the
increased inflammation and recruitment of cells by pathogen and vector factors. The host cellRickettsia interaction allows for pathogen regulation of the initial host immune response and
potentially dissemination throughout the body (Fang et al. 2007; Murphy, Wisseman, and Fiset
1978). As the disease progresses, complication can arise in more severe cases with multiple
facets of the host systems, including gastrointestinal issues, signs of central nervous system
infection like seizures and a coma, pulmonary disease, hepatic and renal failure, myocarditis, and
overall vascular collapse (Helmick, Bernard, and D’Angelo 1984; Rallis et al. 1993).
1.1.3. Rickettsia Genetic Diversity
Currently, there are approximately 30 species (http://www.bacterio.net) within the genus
Rickettsia with regular additions of candidate species due to the increasing number of molecular
techniques available to better distinguish between organisms. The factors predominantly used to
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divide rickettsial species are based on type of arthropod vector, differences in antigenicity and
disease presentation, and more recently genetic factors (Dumler and Walker 2005; Gillespie et al.
2008). Initially, the Rickettsia genus was divided into the Ancestral Group (AG) and Spotted
Fever Group (SFG) transmitted by the Ixodidae (hard tick) family of ticks, and the Typhus group
(TG) transmitted by fleas or louse (Gillespie et al. 2008). However, in the early 21st century, with
increases in advanced sequencing technology, it was proposed that the organisms be further
divided leading to the divergence of the Transitional Group (TRG), which have similarities to
both SFG and TG (Gillespie et al. 2008). Among these rickettsial groups, excluding the AG, are
species that are the causative agents of an array of human diseases including Mediterranean
spotted fever, Rocky Mountain spotted fever, Queensland tick typhus, rickettsialpox, and
endemic typhus (Azad and Beard 1998; Gillespie et al. 2008).
A major contribution to the variety seen within the Rickettsia genus is the varying
genome sizes, pseudogenization, open reading frame (ORF) composition, and other defining
genetic factors. The first Rickettsia genome to be sequenced upon the pioneering of the genomics
era was Rickettsia prowazekii. Interestingly, the core of this and later sequenced rickettsial
genomes shares similarities with mitochondrial DNA, including the presence of functional or
partially functional energy pathways (Driscoll et al. 2017; Andersson et al. 1998; Gray 1998).
This increase in sequence availability of rickettsial genomes also led to defining reductive
evolution at varying amounts across different Rickettsia groups, with more virulent species
showing more results from this process (Merhej and Raoult 2011; Andersson and Kurland 1998).
Reductive evolution is defined as the presence of irreversible deletions within a microorganism
genome that is an adaptation acquired when shifting to a restrictive endosymbiotic relationship
(Andersson and Kurland 1998). The presence of this phenomenon implies that Rickettsia have
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become increasingly reliant on external resources for survival, suggesting the evolution from a
more self-sufficient mitochondrial-like organism to an obligate intracellular bacteria.
The levels of reductive evolution varies across rickettsial groups and species with more
human pathogenic species, like R. prowazekii and Rickettsia rickettsii, having higher levels of
reductive evolution within their genome compared to the non-human pathogenic counterparts;
thus, the level of reductive evolution between rickettsial species not only varies but likely
correlates with the degree of pathogenicity (Diop, Raoult, and Fournier 2019). Some Rickettsia
species, such as Rickettsia conorii, also have high levels of Rickettsia palindromic elements that
are repeating sequences throughout the genome that can insert within ORFs disrupting
functionality of the encoded gene within that region (Ogata, Audic, Renesto-Audiffren, et al.
2001; Ogata, Audic, Abergel, et al. 2001). Pseudogenization and gene disruption are also
prevalent within multiple rickettsial genomes due to gene duplication, transposon elements, and
other evolutionary forms of gene expression disruption (Gillespie et al. 2008; Gillespie et al.
2012). Interestingly some species, usually non-human pathogens, also have plasmids that
contribute to the diversity and potential functionality of different Rickettsia species (Gillespie et
al. 2007). Conversely, the more pathogenic Rickettsia species have smaller genomes, and
although have high levels of reductive evolution, in general have less transposable elements and
gene duplication events (Diop, Raoult, and Fournier 2019).
The described signs of reductive evolution and methods of pseudogenization within
rickettsial genomes favors the increase of gaps seen in metabolic pathways necessary for
providing the building blocks of life including amino acids, nucleosides, and lipids (Driscoll et
al. 2017). The lack of important enzymes within these pathways strengthens the significance of
the Rickettsia-host cell relationship to acquire required materials for bacterial survival. One
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example of the importance of this dynamic relationship is the lack of glycolysis enzymes and
other traditional energy producing pathways within the bacterial genome (Driscoll et al. 2017).
Energy and other metabolites generated with the production of ATP are essential for organismal
survival and growth. Although Rickettsia lacks efficient ways to make energy, these
microorganisms are still able to use alternative external sources, such as glutamate and
glutamine, for ATP production (Driscoll et al. 2017; Williams and Weiss 1978; Andersson
1998). Conversely, rickettsial genomes also encode for ATP transporters, and R. prowazekii and
R. rickettsii have been shown to produce and upregulate ATP transporters during infection
suggesting an exchange of energy between the host and bacteria (Driscoll et al. 2017; Andersson
1998; Audia and Winkler 2006; Riley, Pruneau, and Martinez 2017); however, the mechanism(s)
by which these bacteria sequester resources for energy has yet to be elucidated. An early study
also showed a requirement of exogenous amino acids, serine and glycine, for growth of R.
prowazekii indicating an inability to make these amino acids itself, further strengthening the
requirement of the host for major macromolecules to survive (Austin and Winkler 1987).
One macromolecule that has yet to be studied in terms of infection is host lipids. A recent
genetic study suggests that Rickettsia have gaps or lack major lipid metabolism pathways in the
bacterial genome. In addition, a recent proteomic study confirmed an importance for host lipid
and fatty acid biosynthesis during macrophage infection by R. conorii. The exact role(s) of de
novo lipid biosynthesis during the infection process has yet to be elucidated (Driscoll et al. 2017;
Curto, Santa, et al. 2019). Unfortunately, the diversity among rickettsial species and the
environment/host each species inhabits, makes it more difficult to define specific host pathways
and molecules that are important across the genus.
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Key genetic factors within all Rickettsia include putative secretion systems and effector
proteins likely preserved during adaptation to maintain the bacterial population and virulence in
pathogenic species. Although conserved virulence factors are present throughout the Rickettsia
genus, various virulence factors also differ across groups and even species within groups. As an
example, surface cell antigens (Sca) are known virulence factors for Rickettsia; however, the
number and types of Sca proteins present in each group of Rickettsia differs significantly
(Gillespie et al. 2015). On the other hand, phospholipases are present within all Rickettsia
species genome and has been shown to be required for exit of the host vacuole during Rickettsia
typhi, R. prowazekii, and R. rickettsii infections (Driskell et al. 2009; Rahman et al. 2010;
Silverman et al. 1992; Winkler and Miller 1982; Walker, Feng, and Popov 2001; Winkler et al.
1983). The diversity of virulence factors in different Rickettsia species are likely important for
maintenance of specific rickettsial populations in varying arthropod vectors and other host
species in which Rickettsia species infect.
1.1.4. Rickettsia Lifecycle
Maintenance of the rickettsial population heavily depends on main aspects of the
Rickettsia lifecycle including vector competency and capacity, transmission methods, and
seasonality and environmental factors that are favorable for vector blood feeding (Raoult and
Roux 1997; Azad and Beard 1998). Conventionally, the Rickettsia lifestyle consists of
transmission from the respective arthropod vector to a mammalian host or bird during arthropod
blood feeding (Azad and Beard 1998). There are two major mechanisms of transmission for
maintenance of Rickettsia in an arthropod population. One method termed horizontal
transmission involves the acquisition of bacteria by a vector during a bloodmeal from an infected
mammalian host and/or co-feeding with a Rickettsia transmitting arthropod. A second method
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termed vertical transmission occurs during molting to the different life stages (transstadial
transmission) and from adult female to offspring (transovarial transmission) (Burgdorfer and
Brinton 1975; Walker and Ismail 2008). Alternatively, some Rickettsia within the TG and TRG
are also capable of being transmitted through arthropod feces (Azad and Traub 1985; Reif et al.
2011; Dieme et al. 2015). Arthropods not only act as a vector for rickettsial transmission but can
also be a reservoir for some species such as non-human pathogenic, endosymbionts like
Rickettsia montanensis and Rickettsia peakockii (Raoult and Roux 1997; Azad and Beard 1998).
Some but not all human pathogenic species, such as R. prowazekii and R. rickettsii, are also
parasitic to the arthropod vector (Burgdorfer and Brinton 1975; Akram, Ladd, and King 2021).
SFG, TG, and TRG Rickettsia remodel the host actin cytoskeleton and stimulate
phosphatidylinositol 3 kinase activity for entry into Vero cells and tick cells (Rennoll-Bankert,
Rahman, et al. 2015; Martinez et al. 2005; Petchampai et al. 2015). Although host mechanics
required for entry are similar across rickettsial groups, the bacterial mechanisms stimulating
internalization varies. For example, SFG R. conorii was shown to be internalized in Vero cells
through an interaction with bacterial outer membrane protein receptor A (OmpA), which is
absent in TG Rickettsia, and host cell Ku70, though other unknown adhesins and invasins are
likely involved (Martinez et al. 2005; Chan et al. 2009). Conversely, a bacterial effector protein,
RalF, found in TG but present as a pseudogene in SFG Rickettsia, was determined to act as a
critical invasion for TG entry in Vero cells. This entry is stimulated by RalF co-localization with
host Arf6, a key player in initiating the host endocytic pathway (Rennoll-Bankert et al. 2016;
Rennoll-Bankert, Rahman, et al. 2015). Once internalized, Rickettsia escape the host endocytic
pathway by quickly disrupting the nascent vacuole membrane. R. prowazekii, R. typhi, and R.
rickettsii use a bacterial phospholipase A2, that is also present within other Rickettsia species
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genomes, to carry-out this process (Rahman et al. 2010; Winkler and Miller 1982; Walker, Feng,
and Popov 2001; Winkler et al. 1983). Once escaped from the vacuole, Rickettsia reside and
replicate within the cytosol, before exiting the host cell through various modes, including lysis
and actin-motility, depending on species (Azad and Beard 1998; Reed et al. 2014). Work has
been done investigating the host immunological response during Rickettsia intracellular infection
(Feng et al. 2004; Walker and Ismail 2008; Riley et al. 2015; Sahni and Rydkina 2009; Riley et
al. 2018; Chan et al. 2011). However, little is known about the metabolic host and bacterial
mechanisms employed for rickettsial survival within the host cytosol.
Although endothelial cells are generally recognized as a major cell type infected by
Rickettsia during mammalian infection, more evidence is accumulating defining the importance
of other host cell in causing the more severe presentations seen with human pathogenic species,
such as R. conorii and R. rickettsii. To date, explorations of non-endothelial cells contribution to
rickettsial infections have been rather limited to exploring the role of immune cells in clearance
of the bacteria in hopes to develop vaccines and immunotherapeutic treatments, and less on
Rickettsia’s role in manipulating and surviving within multiple cell types to benefit overall
mammalian infection (Bechelli et al. 2019; Feng et al. 2004; Riley et al. 2015; Chan et al. 2011;
Bechelli et al. 2009; Riley, Patterson, and Martinez 2012; Bechelli et al. 2021). However,
research has suggested that infection of dendritic cells with R. typhi early in infection increases
host susceptibility to infection (Fang et al. 2007). Similarly, an early study defining the
mechanism of R. conorii killing by infected macrophages, hepatocytes, and monocytes also
suggest an ability for R. conorii to enter and survive within these host cell types when the host
cell is unstimulated upon infection (Feng and Walker 2000). A murine in vivo model of
Mediterranean spotted fever revealed the presence of R. conorii in multiple cell types, including
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granulocytes, monocytes, and lymphocytes particularly in infected liver (Riley et al. 2016). More
recently, there has been accumulating evidence to suggest that growth in macrophages correlates
with virulence of rickettsial species, suggesting the requirement of promiscuous cell infection to
cause a more severe disease presentation (Curto et al. 2016; Kristof et al. 2021). Indeed, research
elucidating the host transcriptomic and proteomic differences during in vitro macrophage
infection with R. conorii has pointed to pathogen evasion of the endocytic pathway and
infection-induced modulation of specific host response that is not seen in non-human pathogenic
counterpart during infection of these phagocytic cells. Among the host responses altered are
those important for macrophage polarization to a M2 response and overall immune modulation,
as well as metabolic pathways involved in this anti-inflammatory response, including lipid
metabolic processes and non-glycolytic ATP production (Curto, Riley, et al. 2019; Curto, Santa,
et al. 2019). Other reports defining host processes activated during Rickettsia australis infection
of macrophages, have indicated activation of the inflammasome and autophagy to evade the host
immune system (Bechelli et al. 2019; Smalley et al. 2016; Bechelli et al. 2021). However, the
requirement of these host processes and their importance to more virulent or other groups of
rickettsial pathogens, and overall mammalian disease development have yet to be addressed.
1.2. Ankyrin Repeat Proteins
One major pathogenicity factor found to be essential for growth and survival for a variety
of bacterial pathogens are secretion systems. There are a range of secretion systems Type I-Type
VIISS (TI-TVIISS) that are structurally and functionally diverse. Despite the diversity one
function encompassing all known secretion systems is the ability to secrete various proteins that
provide the bacteria with a mechanism of interacting with and manipulating a variety of host
processes to provide a hospitable niche for the pathogen (Green and Mecsas 2016). Among some
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of the most characterized effector proteins contain ankyrin repeat-containing proteins (Pan et al.
2008; Al-Khodor et al. 2010a, 2010b).
1.2.1. Ankyrin Repeat Protein Structure and Function
Ankyrin repeat containing proteins (ARPs) are traditionally thought to be structural
motifs that facilitate protein-protein interactions in eukaryotic systems to regulate various
functions including signaling transduction for maintenance of host cell process. To date, ARPs
have not been associated with enzymatic activity and are instead prominent anchors for specific
protein-protein interactions (Jernigan and Bordenstein 2014; Li, Mahajan, and Tsai 2006;
Mosavi, Minor, and Peng 2002). ARPs can be a motif in a larger protein with other domains that
can provide an enzymatic function, or ARPs can stand alone and bind to a protein causing a
steric-driven alteration in function (Mosavi, Minor, and Peng 2002; Li, Mahajan, and Tsai 2006).
A traditional ARP structure is made up of repeating antiparallel α-helices connected by a
β-loop to form a helix-turn-helix shape (Figure 1.1) (Voth 2011; Li, Mahajan, and Tsai 2006). To

Figure 1.1. An ankyrin-repeat protein structure is a
helix-turn-helix shape that consists of repeating αhelices connected by variable β-loops (Voth 2011).
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keep the repeating structure, some residues within each ankyrin are well-conserved. These wellconserved motifs form bonds and hydrophobic interactions that provide required stability to the
ankyrin protein and overall ARP structure (Li, Mahajan, and Tsai 2006). The formation of these
conserved interactions allows for the combined ankyrin proteins to stack into a compact, concave
shape that in the presence of 32 combined ankyrin repeats will form a completed superhelical
turn (Li, Mahajan, and Tsai 2006). Although the topology of all ARPs is very similar, there are
diverse factors involved in the protein structure and composition that provide specificity for
individual protein-protein interactions. These ARPs ability to participate in various
protein:protein interactions throughout the cell is attributed to the variability within the structure
and individual repeats that provide this specificity and stable protein interactions (Jernigan and
Bordenstein 2014; Al-Khodor et al. 2010a; Li, Mahajan, and Tsai 2006). Among the factors that
contribute to specificity of a particular ARP are: i) changes in exposed external amino acid
residues that are not conserved or important for overall topology; ii) the connecting protein
domains that play a role in determining the ARPs orientation; iii) the number of ankyrin repeats;
iv) differences in length of helices and residues ending a single helix; v) variation in β-loop
length and confirmation (Li, Mahajan, and Tsai 2006). With the specificity of individual ARPs
also comes the potential for functional variability among ARPs. The differences in functionality
is dependent on the domains connected to the ARPs, as well as the area of the ARP:target protein
interaction. For example, different ARPs can interact with the same target, but can modulate the
response differently. Conversely, one ARP can form stable interactions with various targets
based on intracellular and environmental cues to cause a specific response (Li, Mahajan, and
Tsai 2006).
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1.2.2. Ankyrin Repeat Proteins in Intracellular Pathogens
Though ARPs were discovered and are well characterized within eukaryotic systems,
their presence is not limited to eukaryotes. While less frequent within the genome, bacteria have
been shown to also contain ARPs with high homology to those found in eukaryotic systems (AlKhodor et al. 2010a). Specifically, bacteria that have a strong or required symbiotic relationship
with a eukaryotic host, such as facultative and obligate intracellular bacteria, contain a high
number of ARPs (Jernigan and Bordenstein 2014); though, ARPs are also found in free-living
microorganisms (Al-Khodor et al. 2010a). The presence of ARPs within intracellular pathogen
genomes is predicted to be derived from evolutionary phenomenon, like horizontal gene transfer,
convergent evolution, or maintained from a common ancestor (Gillespie et al. 2008). Thus, the
increase in ARPs in intracellular pathogens is likely due to the need for the bacteria to adapt to
an intracellular lifestyle and interact with host molecules to facilitate an efficient infection. In
fact, intracellular bacterial ARPs are typically deemed as putative effector proteins that are part
of a pathogens secretome, and generally provide increased bacterial virulence and/or
sustainability (Gillespie et al. 2015; Rikihisa and Lin 2010; Pan et al. 2008). Among the defined
bacterial ARPs are proteins secreted by the TIVSS (Pan et al. 2008; Lin et al. 2007; Voth et al.
2009; Habyarimana et al. 2010) or TISS (VieBrock et al. 2014; Wakeel et al. 2011; Kaur et al.
2012) though the full extent of their contribution to virulence is rather undefined for the majority
of intracellular bacterial pathogens. Thus, it is important to better characterize the bacterial
encoded ARPs to better understand the host:pathogen dynamic to provide insight necessary for
development of alternative targets for effective treatments and preventative strategies.
Genomic analyses have indicated that rickettsial species contain the genetic requirements
for functional secretion systems, such as the TISS and TIVSS (Gillespie et al. 2015). Various
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pathogenic Rickettsia species also encode for a varying number of ARPs within the genome
(Gillespie et al. 2008), however, little is known about the expression or functionality of these
bioinformatically determined putative effectors. Among the few rickettsial ARPs beginning to be
characterized (Table 1.1) is rickettsial ARP-1 (RARP-1), which was demonstrated in the TG,
Table 1.1. A list of ankyrin-repeat proteins that have been experimentally shown to provide
functionality and/or are secreted by a bacterial secretion system during intracellular infection
with rickettsial human pathogens.
Bacteria
Rickettsia typhi

Rickettsia
rickettsii

Ankyrin-repeat
protein name

Function/localization

TISS
(Kaur et
al. 2012)

RARP-1

RARP-2

Secretion
System

Fragmentation of trans-golgi; inhibits MHC-I presentation
on the host cell (Aistleitner et al. 2020)

TIVSS
(Lehman
et al.
2018)

with R. typhi, to be polycistronically transcribed with TolC, the major component of the TISS.
This polycistronic transcription facilitates the secretion of RARP-1 during early stages of
intracellular infection (Kaur et al. 2012). Despite the evidence of secretion of RARP-1, the
function remains undetermined. Due to the diversity within the Rickettsia genus, some potential
effector proteins are present in one group or species and not in another. In fact, genetically there
are differences in the number and homology of ARPs present in the genomes of different groups
of Rickettsia as well as within the groups between species (Gillespie et al. 2008). With that in
mind, there are RARP-1 homologs present within the SFG of Rickettsia, suggesting a potential
importance of this effector to overall Rickettsia infection. Alternatively, the SFG R. rickettsii also
contains an ARP, RARP-2, that is a TIV secreted effector protein shown to interact with the
endoplasmic recticulum and golgi apparatus recycling pathway to disrupt major
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histocompatibility complex-1 presentation on infected cells. Although RARP-2 was shown to be
important to infection, genetic complementation in a non-pathogenic R. rickettsii strain did not
restore virulence, indicating multiple factors are required to reestablish pathogenesis (Lehman et
al. 2018; Aistleitner et al. 2020). Among those factors could be ARPs, including a RARP-1
homolog, that were shown to be transcriptionally upregulated during in vivo infection with R.
rickettsii, however, these factors have yet to be characterized (Riley, Pruneau, and Martinez
2017).
Unlike Rickettsia, a variety of ARPs have been investigated in various other intracellular
bacteria (Table 1.2). Among these bacteria are some closely related to Rickettsia including
Orientia tsutsugamushi, Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Anaplasma
marginale. As mentioned, ARPs are associated with bacterial secretion systems as effector
proteins. Though, the type of secretion system used varies. Indeed, O. tsutsugamushi and E.
chaffeensis encodes many ARPs that are TISS effectors and O. tsutsugamushi localize to
organelles, such as the endoplasmic recticulum, golgi apparatus, and nucleus (VieBrock et al.
2014; Wakeel et al. 2011; Kaur et al. 2012). Conversely, ARPs investigated within C. burnetii,
A. phagocytophilum, A. marginale, and L. pneumophila have been shown to be secreted through
a TIVSS (Pan et al. 2008; Lin et al. 2007; Voth et al. 2009; Habyarimana et al. 2010). ARP
expression can also be dependent on host cell type. For example, those pathogens, like vectorborne bacteria A. marginale, and protozoan and mammalian dwelling bacteria L. pneumophila,
that have to infect multiple cell types to maintain its population requires specific ARPs
depending on cell type (Ramabu et al. 2011; Price, Al-Khodor, et al. 2010; Al-Khodor et al.
2008; Von Dwingelo et al. 2019).
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Some of these bacterial ARPs also contain functional domains, the more prominent to
date being a F-box domain. The eukaryotic F-box domain is known for mediating ubiquitination
of proteins (Al-Quadan and Kwaik 2011; Price et al. 2009; Min et al. 2014; Beyer et al. 2015;
Evans et al. 2018). In bacterial effectors, such as those found in O. tsutsugamushi and Legionella
pneumophila, effectors proteins with this F-box domain have been associated with hijacking the
host polyubiquitination machinery for manipulation of host processes during intracellular
infection (Al-Quadan and Kwaik 2011; Price et al. 2009; Min et al. 2014; Beyer et al. 2015;
Evans et al. 2018). Aside from the F-box domain, one of the most well-characterized bacterial
ARPs, L. pneumophila AnkX, contains a FIC-domain required for its function as a
phosphocholine transferase that modulates host Rab GTPases for manipulation of the endocytic
recycling pathway and deterrence of phagosome maturation to promote bacterial survival within
the host cell (Mukherjee et al. 2011; Allgood et al. 2017; Campanacci et al. 2013; Ernst et al.
2020).
Though the mechanism and domains required for proper function are not fully
understood, many intracellular bacterial pathogens have been shown to utilize ARPs as host
transcription and translation regulators. This includes the close relatives of Rickettsia, A.
phagocytophilum, E. chaffeensis and O. tsutsugamushi, that utilize unique ARPs to traffic to the
nucleus and modulate the transcriptional host response. Among these transcription regulators is
the O. tsutsugamushi F-box containing ARP that regulates NFkB transcriptional regulation
(Evans et al. 2018), and A. phagocytophilum and E. chaffeensis ARPs that bind directly to
nucleotide elements in the genome to modulate transcription (Zhu et al. 2009; Rennoll-Bankert,
Garcia-Garcia, et al. 2015; Park et al. 2004). As mentioned previously, the same ARP can have
multiple functions, for example L. pneumophila AnkX along with its phosphocholine transferase
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activity, also modulates nuclear proteins as a way of regulating the host immune response on the
transcriptional level (Campanacci et al. 2013; Gavriljuk et al. 2016; Yu et al. 2018). On the
translational level, O. tsutsugamushi Ank1 is involved in regulation of protein synthesis through
its F-box motif for modulation of the immune response (Evans et al. 2018).
To date, only few ARPs have been associated with regulation of host metabolic
processes. These include O. tsutsugamushi Ank4, that is important for nutrient acquisition from
Table 1.2. A list of ankyrin-repeat proteins that have been experimentally shown to provide
functionality and/or are secreted by a bacterial secretion system during intracellular infection
with bacterial human pathogens, excluding Rickettsia.
Bacteria

Ankyrinrepeat protein
name

Function/localization

Secretion
System

Orientia
tsutsugamushi

Ank4

Regulates ER stress for sequestering of host amino acids
necessary for survival (Rodino et al. 2018); Contains an
F-box motifs to modulate host polyubiquitination
machinery (Beyer et al. 2015)

TISS
(VieBrock et
al. 2014)

Ank9

Contains an F-box motif to modulate host
polyubiquitination machinery (Beyer et al. 2015);
regulates Golgi-to-ER trafficking (Beyer et al. 2017)

TISS
(VieBrock et
al. 2014)

Ank6

Translocates to nucleus to inhibit p65 nuclear
accumulation and NFkB transcription regulation (Evans
et al. 2018)

TISS
(VieBrock et
al. 2014)

Ank1

Translocates to nucleus to inhibit p65 nuclear
accumulation and NFkB transcription regulation (Evans
et al. 2018); Contains an F-box motif to modulate host
polyubiquitination machinery (Beyer et al. 2015);
Regulate protein synthesis and ubiquitination for Eflα
downregulation (Min et al. 2014)

TISS
(VieBrock et
al. 2014)

Ank2, Ank5,
Ank8, Ank10,
Ank15, Ank16,
Ank20

Localizes to the ER (VieBrock et al. 2014); Contains an
F-box motif to modulate host polyubiquitination
machinery (Beyer et al. 2015)

TISS
(VieBrock et
al. 2014)

(table cont’d)
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Bacteria

Ankyrinrepeat protein
name

Function/localization

Secretion
System

Orientia
tsutsugamushi

Ank3, Ank11,
Ank18, Ank19

Localizes to the ER (VieBrock et al. 2014)

TISS
(VieBrock et
al. 2014)

Ank4, Ank6,
Ank9, Ank12,
Ank13, Ank14,
Ank17

Contains an F-box motif to modulate host
polyubiquitination machinery (Beyer et al. 2015)

Ehrlichia
chaffeensis

Ank200

Translocates to nucleus (Zhu et al. 2009); targets host
gene promoters with Alu elements to modulate host
pathways (Zhu et al. 2009)

TISS
(Wakeel et
al. 2011)

Anaplasma
phagocytophilum

AnkA

Localize in cytosol and nucleus (Rennoll-Bankert,
Garcia-Garcia, et al. 2015); bind nuclear proteins and
interact with AT-rich regions to modulate host
transcription (Rennoll-Bankert, Garcia-Garcia, et al.
2015; Park et al. 2004)

TIVSS (Lin
et al. 2007)

Anaplasma
marginale

AnkA

Expressed in erythrocytes (Ramabu et al. 2011); localized
to cytosol (Ramabu et al. 2011)

AnkB

Expressed in erythrocytes and tick cells (Ramabu et al.
2011); localized to cytosol (Ramabu et al. 2011)

AnkC

Expressed in tick cells (Ramabu et al. 2011); localized to
cytosol (Ramabu et al. 2011)

Legionella
pneumophila

AnkX

Targets Rab GTPases through phosphocholination via
FIC domain (Allgood et al. 2017; Campanacci et al. 2013;
Gavriljuk et al. 2016; Ernst et al. 2020); prevents fusion
of pathogen-containing vacuole with the host lysosome
(Allgood et al. 2017); targets host nuclear proteins to
modulate host inflammatory response (Yu et al. 2018);
disrupts ER recycling (Allgood et al. 2017)

TIVSS (Pan
et al. 2008)

Legionella
pneumophila

AnkB

F-box domain that is required for recruitment of
polyubiquitinated proteins to Legionella-containing
vacuole (Al-Quadan and Kwaik 2011; Price et al. 2009);
Required for replication in macrophages and protozoa
hosts (Price, Al-Khodor, et al. 2010; Al-Khodor et al.
2008); Eukaryotic prenylation is important for
functionality (Price, Jones, et al. 2010)

TIVSS (AlKhodor et al.
2008)

(table cont’d)
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Bacteria

Ankyrinrepeat
protein name

Function/localization

Secretion
System

Legionella
pneumophila

AnkH

Required for intracellular replication (Habyarimana et
al. 2008); Reprograms host transcription during
macrophage infection (Von Dwingelo et al. 2019)

TIVSS
(Habyarimana
et al. 2010)

AnkJ

Required for intracellular replication (Habyarimana et
al. 2008)

TIVSS
(Habyarimana
et al. 2010)

AnkG

Interferes with apoptosis (Luhrmann et al. 2010);
localizes to host microtubules (Voth et al. 2009)

TIVSS (Voth
et al. 2009)

AnkJ

Localizes to mitochondria (Voth et al. 2009)

TIVSS (Voth
et al. 2009)

AnkN

Localizes to pathogen vacuole membrane (Voth et al.
2009)

TIVSS (Voth
et al. 2009)

AnkO

Localizes to pathogen vacuole membrane (Voth et al.
2009)

TIVSS (Voth
et al. 2009)

Coxiella burnetii

AnkA, AnkB,
AnkF, AnkH,
AnkI, AnkM,
AnkP
Pseudamonas
aeruginosa

AnkB

TIVSS (Voth
et al. 2009)

Important for regulation of oxidative stress and
resistance to hydrogen peroxide (Ochsner et al. 2000;
Howell et al. 2000)

the host cell (Rodino et al. 2018) and Pseudomonas aeruginosa which is involved in regulation
of host oxidative stresses (Howell et al. 2000; Ochsner et al. 2000); however, lack of full
characterization of most bacterial ARPs and the ability of ARPs to serve multiple functions has
not ruled this possibility out. Another point to note, is that all intracellular bacterial ARPs that
are being investigated this far are found within Gram-negative bacteria. Currently, ARPs within
Gram-positive pathogenic bacteria have not yet been elucidated.
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1.3. Macrophage Paradox
The macrophage paradox encompasses the range of intracellular bacterial species that are
able to infect and survive in macrophages despite the anti-microbial properties within this host
cell (Hirayama, Iida, and Nakase 2017). Although macrophages contain multiple anti-bacterial
mechanisms, these cells have characteristics that can be advantageous for intracellular pathogen
infection. Among these beneficial features are the long lifespan of macrophages, the nutrient
dense phagocytic environment with high levels of metabolic plasticity, and the evasion of host
immune system and induced trafficking for dissemination of the pathogen (Price and Vance
2014). Due to the ubiquitous nature of macrophages, even those intracellular pathogens that
prefer other host cell types will likely encounter a macrophage during mammalian infection. The
phagocytic defense/clean-up role macrophages play for the mammalian host allows for
macrophage:pathogen contact either after target cell lysis or another form of cell-death during
active infection, or initially at the site of mammalian infection (Price and Vance 2014; Epelman,
Lavine, and Randolph 2014; Perdiguero and Geissmann 2016). A variety of bacterial
mechanisms for macrophage manipulation by intracellular pathogens have been defined to
combat the anti-microbial responses during infection. Most bacterial survival systems are
multifactorial in that pathogen sustainability within macrophages requires the employment of
multiple mechanisms to produce a favorable niche. Some well-characterized examples include a
combination of: i) utilization of the pathogens secretome for manipulation of specific host
immune processes (Price and Vance 2014); ii) trafficking, deterred maturation, or lysis of the
pathogen containing vacuole (Mitchell, Chen, and Portnoy 2016); iii) shift of the macrophage
response to an anti-inflammatory M2 response (Price and Vance 2014); iv) increased production
of metabolites within the highly plastic and diverse macrophage to produce a favorably nutritious
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intracellular environment (Price and Vance 2014); v) regulation of cell-death for maintenance of
a favorable niche (Price and Vance 2014; Mitchell, Chen, and Portnoy 2016).
Among these paradoxical microbes are those that rely on the shifting of macrophage
polarization to a M2 response during infection. Some intracellular pathogens have developed
mechanisms to promote M2 polarization during infection of macrophages for production of a
favorable niche for exponential growth, survival, and persistence. A major feature of
macrophage polarization is a shift in host cell metabolic processes, including amino acid, carbon,
and nucleotide metabolism (van den Bossche, O’Neill, and Menon 2017). M2 responses counter
the pro-inflammatory M1 subset by reducing glycolysis, and other metabolic pathways involved
in nitric oxide (NO) and reactive oxygen species (ROS) production. This decrease is
compensated by an increase in alternative carbon metabolism energy pathways, such as fatty acid
synthesis (FAS) and fatty acid β-oxidation (FAO), and anti-inflammatory processes important
for IL-4 production and signaling (Table 1.3) (van den Bossche, O’Neill, and Menon 2017).
As mentioned previously, many intracellular bacteria have indicated promoting a M2
response during macrophage infection. M. tuberculosis is one of the most well studied bacteria
during intracellular infection of macrophages. Not only has M. tuberculosis been associated with
manipulating host macrophages to producing anti-inflammatory signals for evasion of the overall
host immune system but has been shown to produce genetic and epigenetic changes within the
infected macrophage to shift the state to an M2 response (Cole et al. 1998b; Genoula et al. 2020;
de Carvalho et al. 2010; Cumming et al. 2018; Kim et al. 2017; Arnett et al. 2018). This M2
activation alters the host metabolism to shift from a glycolytic driven metabolic response to FAO
and lipid mobilization shown to be required for active survival and replication of M. tuberculosis
(Genoula et al. 2020; Chandra et al. 2020). The change to an M2 response is not only beneficial
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Table 1.3. Metabolic phenotypes that define each subset of macrophages. Adapted from (van
den Bossche, O’Neill, and Menon 2017).

Amino acid metabolism
Glycolysis
Oxidative phosphorylation
(OXPHOS)
Pentose Phosphate Pathway
(PPP)

Fatty acid synthesis (FAS)

M1
Arginine is converted to NO and
iNOS. Glutamine metabolism
regulated trained innate immunity.
Strongly induced and supports proinflammatory macrophage
functions in distinct ways.
Impaired by NO and itaconate.
Electrons flow backwards, driving
ROS production, HIF1α
stabilization, and IL-1β expression.
Induced and required for ROS
generation via NADPH oxidase,
NO production, and nucleotide and
protein synthesis.
Citrate accumulation is required for
FAS, supporting inflammatory
signaling and increased NO and
TNF production.

M2
Arginase-1 metabolizes arginine.
Induced and crucial for IL-4
induced macrophage activation.
Induced and supports the phenotype
of IL-4-induced macrophages.
Not required/suppressed by the
sedoheptulose kinase CARKL.

Suggested to fuel FAO.

CPT1a is needed for M2
polarization. CPT2 is not needed.
Needed for NLRP3 inflammasome
Fatty acid oxidation (FAO)
Effects of the CPT1 inhibitor
IL-1β secretion.
etomoxir appear highly context
dependent.
** Hypoxia inducible factor (HIF1α); Carbohydrate kinase-like (CARKL); Reactive oxygen species (ROS); Nitric
oxide (NO); Inducible nitric oxide synthase (iNOS); Carnitine palmitoyl transferase (CPT1a or 2)

for anti-inflammatory purposes but can also provide the pathogen with the metabolic
requirements necessary for bacterial survival and replication in macrophages. Several other
intracellular bacterial pathogens, including Listeria monocytogenes, Salmonella typhimurium,
Chlamydia pneumonia, and Francisella tularensis, have been shown to shift infected
macrophages to a more M2 phenotype characterized by a shift in metabolism. Specifically, M.
tuberculosis, C. pneumonia, and F. tularensis have been associated with manipulation of
upstream FAO and lipid metabolism signals, peroxisome proliferator-activating receptors
(PPAR)ɣ and PPARα, to stimulate a more M2 metabolic phenotype for bacterial sequestering of
energy and lipid metabolites (Mei et al. 2009; Crane et al. 2013; Kim et al. 2017). Alternatively,
other pathogens, such as Brucella abortus, alter PPARɣ function to shift infected macrophages to
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an M2 response for maintenance of glucose abundance for bacterial use and the host cell lifespan
(Xavier et al. 2013).
Little work has been done investigating the macrophage response to rickettsial infection.
However, genomic analysis of R. conorii infected macrophages has revealed a significant
alteration in genes encoding for pro-survival mechanisms, suggesting a likely shift to an antiinflammatory environment (Curto, Riley, et al. 2019). Therefore, more work is required to better
define the pathogen-macrophage relationship and potential role these interactions play in overall
mammalian infection.
1.4. Modulation of Host Lipid Pathways by Pathogenic Intracellular Bacteria
Lipids are broadly described as hydrophobic or amphipathic molecules that are involved
in various biological functions including mediating immune signaling, regulating vesicle
trafficking, providing energy storage and production, and structural membrane composition
(Bell 1986; Benveniste 1974; Berridge and Irvine 1989; Hannun and Bell 1989; Fahy et al. 2005;
Haucke and Di Paolo 2007; Moonlennar et al. 1986; Nishizuka 1986; Simons and Vaz 2004;
Bankaitis et al. 1990). Lipids are a large, diverse group of molecules that provide various specific
functions required by the host cell to maintain homeostasis. These lipids can be divided into
various classes that are highly organized and provide very specialized functions (Fahy et al.
2005). Furthermore, because of the essentiality and multifunctional property of host lipids for
cell maintenance, intracellular pathogens have adapted mechanisms to employ a number of these
lipids throughout infection for both host cell regulation, and pathogen replication and
sustainability (van der Meer-Janssen et al. 2010).
Intracellular pathogens modify host lipid composition by regulating host cell uptake of
exogenous lipids from the environment and modulating the expression of enzymes involved in
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the host de novo lipid biosynthetic pathways (Borthakur et al. 2006; Kapadia and Chisari 2005;
Philips, Rubin, and Perrimon 2005; Su et al. 2002; Agaisse et al. 2005). This alteration in host
lipid composition can be beneficial to the pathogen by providing a number of different functions
including: i) Employing storage and/or free lipids for energy production. Fatty acids within host
lipid storage compartments, known as lipid droplets (LDs), and free fatty acids can be
catabolized by various methods, such as lipolysis, lipophagy, and selective breakdown via
phospholipases. These processes differ in that lipolysis releases lipids through hydrolysis,
lipophagy utilizes host autophagy machinery to breakdown lipids within lipid droplets, and
phospholipases selectively catabolize specific species of lipids some of which are associated with
LDs. The lipids released can then be used in the β-fatty acid oxidation (FAO) pathway, which
enzymatically breaks down fatty acids to acetyl-CoA for use in oxidative phosphorylation
(OXPHOS) for energy production (Singh et al. 2009). Pathogens are also able to release and
sequester metabolites within these catabolic pathways by use of bacterial phospholipases for selfgeneration of energy. The regulation of host lipid metabolism to promote shifts in energy
production pathways has also been implemented in modulating host cell persistence, pathogen
sustainability, and anti-inflammatory mechanisms. ii) Pathogen membrane production. Some
intracellular pathogens have been shown to have unique lipids within their membrane structures
that are unlike common bacterial lipids and that are unable to be made by the pathogen
machinery encoded in the genome. Thus, is it likely that the lipids are acquired from the host and
are incorporated into the pathogen membrane. iii) Invasion of host signaling pathways and the
host immune system. Lipid organization within host membranes play an important role in the
regulation of signaling pathways by creating “hot spots,” known as lipid rafts, for enabling the
association of receptors with external and internal stimuli. These functional, highly organized
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membrane regions are utilized by various intracellular bacterial pathogens for entry into the host
cell (Toledo and Benach 2015). There are also fatty acid molecules released from LDs, such as
arachidonic acids, that are precursors of host immune modulators, such as prostaglandins and
leukotrienes, and have a key role in the presentation of disease during pathogen infection
(Roingeard and Melo 2017; Bozza et al. 2011; Pereira-Dutra et al. 2019).
Human pathogenic intracellular bacteria have developed mechanisms that initiate the
employment of host lipids to cause disease during mammalian infection. Among the functions
that require host lipids are bacterial entry into the host cell, formation of an intracellular
compartment, metabolic requirements for bacterial survival and replication, and disease initiation
and progression. However, because intracellular bacterial pathogens differ in the mechanisms
used to colonize cells, it is likely that host lipid manipulation during infection varies between
different bacterial species (Kumar and Valdivia 2009). Specifically, intracellular bacteria can be
separated into those that persist in a vacuolar compartment inside the host cell and those that
survive and replicate within the host cell cytosol. Together, the differences among the
intracellular bacteria indicate a requirement of host cell lipids that varies among and within
vacuolar and cytosolic groups. This review addresses current knowledge on the alteration and
use of host lipids during human pathogenic intracellular bacterial infection. The research
discussed highlights differences in vacuolar and cytosolic bacteria’s use of host lipids for
pathogen membrane structure, host LD alterations during infection, and lipid utilization for
energy production.
1.4.1. Intracellular Bacteria That Replicate Inside a Vacuole During Infection
As briefly mentioned previously, vacuolar bacterial pathogens are defined as species that
remain within the vacuole formed upon entry into the host cell, though not all vacuoles are
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created equally (Kumar and Valdivia 2009; Case et al. 2016). The pathogen-containing vacuoles
(PCVs) are very specific to each pathogen with differences in the suitable intravacuolar acidity
for pathogen growth. The vacuole markers and composition are indicative of the stages of
vacuole transport pathways that the PCV is derived from or halted in and the presence of
intravacuolar nutrients and associated host cell organelles. Many vacuolar pathogens, including
Coxiella burnetii, Chlamydia spp., Mycobacterium spp., Anaplasma phagocytophilum, Ehrlichia
chaffeensis, Brucella abortus, Legionella pneumophila, and Salmonella spp., have been shown to
manipulate host lipids during intracellular infection for an array of defined and speculated
functions involved in bacterial and vacuolar membrane production, foam cell presentation and
immune modulator production, and energy production.
1.4.1.1. Host Lipids Provide Structural Integrity to Pathogen-Associated Membranes
Bacterial membranes are limited in their composition of lipid species when compared to
their eukaryotic counterparts. The predominant lipids present in standard Gram-negative and
Gram-positive bacterial membranes are cardiolipin, phosphatidylglycerol (PG),
phosphatidylethanolamine (PE), phosphatidic acid (PA), and phosphatidylserine (PS), with
machinery lacking for biosynthesis of cholesterol and, in some intracellular bacteria,
phosphatidylcholine (PC). In general, bacterial membrane lipids are unsaturated and can exhibit
distinct branching patterns among the various bacteria (Sohlenkamp and Deiger 2016; Renner
and DB 2011). Many vacuolar intracellular bacteria recruit and incorporate specific host lipids as
structural components for both the host-derived PCVs and bacterial membrane. Although,
intracellular bacteria do not encode the enzymes necessary for production of cholesterol and
other lipids commonly found within eukaryotic cells, they have adapted mechanisms for
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modification of sequestered host lipids for incorporation into structural membranes during
infection.
Chlamydia spp. are vacuolar pathogens that typically target epithelial cells in areas of
species-specific tropism and can actively replicate in vacuoles within recruited macrophages
during infection (van Ooij, Apodaca, and Engel 1997). A characteristic of the Chlamydia-PCV is
that the membrane contains Golgi apparatus-derived membrane markers indicative of a nonacidic, nutrient-rich vacuole unlikely to interact with the lysosome during late stages of the
endocytic pathway (Carabeo, Mead, and Hackstadt 2003; Hackstadt et al. 1996). Association of
the PCV with the host Golgi apparatus, which acts as a nutrient-rich recycling and trafficking
organelle, also provides nutrients to the bacteria. During human and mouse fibroblast infection,
the Chlamydia-containing vacuole contains cholesterol-rich microdomains that comprise an
abundance of PCV membrane-associated bacterial proteins (Figure 1.2). These bacterial PCV
proteins are important for interacting with the host proteins, such as Src-family kinases, to
modulate vacuole trafficking via the host microtubule network. This trafficking is required to
facilitate the PCV and Golgi-derived endosome fusion for nutrient sharing and genetic exchange
required for the development of disease (Mital et al. 2015; Mital et al. 2010; Richards,
Knowlton, and Grieshaber 2013). In addition to the incorporation of host cholesterol into the
PCV, Chlamydia spp., such as C. trachomatis and C. pneumoniae, also actively recruit host
cholesterol and free fatty acids through initiation of exogenous lipoprotein recruitment and de
novo lipid synthesis for fatty acid overaccumulation within host cells (Carabeo, Mead, and
Hackstadt 2003; Gilk et al. 2013) (Figure 1.2). Interestingly, during C. trachomatis infection of
Hep-2 epithelial cells and mouse and human fibroblasts, host compartments, such as lipid
droplets (LDs) and host peroxisomes, along with free fatty acids, colocalize at the PCV (Kumar,
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Cocchiaro, and Valdivia 2006; Saka et al. 2015). The association of these host cellular
components at the PCV allows for efficient peroxisome-driven lipolysis of associated fatty acids,
specifically PC and lysophosphatidylcholine (lyso-PC), that are unable to be made by C.
trachomatis. It is important to note that although peroxisome-driven lipolysis is a known source
of lipids for the bacteria, lipid droplet-associated lipases are also likely involved in providing the
required lipids for C. pneumoniae growth (Kumar, Cocchiaro, and Valdivia 2006). Thus, these
events allow C. trachomatis to scavenge and modify the catabolized lipids for incorporation in
the bacterial membrane (Kumar, Cocchiaro, and Valdivia 2006; Yao, Cherian, et al. 2015; Yao,
Dodson, et al. 2015; Boncompain et al. 2014) (Figure 1.2). Both host and chlamydial proteins
play crucial roles in the sequestering and modification of host PC for incorporation into the
bacterial membrane. Specifically, the proteins involved in PC modification are the human
proteins, human acyl-CoA:lyso-PC acyltransferase 1, CLA1 lipid transporter, and human
acyl-CoA carrier 6, along with the pathogen protein, chlamydial lyso-PC acyltransferase. The
combination of these proteins ultimately re-acetylates host PC for bacterial use. These bacterial
and host modifications provide PC species with an increased branch number, making these
sequestered lipids similar to typical bacteria-made membrane lipids suitable for the production of
bacterial progeny (Sohlenkamp and Deiger 2016; Soupene et al. 2012; Soupene, Wang, and
Kuypers 2015; Cocchiaro et al. 2008; Cox et al. 2016). C. trachomatis also encodes
phosphatidylserine decarboxylase and acyl-ACP synthase enzymes supporting the notion that
these bacteria have the ability to modify and utilize host lipids during infection (Peters et al.
2012; Soupene and Kuypers 2017). Although C. trachomatis is able to modify host PCs, this
bacteria is also able to produce other phospholipid species utilizing the bacterial type II fatty acid
synthesis (FASII) pathway, which when combined with host lipid modification of scavenged
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Figure 1.2. Mechanisms for acquisition and utilization of host lipids by intracellular pathogens.
Intracellular pathogens that reside within a vacuole utilize host lipids for various processes
during infection. This model depicts the host lipid pathways and methods exploited by various
vacuolar bacterial species to enhance intracellular and, ultimately, mammalian infection. The
approaches employed by these pathogenic bacteria include i) lipid acquisition into pathogenassociated membranes as seen in Ehrlichia, Anaplasma, Chlamydia, and Coxiella (from left to
right); ii) pathogen- and host-stimulated lipid droplet modulation required during Chlamydia,
Coxiella, Mycobacterium, and Salmonella infection (from left to right); iii) immune modulation
and lipid inflammatory mediator production from lipid droplets seen during Chlamydia,
Coxiella, and Mycobacterium infection (from left to right); iv) acquirement of host fatty acid βoxidation (FAO) metabolites for energy production by Mycobacterium and modulation of host
FAO regulators by Chlamydia; v) regulation of bacterial stage transition of Legionella initiated
by host intracellular lipid composition. The legend on the bottom left-hand side of the model
shows a representative image of the structures used in the panels describing each pathogens’
utilization of host lipids. Toll-like receptor 2 (TLR2); NOD-like receptor protein 3 (NLRP3);
peroxisome proliferation activation receptor α (PPARα); peroxisome proliferation activation
receptor ɣ (PPARɣ); adipose triglyceride lipase (ATGL); fatty acid binding protein (FABP4);
patatin-like phospholipase domain containing protein 2 (PNPLA2); transcription factor EB
(TFEB); perilipin 2 (plin2) (Allen and Martinez 2020).
lipids, allows for efficient reproduction during intracellular infection (Yao et al. 2014).
Anaplasma phagocytophilum and Ehrlichia chaffeensis are closely related bacterial
species that halt the phagosome–lysosome fusion step of the endocytic pathway and reside
within a non-acidic, early and late endosome, respectively, during intracellular infection
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(Truchan et al. 2016; Rikihisa 2010). During mammalian infection, A. phagocytophilum
targets neutrophils, and E. chaffeensis predominantly infects monocytes (Rikihisa 2010).
Similar to C. trachomatis, A. phagocytophilum and E. chaffeensis, require cholesterol for
persistence but do not genetically encode for anabolic cholesterol pathways; thus,
cholesterol present within bacterial compartments is captured from the host (Samanta et al.
2017; Lin and Rikihisa 2003a). Similar to C. trachomatis PCVs, A. phagocytophilum PCVs
contain cholesterol-rich domains to enable microtubule trafficking for nutrient-rich
endosome fusion, though the specific protein:protein interactions involved have yet to be
elucidated (Lin et al. 2020). However, unlike Chlamydia spp., A. phagocytophilum infection
of HL-60 promyeloblasts does not require host de novo cholesterol synthesis and, instead,
actively stimulates uptake of lipoproteins by the host cell and recruitment to the PCV
through regulation of the Niemann–Pick disease type C1 (NPC1)-mediated intracellular
cholesterol trafficking (Xiong, Lin, and Rikihisa 2009; Xiong et al. 2019; Xiong and
Rikihisa 2012). The mechanism for sequestering cholesterol from the host cell during E.
chaffeensis infection is not well defined; however, host cholesterol is incorporated into the
bacterial membranes of both A. phagocytophilum and E. chaffeensis (Figure 1.2). Both A.
phagocytophilum and E. chaffeensis lack the lipid-A protective layer and traditional
lipopolysaccharide structures seen in most Gram-negative bacterial outer membranes.
Therefore, it is likely that the addition of host cholesterol within the bacterial cell membrane
is important in providing rigidity and protection that these bacteria otherwise lack during
intracellular infection (Xiong, Lin, and Rikihisa 2009; Lin and Rikihisa 2003b). Recently, E.
chaffeensis was also shown to encode a partial glycerophospholipid pathway indicating a
potential requirement of host glycerophospholipids and intermediates for the production of
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various membrane lipids. This requirement for host membrane intermediates is supported by
the finding that E. chaffeensis replication in monocytic THP-1 cells is diminished when host
de novo fatty acid synthesis and subsequent phospholipid production is inhibited (Lin et al.
2020). The process of sequestering host lipids for E. chaffeensis membrane construction is
thought to be initiated by a type IV secretion system (T4SS) bacterial effector protein(s), as
lipid acquisition is perturbed when bacterial protein synthesis and T4SS secretion is
inhibited (Lin et al. 2020).
Conversely, C. burnetii promotes phagolysosome maturation, during macrophage
infection, to form an acidic parasitophorous vacuole that contains an abundance of host
cholesterol and other sterols in the PCV membrane (Ghigo, Colombo, and Heinzen 2012).
Though C. burnetii infection does not require cholesterol specifically for successful
infection, the regulation of the overall sterol composition within the parasitophorous vacuole
is necessary for the regulation of infection stages and growth of the PCV (Howe and
Heinzen 2006). More recent studies indicate that the sterol composition in this PCV is
important for regulation of the v-ATPase pump required to maintain optimum acidity within
the Coxiella-containing vacuole. Specifically, this study showed a correlation of an increase
in host cholesterol within the PCV membrane and increases in PCV acidity during later
stages of mouse embryonic fibroblast C. burnetii infection (Mulye et al. 2017; Dragan,
Kurten, and Voth 2019) (Figure 1.2). Inhibition of bacterial protein synthesis followed by a
decrease in sterol recruitment suggests that host sterol composition within the PCV is
actively regulated by Coxiella effector proteins, which likely modulate endosomal
trafficking and cholesterol acquisition (Newton, McDonough, and Roy 2013; Samanta et al.
2019). C. burnetii also contains an active sterol reductase, which catalyzes the last step in
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the cholesterol biosynthesis pathway, implying a possible use of host sterol intermediates for
bacterial completion of cholesterol production (Gilk, Beare, and Heinzen 2010). Unlike
other intracellular pathogens such as Chlamydia spp., E. chaffeensis, and A.
phagocytophilum, the use of host cholesterol or lipids for C. burnetii membrane production
is undefined. The presence of complete bacterial fatty acid and phospholipid biosynthesis
pathways within the C. burnetii genome suggests that host phospholipid incorporation may
not be required for replication. Nevertheless, as described for C. trachomatis, host lipid
incorporation in bacterial membranes may be coupled with endogenous bacterial membrane
production pathways for improved intracellular replication (Gilk, Beare, and Heinzen 2010).
Several studies support the requirement of host lipids for the structural integrity of
obligate intracellular pathogens discussed above; however, the requirement of host lipids for
de novo membrane synthesis in facultative intracellular bacterial species is not well defined.
Genetically, facultative intracellular pathogens contain a higher number of complete
biosynthesis pathways overall compared to obligate intracellular bacteria, and the ability to
survive and replicate extracellularly indicates a lower reliance on the host for required
nutrients (Merhej et al. 2009; Casadevall 2008). However, facultative intracellular
Salmonella spp. infect macrophages and reside within undeveloped phagosomes that
contains host cholesterol thought to be acquired during entry, which plays a role in early
vacuolar trafficking (Holden 2002). Similar to Chlamydia, the cholesterol within the
Salmonella-PCV is actively recruited to the membrane and is an important regulator of
host:pathogen protein interactions by providing structured “hot spots,” such as lipid rafts, on
the PCV membrane that facilitate Salmonella protein presentation and association with host
proteins in the cytosol (Catron et al. 2002). This active recruitment is achieved through the
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type III secretion system (T3SS) effector protein, SseJ, which has acyltransferase activity
(MacIntyre and Buckley 1978; Buckley 1982; Nawabi, Catron, and Haldar 2008; RuizAlbert et al. 2002) (Figure 1.2). A mutation in sseJ during mouse infection attenuates
virulence and causes a decrease in PCV production, supporting the requirement and use of
SseJ as an acyltransferase used to modify membrane lipids for incorporation into the PCV
(Ruiz-Albert et al. 2002).
1.4.1.2. Host Lipid-Droplet Modulation
Lipid droplets (LDs) are a host cellular compartments used to store predominantly
neutral, esterified cholesterol and triacylglycerols, surrounded by a phospholipid monolayer
with lipid-associated proteins, which can serve various functions including energy
production and immune response modulation (Libbing et al. 2019; Olzmann and Carvalho
2019). Some pathogens, such as Chlamydia pneumoniae, Chlamydia trachomatis, Coxiella
burnetii, and M. tuberculosis produce foam cells during macrophage infection, characterized
by an overaccumulation of LDs within the host cell (Ley, Miller, and Hedrick 2011). This
lipid accumulation in macrophages and the subsequent alteration of metabolism and immune
signaling correlate with changes in macrophage polarization, which have been shown to be
important during macrophage infection by various intracellular pathogens (Suzuki et al.
2012; Shashkin, Dragulev, and Ley 2005).
Chlamydia pneumoniae and C. trachomatis induce a “foamy” cell phenotype during
macrophage infection by employing a bacterial cholesterol esterification enzyme, CT149, to
form cholesterol esters that are subsequently stored in LDs (Peters et al. 2012). During
macrophage infection, C. pneumoniae also actively downregulates host transcription factors,
peroxisome proliferator-activated receptors (PPAR) α and ɣ. These two proteins are both
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known to be involved in the regulation of LD breakdown and cholesterol efflux, providing a
likely mechanism for the formation of the foam cell phenotype during infection (Mei et al.
2009; He et al. 2009; Cheng et al. 2014a; Barbier et al. 2002). Immune regulation also
occurs through the stimulation of the host inflammasome, NLRP3, and toll-like receptor
(TLR) 2 to subsequently increase LD formation in infected macrophages. However, the
function(s) or consequences of host lipid overaccumulation into LDs during infection by C.
pneumoniae is not yet clearly elucidated (Itoh et al. 2014; Cao et al. 2007). Conversely, C.
trachomatis employs the modulation of fatty acids within host LDs for immune response
regulation by recruiting host triacylglycerol lipases to the LDs associated with the bacterial
PCVs. These host lipases breakdown the stored triacylglycerols within the LDs into immune
signaling intermediates, such as arachidonic acid, to be converted into immune mediators,
such as prostaglandins, for enhancement of tissue damage and overall disease during
mammalian infection (Fukuda et al. 2005; Cocchiaro et al. 2008). Stimulation of lipases for
prostaglandin production can be induced by pathogen infection of a single cell and by host
cell–to–host cell signaling caused by the infection. Therefore, infected and uninfected
bystander cells within a mammalian host are likely involved in overall prostaglandin
production during infection. As described previously, lipids are also scavenged from PCVassociated LDs for bacterial membrane production (Sohlenkamp and Deiger 2016; Soupene
et al. 2012; Soupene, Wang, and Kuypers 2015; Cocchiaro et al. 2008) (Figure 1.2). It is
important to note that although LDs are a major source of lipids for C. trachomatis during
intracellular growth, these host structures are not required during mouse embryonic
fibroblast infection. Interestingly, during inhibition of LD formation in mouse embryonic
fibroblasts, C. trachomatis is able to efficiently grow when free fatty acids are
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supplemented. This suggests that the bacteria are able to recruit free fatty acids and other
host lipids not related to LDs to the PCV as a way of compensating for a lack of lipids
within LDs (Sharma et al. 2018).
Similarly, C. burnetii’s formation of foam cells is actively modulated by bacterial
effector proteins and is dependent on an increase in fatty acid recruitment to the endoplasmic
reticulum for packaging into host LDs (Mulye, Zapata, and Gilk 2018). During C. burnetii
infection of macrophages, the expression of host proteins involved in LD breakdown,
including patatin-like phospholipase domain containing protein 2 (PNPLA2) or adipose
triglyceride lipase (ATGL), acyl-CoA:cholesterol transferase, and fatty acid binding protein
(FABP4), is modulated suggesting a requirement of host lipids within LDs, such as
cholesterol esters and triacylglycerols, during infection (Mulye, Zapata, and Gilk 2018; Ren
et al. 2003; McDonough et al. 2013; Mahapatra, Ayoubi, and Shaw 2010). The regulation of
ATGL and FABP4 indicate a release of free fatty acids and cholesterol from host LDs for C.
burnetii nutrient acquisition and membrane production as described previously (Mulye,
Zapata, and Gilk 2018). C. burnetii also encodes a bacterial phospholipase A enzyme that is
involved in accumulating free fatty acids, possibly for membrane and energy production or
immune regulation during infection (Stead et al. 2018). Similar to C. trachomatis, C.
burnetii infection also utilizes prostaglandins derived from host LD intermediates to
promote intracellular growth and disease presentation (Koster, Williams, and Goodwin
1985; Shannon and Heinzen 2009; Izzo and Marmion 1993) (Figure 1.2). Interestingly, the
inhibition of acyl-CoA anabolism and de novo lipid synthesis involved in production of host
LDs enhances C. burnetii growth during macrophage infection. Conversely,
pharmacological inhibition of LD catabolism is detrimental to C. burnetii infection.
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Together, these results suggest that lipids derived from host LDs and likely exogenousderived lipids are essential for modulation of the host immune response and nutrient
acquisition during C. burnetii macrophage infection (Mulye, Zapata, and Gilk 2018).
Little is known about the mechanisms employed to modulate host LDs during A.
phagocytophilum and E. chaffeensis infection of the respective target cells. During infection
of promyelocytic cells, A. phagocytophilum increases expression of perilipin 1 (PLIN1), the
major host protein important for regulation of LD formation and lipolysis, suggesting a
possible role of host LDs as a source of cholesterol and fatty acids. However, the exact
function of host LDs for A. phagocytophilum infection is still not yet elucidated (ManzanoRoman et al. 2008; Tansey et al. 2004; de la Fuente et al. 2005; Moore et al. 2005; Miyoshi
et al. 2006). Interestingly, E. chaffeensis has not been shown to have an association with
host LDs or LD-related host molecules. Similar to A. phagocytophilum, the requirement of
host cholesterol for successful infection implies a possible use of host LDs for cholesterol
acquisition during infection.
Facultative intracellular pathogens from the genus Mycobacterium provide classic
examples of producing a foam cell phenotype required for persistence during alveolar
macrophage and overall mammalian infection. Many bacterial and host mechanisms are
employed to produce and maintain the foam cell state during mycobacterial infection with
various Mycobacterium spp. For example, M. tuberculosis and M. leprae infection increases
transcription of bacterial genes involved in LD accumulation, plin2 (coding for perilipin 2)
and acyl-CoA synthase, while M. tuberculosis also modulates host transcription factors
PPARα and ɣ, similar to C. pneumoniae (Kim et al. 2010; Kim et al. 2017; Salamon et al.
2014; Daniel, Sirakova, and Kolattukudy 2014; Daniel et al. 2016; Mattos et al. 2010;
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Tanigawa et al. 2008). Unlike C. pneumoniae, M. tuberculosis’s growth during infection is
increased by an upregulation in PPARɣ and subsequent triacylglycerol production and
accumulation of host LDs. M. tuberculosis growth is also downregulated when LD
catabolism is increased by transcription factor EB (TFEB)-initiation and subsequent PPARα
expression. Together, these data suggest an importance of LD overaccumulation during
macrophage infection (Kim et al. 2017; Salamon et al. 2014). Similar to that of C.
pneumoniae and C. burnetii, M. leprae infection also increases prostaglandin production,
which then stimulates other immune modulatory molecules, such as IL-10 and TGFβ
required for bacterial survival and persistence (Mattos et al. 2010; D’Avila et al. 2006).
Interestingly, M. tuberculosis is capable of producing triacylglycerol-rich bacterial LD
storages during the dormancy stage of infection (Daniel, Sirakova, and Kolattukudy 2014;
Daniel et al. 2016; Daniel et al. 2011; Armstrong et al. 2016; Elamin et al. 2011; Peyron et
al. 2008); however, M. tuberculosis still associates with host LDs suggesting utilization of
host storages for nutrient acquisition to increase efficiency and persistence during long-term
mammalian infection (Peyron et al. 2008). M. tuberculosis and M. leprae also encode
phospholipase C and other bacterial lipases used to release free fatty acids from storage
lipids as carbon sources for increased infection efficiency (Cole et al. 1998a; Cruz et al.
2008) (Figure 1.2). Similar to C. trachomatis, M. tuberculosis is also able to survive in the
absence of host LDs suggesting a bacterial mechanism for sequestering free fatty acids from
other host sources (Knight et al. 2018).
Host LD accumulation may also be indicative of the virulence potential of various
Mycobacterium strains. For instance, it is speculated that the formation of LDs is detrimental
to less pathogenic strains of M. tuberculosis during infection likely due to the increased
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availability of signaling precursors able to be released from host LDs to produce a
bactericidal response (Dunn and North 1995). Conversely, infection with the highly
pathogenic M. tuberculosis strain, H37Rv, supports that increased host LD formation is
beneficial for bacterial growth and persistence, in that, the signaling molecules from LDs
assist in producing the anti-inflammatory response required for the production of necrotic
tissue and granuloma formation during severe mammalian infection (Jaisinghani et al.
2018).
Comparably, Brucella abortus, a facultative, intracellular bacteria that resides within
the endoplasmic reticulum-associated vacuoles, increases host PPARɣ expression during
infection. However, as observed for M. tuberculosis, this increase potentially modulates host
triacylglycerol production and subsequent accumulation in LDs (Xavier et al. 2013).
Another facultative intracellular pathogen that is thought to associate with host LDs is
Salmonella typhimurium. Unlike, the pathogens described above, studies have suggested that
the association of S. typhimurium with host LDs is based on the defined functionality of
T3SS effector proteins, such as SseJ and SseL. As mentioned previously, SseJ not only has
acyltransferase activity but also possesses cholesterol esterase activity similar to the C.
trachomatis enzyme used to increase host LD production described above (MacIntyre and
Buckley 1978; Buckley 1982; Nawabi, Catron, and Haldar 2008; Ruiz-Albert et al. 2002).
Infection of host cells with a C. trachomatis sseJ mutant results in a decrease in PCV
production and in a decrease of LD accumulation. Together, these data support the use of
SseJ as a cholesterol esterase for accumulation of stored cholesterol in host LDs during
infection (Nawabi, Catron, and Haldar 2008; Ruiz-Albert et al. 2002). On the other hand,
SseL contains deubiquitnase activity and sseL mutants stimulate an overaccumulation of
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host LDs (Figure 1.2). This strongly suggests that SseL and SseJ play a role in the
maintenance of lipid homeostasis during infection, for direct bacterial use, and likely play
roles in the modulation of the host response as described for other pathogens mentioned
(Arena et al. 2011; Antunes et al. 2011).
1.4.1.3. Fatty Acid β-Oxidation for Energy Production
The ability of bacterial pathogens to generate energy is required for survival and
replication during infection of a mammalian host. There are a well-known and characterized
range of biosynthesis pathways, both host and bacterial, that have the potential to be
employed for energy production. A wide range of bacteria utilize glucose, or a sugar carbon
source derivative, as a quick energy source. Glucose is most efficiently used through
glycolysis followed by cellular respiration or other aerobic processes (Passalacqua,
Charbonneau, and O'Riordan 2016). However, glucose and other sugars are not the only
carbon sources available and utilized for energy production. Lipids as a carbon source
provide more energy per molecule and can be processed through fatty acid β-oxidation
(FAO), a pathway found in both microbes and eukaryotes, to produce acetyl-CoA for use in
cellular respiration (Passalacqua, Charbonneau, and O'Riordan 2016; Lodish et al. 2000).
Generally, extracellular bacteria depend less on host processes and encode for the energy
pathways necessary for efficient survival, growth, and disease progression. In contrast,
intracellular bacteria rely more heavily on nutrients provided by host biosynthesis processes
for efficient infection and growth.
As mentioned previously, facultative intracellular bacteria typically have functional
pathways that allow these organisms to survive and replicate in both extracellular and
intracellular environments, whereas obligate intracellular pathogens rely heavily on host
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metabolites during infection (Merhej et al. 2009; Casadevall 2008). For example, M.
tuberculosis employs multiple mechanisms to sequester host lipids as a carbon source. This
facultative intracellular bacteria encodes phospholipases, such as phospholipase C, to
breakdown host lipids before employment of bacterial mammalian cell entry (Mce) protein
transporter complexes and homologs of flavin adenine dinucleotide (Fad) transporter protein
to import cholesterol and fatty acids into the bacterial cell (Raynaud et al. 2002; Jackson,
Stadthagen, and B. 2007; Nazarova et al. 2017). Cholesterol and fatty acids are the primary
carbon source used for M. tuberculosis’s production of energy, making host lipid production
important for sustainable and efficient infection (Nazarova et al. 2017; Pandey and Sassetti
2008; Takayama, Wang, and Besra 2005; Bloch and Segal 1956). Interestingly, M.
tuberculosis also encodes for 200 distinct enzymes used for lipid metabolism that are
involved in shuttling and processing degraded fatty acids during in vivo infection (Cole et al.
1998a; Lui, Yu, and Russell 2003; Marrero et al. 2010; McKinney et al. 2000). There are
two main pathways utilized by M. tuberculosis for bacterial lipid catabolism, i.e., FAO and
the glyoxylate shunt, with the latter being the dominant pathway. Interestingly, the M.
tuberculosis genome has a large amount of redundancy regarding predicted enzymes within
the FAO pathway to predominantly catabolize lipids into acetyl-CoA, which is then shuttled
to the tricarboxylic acid cycle (TCA) indicating a potential significance of this secondary
pathway during infection (Williams et al. 2011; Graham and Clar-Curtiss 1999) (Figure 1.2).
The utilization of various lipids as an energy source and the redundancy of lipid metabolic
pathways allow M. tuberculosis to have enhanced plasticity and adaptability and to persist
during long-term mammalian infection (de Carvalho et al. 2010). It is important to note that
because of the plasticity of M. tuberculosis metabolism, cholesterol is not required for active
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M. tuberculosis infection. Nevertheless, the use of cholesterol as a major carbon source is
necessary for increased persistence during chronic infections (Sassetti and Rubin 2003).
Although M. tuberculosis is able to self-process exogenous cholesterol and lipids as a carbon
source through bacterial FAO, a recent study indicates a requirement of active host FAO
during infection. Host FAO is important for regulation of antibacterial responses such as
reactive oxygen species production and phagosome acidification. M. tuberculosis, therefore,
is thought to stimulate FAO during infection to promote downregulation of these
bactericidal responses (Chandra et al. 2020).
Interestingly, the obligate intracellular bacteria, Chlamydia spp. lack a large array of
metabolic and lipid biosynthesis pathway thereby relying on the host for pathway
intermediates and scavenged lipid nutrients (Stephens et al. 1998). As described previously,
C. pneumoniae replication requires the host lipid transport protein, FABP4, which regulates
the release of free fatty acids from the host LDs, typically for host FAO and subsequent ATP
production. These data suggest that C. pneumoniae may utilize host lipids as an intracellular
energy source (Walenna et al. 2018) (Figure 1.2). In addition, a facultative intracellular
bacterium, Legionella pneumophila, infects alveolar macrophages and replicates within an
ER-derived PCV and requires host FAO during infection (Sturgill-Koszycki and Swanson
2000; Trigui et al. 2015; Dalebroux, Edwards, and Swanson 2009). The host FAO regulation
has not been shown to be used as a method of energy production for the bacteria but instead
is a mechanism for modulating bacterial growth states during the transition from a
replicative stage upon host cell entry. This shift in bacterial stages is regulated by nutrient
acquisition in the form of ER-derived vacuole fusion with the PCV (Robinson and Roy
2006). Later in the replication stage, modulation of sphingolipid metabolism and autophagy
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initiates auto-phagolysosome fusion with the PCV providing lysosomal characteristics such
as encoded lipolytic enzymes giving potential for breakdown and utilization of other
nutrients such as lipids (Sturgill-Koszycki and Swanson 2000; Choy et al. 2012; Rolando et
al. 2016). Once the PCV is depleted of the nutrients required for active replication, L.
pneumophila shifts to a “transmission phenotype,” characterized by bacterial flagella
activation and a downregulation in bacterial metabolism. During the life stages of
intracellular infection, L. pneumophila monitors depletion of fatty acid levels, including host
malonyl-CoA and intermediates of FAO-derived acyl-chain breakdown, to initiate the
stringent response triggered by ppGpp synthetases and SPoT, which regulates the
phenotypic shifts required during the L. pneumophila lifecycle (Trigui et al. 2015;
Dalebroux, Edwards, and Swanson 2009; Edwards, Dalebroux, and Swanson 2009; Hammer
and Swanson 1999; Dalebroux et al. 2010; Zusman, Gal-Mor, and Segal 2002) (Figure 1.2).
1.4.2. Intracellular Bacteria That Replicate Within the Cytosol
In contrast to the pathogenic bacteria described above, there is a smaller group of
intracellular bacteria that does not actively modulate trafficking of an intracellular vesicular
compartment but rather employs mechanisms to escape a membranous vacuole after entry
into the host cell to survive and reproduce within the host cytosol. To escape the vacuole,
some cytosolic pathogens, including Listeria monocytogenes and various pathogenic
Rickettsia species (spp.), employ bacterial phospholipases and toxins to breakdown the
vacuole membrane for exit into the cytoplasm (Weiner et al. 2016; Mellouk et al. 2014;
Dong et al. 2012; Michel et al. 1990; Bielecki et al. 1990; Cossart et al. 1989; Whitworth et
al. 2005; Driskell et al. 2009; Winkler et al. 1983). Similar to vacuolar pathogens, there is
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large genomic diversity within the group of cytosolic intracellular bacteria comprised of
both facultative and obligate intracellular bacteria (Merhej et al. 2009; Casadevall 2008).
1.4.2.1. Host Lipids Provide Structural Integrity to Bacterial Membranes
The phospholipid and lipid membrane spp. that compose bacterial membranes are
similar for most bacterial species as described previously. A distinct difference when
discussing membranes associated with vacuolar pathogens and cytosolic pathogens is the
presence of a PCV during vacuolar bacterial infection. As discussed previously, various host
lipids are recruited to the PCV membrane to provide a variety of functions for the vacuolar
bacteria. Cytosolic bacteria, however, do not remain within a vacuole; thus, the
incorporation of host lipids into pathogen-associated membranes during replication is
limited to the bacterial membrane. Most studies discussing the incorporation of host lipids
into the cytosolic bacterial membranes focused on elucidating bacterial membrane
compositions and speculated that various lipid classes originated from the infected host cell.
Genomic analysis of various Rickettsia spp. and another related bacterial species,
Orientia tsutsugamushi, indicates gaps within the biosynthetic pathways necessary to
construct the bacterial cell wall and membrane structure. This suggests a requirement of host
lipid metabolites for membrane production during intracellular replication and growth (Chu
et al. 2006; Ray and Cronan Jr. 1976; Amano et al. 1987). A more recent genomic study
denoted multiple lipid anabolic pathways that are missing or incomplete, within various
rickettsial genomes, implying a large reliance on the host to provide the enzymes and
intermediates necessary for full functional lipid biosynthesis pathways. Among the lipid
metabolic pathways lacking or incomplete in the described Rickettsia spp. are pathways
involved in lipopolysaccharide production and fatty acid and PC synthesis, supporting the
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implication that there is a heavy rickettsial reliance on host enzymes and metabolic
intermediates for lipid products required for adequate building of the bacterial membrane
(Driscoll et al. 2017). Interestingly, previous experiments investigating the phospholipid
composition of Rickettsia prowazekii in chicken embryo yolk sacs indicated the presence of
PC and cardiolipins, later found to compose 5.1% and 2.1% of the membrane lipid
composition, respectively (Zezerov, Loginov, and Berezneva 1985) (Figure 1.3). Gramnegative bacterial membranes are predominantly composed of saturated and branched fatty
acid chains, with limited sterol structures (Sohlenkamp and Deiger 2016; Renner and DB
2011). PC is not a normal component of the canonical Gram-negative inner or outer
membrane, suggesting that the PC is likely sequestered from the host (Winkler and Miller
1978). Studies have also shown that Rickettsia rickettsii membranes contain a moderate
amount of unsaturated lipids and that R. prowazekii membranes contain cholesterol, in
further support that membrane components may be actively acquired from the infected host
cell (Zezerov, Loginov, and Berezneva 1985; Tzianabos, Moss, and McDade 1981).
Recently, a proteomic study defining host alterations during Rickettsia conorii infection of
macrophages showed that inhibition of host fatty acid synthase (FASN), an enzyme required
for lipid biosynthesis, is detrimental for bacterial replication and survival. A major role in
the host cell and possible requirement of FASN for R. conorii growth is the production of
phospholipids for membrane production, though the function of host FASN-produced lipids
is not defined (Curto, Santa, et al. 2019) (Figure 1.3).
1.4.2.2. Fatty Acid β-Oxidation for Energy Production
As described for intracellular pathogens that reside inside a vacuole, energy
metabolism is an essential factor involved in the maintenance and sustainability of active
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Figure 1.3. Potential host lipid pathways altered during cytosolic Rickettsia infection. A
representative cytosolic, intracellular bacteria species, Rickettsia conorii, requires host fatty
acid synthase, and therefore, free fatty acids for successful replication. Mammalian infection
with rickettsial pathogens also alters host prostaglandin production to stimulate the
presentation of disease. Metabolically, Rickettsia spp. are not self-sufficient and require the
host for survival; however, the host pathways required for energy production and subsequent
bacterial survival are largely unknown. Evidence suggests that host glycolysis is
downregulated leaving other metabolic pathways, such as fatty acid β-oxidation (FAO), as
likely candidates for carbon source generation required for oxidative phosphorylation and
ATP production. Early studies also suggest the alteration and incorporation of host
phosphatidylcholine into the rickettsial membrane, thus indicating a likely requirement of
host lipid pathways for bacterial membrane structure during infection. Red arrows indicate
speculated host processes and functions of host metabolites during cytosolic infection. Blue
figures and words indicate known alterations that occur during infection. Black arrows
indicate common pathways and functions of host metabolites. The legend on the right-hand
side of the model shows a representative image of the structures use to describe Rickettsia
utilization of host lipids within infected host cells (Allen and Martinez 2020).
infection. Due to the genomic decay and increased reliance on host processes and the
importance of energy for efficient intracellular pathogen infection, much research has been
done to elucidate the host energy pathways required during infection. Although there is an
increased reliance on the host metabolism during intracellular infection, some pathogens still
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contain energy pathways necessary for self-sustainable energy production. One of the major
energy-producing pathways is FAO, which catabolizes lipids, either acquired from
exogenous lipids, de novo lipids, or lipid storages, for acetyl-CoA generation and use in host
or bacterial OXPHOS. It is important to note that when comparing energy metabolism
between vacuolar and cytosolic intracellular pathogens, the nutrients within the cellular
compartments are vastly different. For example, vacuolar bacteria have adapted to utilize a
diverse range of metabolites that are recruited and associated with PCVs during infection. In
contrast, cytosolic bacteria do not employ this strategy and are limited to using available
metabolites within the cytosol for energy production.
A study of host metabolites presents during L. monocytogenes infection of
Drosophila melanogaster, for example, showed an overall downregulation in energy
metabolites, such as triglycerides, glycogen storages, and other intermediates required for
the major energy pathways, FAO and glycolysis. This downregulated shift in metabolism is
speculated to be an antibacterial response to prevent bacterial use of energy stores or to be a
bacterial mechanism employed to block antibacterial responses, such as use of major energy
metabolites for regulation of reactive oxygen species used by the host cell as an antibacterial
mechanism, as seen with M. tuberculosis (Chambers, Song, and Schneider 2012; Chandra et
al. 2020).
Similar to Mycobacterium spp. variation in virulent potential, Rickettsia spp. also
vary in their capacity to cause disease in mammals. A recent study demonstrated that a
recognized human pathogen, R. conorii, is able to invade into and efficiently replicate within
both non-phagocytic and phagocytic mammalian cells. In contrast, Rickettsia montanensis, a
species that is not recognized as pathogenic to mammals, can proliferate in epithelial cells
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but is rapidly killed intracellularly in macrophage-like THP-1 cells. This study suggested
that growth within professional phagocytic cells may be a key determinant to distinguish
pathogenic Rickettsia spp. from non-pathogenic species (Curto et al. 2016). In addition, a
proteomic study revealed the differential host protein changes that occur when macrophagelike THP-1 cells are infected with either R. conorii or R. montanensis. In the R. conorii
infected cells, host glycolysis and other sugar metabolic processes were downregulated
while proteins involved in OXPHOS were upregulated. In contrast, infection with R.
montanensis did not result in these changes. The observed overall increase in OXPHOS and
decrease in glycolysis during R. conorii infection of macrophages, strongly suggested that
non-sugar carbon sources, such as lipids, are likely important for energy production. This
proteomic analysis also indicated a shift in host lipid metabolic pathways and a requirement
of the anabolic FASN, discussed previously, for de novo production of host lipids (Figure
1.3). These metabolic shifts are also not observed during R. montanensis infection of
macrophages. Taken together, these results suggest that the ability to stimulate specific host
metabolic pathways within macrophages and possibly other target cells likely contributes to
the virulence potential of R. conorii and related pathogenic spotted fever group Rickettsia
species (Curto, Santa, et al. 2019). Similar to R. conorii, the closely related cytosolic
bacteria O. tsutsugamushi also shifts the host cell metabolic response to decrease host
glycolysis during in vivo infection of a mouse model, suggesting a likely use of lipids as
carbon sources. However, the O. tsutsugamushi preferred carbon source for energy
production during infection is still unclear (Jung et al. 2015). Although the use of the newly
synthesized lipid species is yet to be defined, it is possible that these fatty acids could be
used as a carbon source for ATP production during rickettsial macrophage infection (Curto,
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Santa, et al. 2019). In support of this hypothesis, a previous study of another human
pathogenic species, Rickettsia typhi, identified a gene, tlc1, present in rickettsial genomes
that encodes active transporter that is sufficient for ATP transport (Audia and Winkler
2006). Similarly, the O. tsutsugamushi genome also contains genes predicted to encode
redundant ATP transport systems and lacks certain enzymes necessary for ATP production
(Min et al. 2008). Together, these data strongly suggest that this class of obligate,
intracellular bacteria acquire host-derived ATP to meet metabolic requirements.
Another pathogen that manipulates the host during infection for regulation of host
energy production is the facultative intracellular bacteria, Francisella tularensis. Similar to
Rickettsia, studies have suggested that F. tularensis initiates utilization and acquisition of
alternative carbon sources, such as glutamate and fatty acids, during infection. These
sequestered metabolites are used for mitochondrial respiration and host ATP production
during early stages of infection. Although the host metabolic profile is known, the exact
mechanism and advantage to the host and/or bacteria has yet to be defined (Jessop et al.
2018).
1.4.2.3. Host Lipid-Droplet Modulation
Unlike some of the vacuolar pathogens, the foam cell phenotype is not defined
among cytosolic pathogens. O. tsutsugamushi stimulates an increase in triacylglycerol-rich
LDs in murine fibroblasts suggesting that these LDs may serve as a nutrient source for
energy production (Ogawa et al. 2014). Conversely, infection of Drosophila melanogaster
with L. monocytogenes, results in a decrease in triacylglycerols and subsequent LD
structures during infection in this model system, suggesting lipids within host LDs are likely
being utilized during infection for functions such as host energy production discussed
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previously (Chambers, Song, and Schneider 2012). In contrast, rickettsial species have not
been associated with the utilization of host LDs for energy production; however, these
bacteria do encode phospholipases within the genome. Phospholipases are enzymes that
have been linked with other bacterial species described previously for generation of LDderived lipid immune regulators. Specifically, the phospholipase A2 enzymes have been
shown to be present and functional in R. typhi and R. prowazekii suggesting the ability to
actively release fatty acids from host LDs for functions yet to be elucidated (Driskell et al.
2009; Winkler et al. 1983; Rahman et al. 2010; Walker, Feng, and Popov 2001; Hurley et al.
2011; Winkler and Miller 1982). Among the R. prowazekii and R. typhi phospholipase
enzymes are RP534 and RT0522, respectively, that are proteins homologous to
Pseudomonas aeruginosa, ExoU, which hydrolyzes fatty acids from LD for the production
of prostaglandins. Some studies have demonstrated that Rickettsia spp. stimulate an increase
in prostaglandin production during in vivo and in vitro infection models indicating that these
mechanisms discussed could be used for the production of lipid immune modulators derived
from host LDs as described for C. pneumoniae, C. burnetii, and M. leprae (Hurley et al.
2011; Walker et al. 1990; Rydkina et al. 2006) (Figure 1.3). Similarly, L. monocytogenes
and Shigella dysenteriae also increase prostaglandin levels during in vivo infection of a
mouse model for immune suppression, suggesting LD release of lipid modulators, however,
the mechanism has yet to be defined (Yuhas et al. 2005; Petit et al. 1985). In addition, F.
tularensis, a facultative intracellular bacteria that resides within the late phagosome prior to
release into the cytosol, modulates host TLR2 signaling and the transcription factor PPARα,
which as described for C. pneumoniae can have implications on LD production during
macrophage infection (Golovliov et al. 2003; Santic, Molmeret, and Abu Kwaik 2007;
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Clemens, Lee, and Horwitz 2004; Crane et al. 2013). Moreover, similar to other cytosolic
bacterial infections, F. tularensis macrophage infection also increases host prostaglandin
production via host phospholipases (Crane et al. 2013; Navratil et al. 2014; Woolard et al.
2007); although, bacterial factors directly involved in prostaglandin release and other LD
functions during F. tularensis infection are still unknown.
1.4.3. Conclusions
Both obligate and facultative intracellular bacteria have developed several strategies
to regulate and manipulate host processes for efficient intracellular growth. Among these is
the modulation of host lipid metabolism that has been demonstrated not only to be required
for the maintenance of host cell homeostasis but also to be implemented in various
intracellular infections for increased persistence and disease progression. The key lipid
pathways employed by intracellular bacterial pathogens for proliferation and sustainable
infection include, but are not limited to, membrane fatty acid biosynthesis, LD regulation,
and lipid catabolism through FAO for energy production. The current knowledge on host
lipid metabolism utilization by various species of intracellular bacteria is fairly limited, in
that, much of the previous research addresses the recruitment and sequestering of lipids to
the PCV for various functions during infection with bacteria that reside within a vacuole. As
demonstrated here, there are large experimental gaps, specifically in facultative and
cytosolic intracellular bacteria, where host lipids have the potential to play specific roles in
infection; however, the functions and mechanisms involved in this use of host lipid
metabolic processes are not well defined compared to some of their vacuolar counterparts.
Therefore, it is necessary to further investigate the importance of host lipids for intracellular
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bacterial infection to better understand the host:pathogen relationship required to provide
potential targets for increases in therapeutics against these human disease causing agents.
1.5. Thesis Scope
Vector-borne diseases have been a major source of outbreaks throughout history.
According to the World Health Organization, greater than 17% of all infectious disease
cases are caused by newly and re-emerging vector-borne disease agents ('Vector-borne
diseases' 2020). Rickettsial disease cases, specifically, have increased within the 21st
century. This rise in cases can be likely attributed to a disease awareness and better
diagnostics, and changes in climate driving broadening and migrating vector populations
(McQuiston and Paddock 2012). Due to the lack of a vaccine and limited therapeutics
against rickettsial diseases, the imminent threat of life-threatening rickettsial infections and
bioterrorism weapons are prominent (Rolain et al. 1998; Raoult et al. 1987a). Therefore,
grasping a better understanding of the mammalian host-pathogen relationship to define key
features of pathogenesis to develop better therapeutics is of the utmost importance.
Traditionally, host endothelial cells are accepted as the primary target cell during
mammalian infection with Rickettsia. Thus, the vast majority of studies defining hostpathogen interactions required for active infection and disease have been conducted in
endothelial cell lines and primary endothelial cells. However, previous reports have
determined that other cell types, including macrophages, are infected by Rickettsia species
as well. In fact, our lab has shown that the ability to infect, survive, and grow within
macrophages correlates with the pathogenicity of rickettsial species (Curto et al. 2016;
Kristof et al. 2021). Therefore, investigating the Rickettsia-host interplay within a variety of
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cells is necessary for understanding all factors required for development of mammalian
infection.
Recently, our lab has conducted a proteome analysis to define host processes that are
changed during pathogenic R. conorii and non-human pathogenic R. montanensis infection
of THP-1 macrophages at a replicative stage of infection (24 hours). Our results show that
when comparing pathogenic infection to its non-pathogenic counterpart, host processes such
as glycolysis and inflammatory processes were downregulated. Other pathways involved in
the M2 macrophage polarization such as lipid metabolism and oxidative phosphorylation
were upregulated. Energy processes, like the tricarboxylic acid cycle, electron transport
chain, and mitochondria transporters, were also upregulated suggesting that alternative
carbon metabolites are involved in continuing energy production during infection. Indeed,
further study indicated that fatty acid synthesis by the enzyme fatty acid synthase is required
for successful macrophage infection with R. conorii. Thus, providing the potential for host
lipid metabolites to be required for the increased energy production pathways seen during R.
conorii infection of macrophages. In contrast, R. montanensis was unable to modulate host
macrophage processes seen during pathogenic infection (Curto, Santa, et al. 2019).
Therefore, we hypothesize that if pathogenic Rickettsia species, such as R. conorii, require
host lipid metabolic processes, then inhibition of these pathways will negatively impact
rickettsial survival and host modulation during infection of macrophages. In the present
studies, a multidirectional approach was taken to address modulation of host lipids during
macrophage infection as well as putative bacterial effectors necessary for alteration of host
responses.
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To further investigate the requirement of lipids during R. conorii macrophage
infection, host LDs were investigated. LDs are a central lipid storage organelle that provides
lipids for various processes to establish homeostasis for the host cell (Olzmann and Carvalho
2019). During intracellular infections, LDs have posed essential for bacterial sequestering of
lipid metabolites as well as for increasing host cell longevity to provide a sustainable niche
for the pathogen (Roingeard and Melo 2017). Herein, LDs were shown to be significantly
modulated early (1hr) in infection. Further investigation suggests that the changes within
LDs are driven by and necessary for the upregulation of FAO seen in the proteomic analysis
and triglyceride lipase-driven lipolysis. Defining the factors required for stimulating these
processes suggest that a bacterial protein is involved.
To further define potential bacterial factors involved in modulating the host
processes described previously, tools were developed to investigate rickettsial ARPs. The
ARPs chosen were deemed to be upregulated during in vivo infection with a similar
rickettsial pathogen, R. rickettsii. The tools required to investigate this including eukaryotic
expression vectors and antibodies specific to each ARP. Providing these tools allow for
advancements in understand host:pathogen interactions and the role these ARPs play in
stimulating host processes that are found herein to be important for rickettsial infections.
The evidence provided within this thesis will shed light on the Rickettsia speciesmacrophage interplay to develop a better understanding of the role infecting non-endothelial
cell types play during overall mammalian infection.
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CHAPTER II. RICKETTSIA CONORII SURVIVAL IN THP-1
MACROPHAGES INVOLVES HOST LIPID DROPLET ALTERATIONS
AND ACTIVE RICKETTSIA PROTEIN PRODUCTION
2.1. Introduction
Rickettsia conorii is a Gram-negative obligate intracellular α-proteobacteria that resides
within the cytosol of mammalian cells. R. conorii is transmitted predominantly in the
Mediterranean basin and Northern Africa by ticks to mammals, with humans being an accidental,
dead-end host (Hackstadt 1996). Infections in humans with pathogenic spotted fever group
(SFG) Rickettsia species can cause fatality in 10-40% of untreated cases, with R. conorii fatality
rates ranging from 3.2% - 32% (Nicholson and Paddock 2017). It is widely accepted that
Rickettsia species can selectively grow in vascular endothelial cells during infections in vivo;
therefore, studies to further define the basis underlying Rickettsia-host cell interactions in vitro
have focused on using primary endothelial cells and endothelial cell lines (Silverman and Bond
1984; Silverman 1984; Walker and Ismail 2008; Walker 1997; Walker et al. 1994; Walker 2007).
However, several studies have demonstrated that R. conorii and other pathogenic SFG Rickettsia
species are more promiscuous in the cell types they infect during in vivo and in vitro models of
rickettsial diseases (Curto et al. 2016; Walker 2007; Riley et al. 2016). Recent studies have
shown that growth by pathogenic SFG Rickettsia species in macrophages is correlated with the
ability of species to cause disease in mammals (Curto, Riley, et al. 2019; Curto, Santa, et al.
2019; Curto et al. 2016; Kristof et al. 2021). Therefore, investigating pathogen-macrophage
interactions is critical to further understand the complex interplay between Rickettsia species and
_____________________________________________________________________________
This chapter was published as “Rickettsia conorii survival in THP-1 macrophages involved host
lipid droplet alterations and active Rickettsia protein production” by PE Allen, RC Noland and
JJ Martinez in Cellular Microbiology, Epub ahead of print, August 31, 2021, Wiley.
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target cells in mammals. To further investigate the consequences of interactions between R.
conorii and macrophages in vitro, a non-biased proteomic analysis of uninfected and R. conoriiinfected THP-1 macrophages was performed to determine global host protein alterations that are
stimulated by R. conorii infection. This study revealed that R. conorii infection leads to an
overall transition of infected macrophages to an anti-inflammatory M2 phenotype (Curto, Santa,
et al. 2019), which is characterized by shifts in host cell energy production and other metabolic
pathways, such as lipid metabolic processes, involved in cell homeostasis (Price and Vance
2014; Curto, Riley, et al. 2019; Curto, Santa, et al. 2019). In addition, host fatty acid synthase
(FASN), an enzyme essential for fatty acid production, is required for R. conorii survival during
THP-1 macrophage infection, thus highlighting a constraint for the production of host lipids for
efficient infection of macrophages (Curto, Santa, et al. 2019). Taken together, these data
reinforce the importance of better elucidating the modulation of host pathways, such as lipid
metabolic processes, that are necessary for shifting macrophage responses to promote survival of
R. conorii.
During mammalian cell infection, Rickettsia species quickly escape a newly formed
phagosome-like vacuole formed upon entry by lysis and reside within the cytosol of the infected
host cell (Hackstadt 1996). Various other intracellular pathogens, predominantly those that reside
within a pathogen containing vacuole, have been shown to interact with and/or alter host lipid
pathways for nutrient acquisition and regulation of cellular responses to survive within the host
cell (reviewed in (Allen and Martinez 2020)). A major host cell components shown to be altered
during intracellular infection with these pathogens are lipid droplets (LDs), which act as cellular
storage compartments composed of triglycerides and other esterified lipids (Libbing et al. 2019;
Olzmann and Carvalho 2018). Dynamic alterations in LD size, number, and composition are
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involved in regulation of multiple host processes including energy production, immune
modulation, membrane integrity, macrophage polarization, and during infection of host cells
(reviewed in (Allen and Martinez 2020)). Additionally, lipid catabolic pathways such as lipasedriven triglyceride lipolysis and fatty acid β-oxidation (FAO) are well-characterized modulators
of LDs that have been associated with infections by various intracellular pathogens (Lodish et al.
2000; Singh et al. 2009; Sathyanarayan, Mashek, and Mashek 2017; Haemmerle et al. 2011;
Fozo and Rucks 2016). A shift in host cell metabolism, including increases in metabolic
pathways such as lipase-drive triglyceride lipolysis and FAO, is a major driver of the M2
phenotype (Price and Vance 2014). In addition, lipid catabolic processes promote host cell
longevity and anti-inflammation characterized by production of sustainable energy from lipids
and other sugar alternative carbon molecules (Lodish et al. 2000; Price and Vance 2014). This
anti-inflammatory metabolic response, including LD modulation and lipid catabolism, is likely
important for development of a hospitable niche for R. conorii during macrophage infection
(Curto, Riley, et al. 2019; Curto, Santa, et al. 2019). However, the mobilization of LDs and
involvement of LD-associated pathways during infections of mammalian cells with R. conorii
and other SFG Rickettsia species has not yet been addressed.
Manipulation of LDs and lipid catabolism for maintenance of host cell homeostasis
during infection is conducted by various regulatory molecules including host peroxisome
proliferator-activated receptors (PPAR) and bacterial mechanisms, such as effector protein
interactions with host pathways like with Salmonella typhimurium SseL, and functional RNAs
interaction at the post-transcriptional step of host processes like with Mycobacterium
tuberculosis miR-33 (Arena et al. 2011; Ouimet et al. 2016). In macrophages, PPARs are part of
a nuclear receptor superfamily that play important roles in transcriptional regulation of proteins
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required for pathways involved in lipid metabolism and macrophage polarization (Zhou et al.
2014; Chawla 2010). Specifically, PPARα is a key player in shifting macrophages to an M2
response by regulating energy metabolism through upregulation of FAO-associated and other
lipid catabolic processes (Chawla 2010). Alternatively, PPARɣ increases uptake and sequesters
gathered lipids into LDs for use upon host cell metabolic shift (Chawla 2010; Hong et al. 2019).
Interestingly, studies investigating the alteration of PPARα and PPARɣ during intracellular
macrophage infection with various pathogens, including Mycobacterium tuberculosis and
Chlamydia pneumoniae, determined that the creation of a metabolically favorable niche for
sustainable infection requires regulation of expression and function of PPARα and PPARɣ (Mei
et al. 2009; Crane et al. 2013; Kim et al. 2017; Cheng et al. 2014a; Reza et al. 2009; Arnett et al.
2018). For M. tuberculosis and C. pneumoniae, modulation of these signaling molecules
promotes development of a foam cell required for bacterial persistence within the infected cell
(Mei et al. 2009; Agarwal et al. 2020; Cheng et al. 2014b; Reza et al. 2009). Salmonella
typhimurium and M. tuberculosis have also been shown to regulate LDs directly during active
bacterial infection suggesting a multitude of mechanisms are potentially involved in modulating
lipid metabolism and the M2 macrophage response observed during R. conorii infection of
macrophages (Arena et al. 2011; Ouimet et al. 2016).
In this study, we demonstrate that LD mobilization is initiated early in R. conorii
infection of phagocytic cells in vitro. Remarkably, stimulation of the early alterations in LDs
requires bacterial de novo protein synthesis suggesting a rickettsial mechanism is involved in
modifying host LD composition. Interestingly, lipid catabolic pathways are required for early
induction of LD modulation and overall bacterial survival, determined by employing specific
pharmacological inhibitors targeting host triglyceride lipases and FAO. Together these data
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suggest that alterations in host LDs regulated by host lipid catabolism are necessary during R.
conorii infection, coinciding with previous studies suggesting a shift to an M2-associated
metabolic response. Intriguingly, regulators of these lipid metabolic pathways, PPARα and
PPARɣ, are expressed at comparable levels to uninfected cells during R. conorii infection of
THP-1 macrophages. In contrast to studies of other intracellular bacteria-host cell interactions
(Mei et al. 2009; Crane et al. 2013; Cheng et al. 2014a; Kim et al. 2017), pharmacological
inhibition of PPARα had no effect on R. conorii survival. Inhibition of PPARɣ activity had a
positive effect on R. conorii growth, while the induction of a foam cell-like phenotype
diminished rickettsial survival. These results give further insight into the significance of host LD
and other lipid processes in establishment of a replicative niche for R. conorii within
macrophages.
2.2. Materials and Methods
2.2.1. Cell lines, Rickettsia growth and purification
THP-1 (ATCC-TIB-202TM) cells were differentiated into macrophage-like cells by
addition of 100nM phorbol 12-myristate 12-acetate (PMA; Sigma-Aldrich) 24 hrs prior to start
of experiment. PMA-treated THP-1 cells (THP-1 macrophages) were infected with R. conorii
Malish7 at a MOI of 2. Cells were grown in RPMI-1640 medium (Gibco) with 10% heatinactivated fetal bovine serum (FBS; R&D Systems). Vero cells (ATCC-CCL-81TM) were used
to propagate R. conorii Malish7 as described previously (Chan et al. 2009; Ammerman, BeierSexton, and Azad 2008). Vero cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) with 10% FBS, 1x non-essential amino acids (Corning), and 0.5 mM sodium
pyruvate (Corning). Cells were maintained in 5% CO2 at 34oC.
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2.2.2. Lipid droplet visualization and Triglyceride Quantification
THP-1 macrophages were seeded at a density of 5x105-1x106 cells/mL on poly-L-lysine
treated in 24 well plates. After 24 hrs, cells were R. conorii infected (MOI of 2) or treated with
pharmacological inhibitor as described below. 24 hrs after treatment, R. conorii Malish7 (MOI of
2) was added to cells and bacterial:host cell contact was induced by centrifugation at 300 xg for
5 min. For chloramphenicol-treatment studies, R. conorii required for infection at an MOI of 2
was incubated, at 34°C and 5% CO2, in RPMI with 10% FBS and 20 ug/mL chloramphenicol
(Heinzen et al. 1993). After 1 hr, chloramphenicol was removed, and THP-1 macrophages were
infected with treated R. conorii as described above. Samples were 4% paraformaldehyde (PFA)fixed at 1-hour post infection (hpi) and 24 hpi for standard infection and 1 hpi for
chloramphenicol or inhibitor treatment studies. Oil Red O isopropanol solution (Electron
Microscopy Sciences) was utilized according to manufacturer’s protocol. Briefly, after 4% PFA
fixation, samples were incubated with 60% isopropanol for 5 min before addition of Oil Red O
mixture (6:4 Oil Red O to H2O) for 20 mins. Washed coverslips were probed as described
previously with anti-R. conorii antibody RcPFA (Chan et al. 2011) followed by Goat α-Rabbit
Alexa Flour-488 (Invitrogen) and DAPI (Thermo Scientific) before being mounted on slides for
visualization with the Olympus Fluoview FV10i confocal microscope (Curto et al. 2016). Ten
fields of view each with 3-15 cells (a total of approximately 100-200 cells) for each treatment
group were gathered for determination of average LD area (µm2) and average LD quantification
within each field using ImageJ software for analysis of particles with a constant threshold. Fields
of view for infected samples contained both uninfected and infected cells with 50-100%
infection and all cells within each field of view were included in the analysis. Experiments were
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repeated three times for a total of 30 fields of view. Colocalization images were analyzed as
described previously (Kristof et al. 2021; Curto et al. 2016).
1x107 THP-1 macrophage cells were seeded in two wells of a six well plate as described
previously. After R. conorii infection (MOI of 2), cells were collected at 1 hpi and 24 hpi and
pelleted at 300 xg for 5 min in 1x PBS. Triglycerides were quantified using the Triglyceride
Quantification kit (Sigma-Aldrich) following manufacturers protocol. Briefly, triglycerides were
released by boiling with 5% NonidetTM P 40 Substitute and pelleted by centrifugation at high
speed for 2 min. Triglyceride was converted to glycerol and fatty acid and quantified by
measurement of fluorescent intensity (lex = 535/lem = 590 nm) using the Molecular Devices
Spectramax M2 microplate reader.
2.2.3. Pharmacological inhibition of host lipid metabolic processes
THP-1 macrophages were seeded in 96 well plates at 5 x 104 cells per 200µl for each
well. Inhibitors were used at concentrations that maintained cell viability and were recommended
by supplier. Inhibitors utilized include Etomoxir (10 µM; Sigma-Aldrich), Orlistat (10 µM;
Sigma-Aldrich), GW6471 (0.5 µM; BioVision), and GW9662 (10 µM; BioVision). DMSO
control cells were treated with equal volumes as inhibitor added. Inhibitors were added 24 hrs
prior to R. conorii infection (MOI of 2) as described above. Samples were harvested at 1 day
post infection (dpi), 3 dpi, and 5 dpi and processed for total gDNA isolation (Invitrogen) (Curto
et al. 2016). After collection and gDNA processing, qPCR was performed with iTaq Universal
Probe Supermix (BioRad) following manufacturers protocol. The PCR reaction was conducted
as follows: 50°C for 2 mins, 95°C for 10 mins, followed by 45 cycles of 95°C for 15 secs, 58°C
for 1 min. R. conorii sca1 normalized to host β-actin was used to quantify the amount of
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Rickettsia per host cell present within each sample. Primers and probes used were described
previously (Riley et al. 2016).
2.2.4 MTT Assay for analysis of THP-1 macrophages viability in the presence of inhibitors
THP-1 macrophages were seeded in 96 well plates at 5 x 104 cells per 200µl for each
well. Varying concentrations of Etomoxir, Orlistat, GW6471, or GW9662 were added. At 6 days
post treatment, the Vybrant MTT Cell Proliferation Assay kit (Invitrogen) was used according to
the manufactures protocol. Briefly, the media was replaced with 100µL of fresh culture media
and 10µL of 12mM MTT stock solution per well before incubation at 34°C. After 2 hrs, 100µL
SDS-HCl solution was added to each well and incubated for 2 hrs. Absorbance was read at
570nm using the Molecular Devices Spectramax M2 microplate reader.
2.2.5. PPARα and PPARɣ mRNA and protein expression
THP-1 macrophages were seeded in 6 well plates at 5x105-1x106 cells/mL with 4mL per
well. Infections were carried out as described above at an MOI of 2. Total RNA was collected
from uninfected control and R. conorii infected THP-1 macrophages at 1 hpi and 24 hpi for
pparα and pparɣ mRNA expression using the PureLink RNA Mini Kit (Invitrogen). Total RNA
from DMSO-, GW6471-, and GW9662-treated cells was collected. Immediately after extraction,
RNA was DNase treated using the TURBO DNA-free kit (Invitrogen) before SYBR-based qRTPCR was performed. Quantitative RT-PCR was performed using qScript One-Step SYBR Green
RT-qPCR (QuantaBio) following the manufactures protocol with the PCR reaction protocol as:
10 mins at 48°C followed by 5 mins at 95°C, then 50 cycles of 10 secs at 95°C, 20 secs at 53°C,
and 30 secs at 68°C, ending with a melt curve analysis from 40°C to 95°C. mRNA expression
was normalized to β-actin for quantification. Primers used for pparα and pparɣ were published
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previously (Mei et al. 2009). The sequences for β-actin primers are forward primer: 5’CCTGTATGCCTCTGGTCGTA-3’ and reverse primer: 5’-CCATCTCCTGCTCGAAGTCT-3’.
Whole cell lysates (WCL) were collected from uninfected control and R. conorii infected
THP-1 macrophages at 1 hpi and 24 hpi. WCLs were quantified and processed as described
previously (Martinez and Cossart 2004). The membranes were blocked with 1X TBST and 2%
BSA before incubation with primary antibodies: anti-PPARα (1:250; Santa Cruz Biotechnology),
anti-PPARɣ (1:250; Santa Cruz Biotechnology) and anti-β-actin (1:1,000; Santa Cruz
Biotechnology). After washing, the membranes were incubated with anti-Mouse horseradish
peroxidase (1:25,000; Sigma-Aldrich). The membranes were visualized using
chemiluminescence horseradish peroxidase substrates for film exposure. Protein detected by
western immunoblot was quantified with ImageJ.
2.2.6. Macrophage lipid loading with oleic acid-albumin
Oleic acid (Enzo Life Sciences) was associated with albumin as previously described
(Brasaemle and Wolins 2016) before addition to THP-1 macrophages. THP-1 macrophages were
seeded in a 24 well plate with coverslips or a 96 well plate at 5 x105-1x106 cells per mL with 1
mL per well or 200 µL per well, respectively. After 24 hrs, oleic acid-albumin or BSA (ThermoScientific) was added to the corresponding cells at a concentration of 400 µM as used previously
to induce a foam cell-like phenotype in THP-1 macrophages (Agarwal et al. 2020). Oleic acidalbumin was incubated with THP-1 cells for 3 hrs before infection with R. conorii at an MOI of
2. Rickettsial survival overtime, and LD visualization and analysis at 1 hpi was conducted as
described above.
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2.2.7. Data analysis and Statistics
Quantitative PCR analysis were analyzed by one-way ANOVA followed by Bonferroni
correction post-hoc and qRT-PCR and western immunoblot results were analyzed by an one-way
Student’s t-test. Significance of average LDs per host cell, average LD area, and triglyceride
quantification was determined by one-way Student’s t-test for comparison of samples in each
time-point independently. Significance for average LDs per host cell and average LD area in the
presence of pharmacological treatments or chloramphenicol were determined by one-way
ANOVA followed by Bonferroni correction post-hoc. MTT assay data was analyzed using the
non-linear regression model. Statistics were performed using GraphPad Prism Version 5.0b.
Significance is defined by p value *≤ 0.05, **≤ 0.05, ***≤0.001.
2.3. Results
2.3.1. Host lipid droplets are altered during R. conorii infection of THP-1 macrophages
LDs are the center of lipid metabolic pathways and are heavily regulated based on
macrophage status (Rosas-Ballina et al. 2020; Wu et al. 2019). To define any changes in host
LDs during R. conorii infection of THP-1 macrophages at early (1 hour post infection; hpi) and
replicative (24 hpi) time points, Oil Red O was used to target the neutral lipids congregated in
LDs. As shown in Figure 1, immunofluorescence microscopy analyses of uninfected and R.
conorii-infected THP-1 macrophages demonstrated that the average number of LDs per host cell
was increased at 1 hpi (Figure 2.1A & C) while the average LD area was significantly decreased
during infection at both 1 hpi (Figure 2.1A & C) and 24 hpi (Figure 2.1B & C). The increase in
LDs that are smaller in size early in the infection may suggest a regulation of fission/fusion of
LDs or an increase in lipids sequestered into LDs while simultaneously being released during
infection. However, the average LD area decreased at 24 hpi without a significant change in LD
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number, indicating that active release of lipids from LDs is occurring at late stages in R. conorii
infection of THP-1 macrophages. To support the observed R. conorii stimulated host LD
dynamics, we quantified triglyceride content in uninfected and R. conorii infected THP-1
macrophages at 1 hpi and 24 hpi. As shown in Figure 2.1D, the triglyceride composition
remained unchanged overall at 1 hpi and was significantly decreased at 24 hpi. These results
indicate an initiation of alterations in LD phenotypic changes early during infection that is
dynamic throughout infection. Interestingly, the intracellular Gram-negative bacteria, Chlamydia
trachomatis has been shown to colocalize with and utilize host lipids from LDs during infection
(Cocchiaro et al. 2008; Kumar, Cocchiaro, and Valdivia 2006). To determine whether R. conorii
employs a similar strategy to gain access to host lipids, immunofluorescence microscopy
analysis on R. conorii-infected THP-1 cells stained with Oil Red O was performed. In contrast to
C. trachomatis, R. conorii does not colocalize with host LDs, suggesting an alternative method
of LD regulation is employed (Figure A.1).
2.3.2. R. conorii protein synthesis is required for initiation of host LD modulation early in
infection
A few bacterial pathogens that reside within a vacuole have demonstrated a requirement
for active bacterial mechanisms to alter LD composition during infection (Arena et al. 2011;
Ouimet et al. 2016). Therefore, we determined whether R. conorii de novo protein synthesis is
involved in initiating the modulation of LDs during THP-1 macrophage infection.
Chloramphenicol is a bacteriostatic antibiotic drug that targets bacterial ribosomes to block de
novo protein synthesis and has been previously shown to block rickettsial protein expression
(Choi et al. 2020; Raoult et al. 1987b; Rolain et al. 1998). To determine if rickettsial de novo
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Figure 2.1. Modulation of host lipid droplets (LDs) during R. conorii THP-1 macrophage
infection. THP-1 macrophages were infected with R. conorii at a multiplicity of infection of 2.
Oil Red O was used for quantification of average LDs per THP-1 cell and average area (µm2) at
1 hour post infection (hpi; A) and 24 hpi (B). Ten fields of view from three independent
experiements with 3-15 cells per field of view were quantified for both uninfected (UN) and R.
conorii (Rc)-infected samples using ImageJ software with a constant threshold for all images.
(C) A single representative image of fields taken at 100X with oil red O (red) signifying LDs, αRickettsia (green) signifying R. conorii, and DAPI (blue) signifying nuclei. White bar is
indicative of 10µm. (D) Triglyceride quantification was performed for three independent
experiments with three experimental replicates of unifected and R. conorii infected samples at 1
hpi and 24 hpi. Significance is represented by p≤0.05 determined by a one-way Student t-test for
each time-point separately. Statistical significance is defined by *p≤0.05, **p≤0.005, or
***p≤0.001.
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protein synthesis is involved in initiating the observed LD phenotype in THP-1 macrophages, R.
conorii was pre-incubated with chloramphenicol or ethanol as a control 1 hr prior to macrophage
infection at a concentration previously utilized for Rickettsia species to inhibit protein synthesis
(Heinzen et al. 1993). As shown in Figure 2.2A & C, inhibition of bacterial protein synthesis
using chloramphenicol prior to R. conorii infection leads to a significant decrease in the average
number of LDs per cell when compared to vehicle treated R. conorii infected cells. In addition,
the R. conorii driven decrease in average LD area is blocked by pre-incubation of rickettsial cells
with chloramphenicol and results in average LD area comparable to uninfected controls (Figure
2.2B & C). Taken together, these results demonstrate that active bacterial infection and de novo
bacterial protein synthesis is required for initiation of LD modulation in infected THP-1
macrophages.
2.3.3. Initiation of early LD modulation seen during R. conorii infection is blocked by
general triglyceride lipase inhibition
Release of lipid from LDs is driven by a multitude of catabolic processes, including
lipases both specific to LDs and trafficked to LDs (Olzmann and Carvalho 2019). The distinct
decrease in average area of LDs during infection suggests that catabolic processes, such as
lipase-driven lipid release, are potentially involved in this process. Orlistat is an FDA-approved
drug that targets the active domain of a multitude of lipases that are specific for hydrolysis of
triglycerides predominantly found within LDs but does not significantly affect the function of
phospholipases. Orlistat has been used previously to define host lipid droplet:intracellular
pathogen interactions (Genoula et al. 2020; Tongluan et al. 2017) and is currently being
investigated for use as an alternative host-directed antiviral treatment (Hitakarun et al. 2020;
Esser et al. 2018; Ammer et al. 2015). Additionally, the concentration of Orlistat used herein was
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Figure 2.2. De novo R. conorii protein synthesis is required for stimulation of LD alterations
seen during THP-1 macrophage infection. R. conorii was pretreated with Chloramphenicol
(Chlora; 20µg/ml) or ethanol (EtOH) prior to THP-1 macrophage infection. Samples were
collected at 1 hour post infection (hpi) before being stained with Oil Red O for quantification.
Ten fields of view from three independent experiments each with 3-15 cells were quantified for
(A) average lipid droplets (LDs) per THP-1 cell and (B) average area (µm2) of all treatment
groups using ImageJ software with a constant threshold. (C) A single representative field was
taken at 100X for each treatment. Oil red O (red) signifies LDs, α-Rickettsia (green) signifies R.
conorii, and DAPI (blue) signifies nuclei. White bar is indicative of 10µm. Significance is
represented by p≤0.05 determined by a one-way ANOVA followed by Bonferroni’s correction
post hoc test. Statistical significance is defined by *p≤0.05, **p≤0.005, ***p≤0.001.
previously shown to have minimal “off-target” effects and allowed THP-1 macrophages to
remain viable (Figure A.2A) (Xiong et al. 2019; Hack, Yanovaki, and Calis 2000). To elucidate
if active release of triglycerides is involved in initiating the LD phenotype defined at the early
stage of infection, Orlistat was added to THP-1 macrophages 24 hrs prior to infection. THP-1
macrophages were infected with R. conorii for 1 hour and processed for immunofluorescence
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microscopy analysis to determine the average LDs per host cell and the average LD area. Similar
to observations seen in Figure 2.1, R. conorii infection of DMSO-treated THP-1 cells led to an
increase in average number of LDs per host cell (Figure 2.3A & C) and a decrease in the average
area of LDs (Figure 2.3B & C). Interestingly, addition of Orlistat to cells prior to R. conorii
infection significantly impacted the early LD changes making the average number of LDs per
cell and average LD area in infected cells comparable to uninfected controls (Figure 2.3A, B, &
C). To define the impact perturbing triglyceride lipases with Orlistat has on R. conorii growth in
THP-1 macrophages, bacterial survival overtime was monitored. As highlighted in Figure 2.3D,
addition of Orlistat prior to R. conorii infection led to a significant decrease in R. conorii survival
in THP-1 macrophages at 3 days post infection (dpi) and 5 dpi, suggesting a requirement for
triglyceride catabolism via lipases during R. conorii infection of macrophages. Taken together,
these results suggest that lipase-driven triglyceride catabolism is required for the significant early
initiation of LD alterations during R. conorii infection and correlates with rickettsial survival in
THP-1 macrophages.
2.3.4. Initiation of early lipid droplet alteration requires active fatty acid β-oxidation
during R. conorii infection of THP-1 macrophages
Although lipase-driven lipolysis of triglycerides is important for initiation of the LD modulation
seen during R. conorii infection of macrophages, there are other lipid catabolic factors that may
also be involved. The recent reports suggesting the promotion of an M2 response during R.
conorii infection supports the use of alternative metabolic pathways, such as those involved in
lipid catabolism during infection (Curto, Riley, et al. 2019; Curto, Santa, et al. 2019). One vital
lipid catabolic pathway that utilizes free fatty acids and stored lipids is FAO (Schlaepfer et al.
2014). A key requirement for FAO is the initial conversion of lipids to acylcarnitine esters by
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Figure 2.3. Pharmacological inhibition of triglyceride targeting lipases prevents the initiation of LD modulation early in R. conorii
THP-1 macrophage infection. THP-1 macrophages were treated with Orlistat (10 µM) 24 hr prior to infection with R. conorii (MOI of
2). Samples for LD analysis were collected at 1 hour post infection (hpi) before being stained with Oil Red O for visualization of LDs.
Ten fields of view from three independent experiements with 3-15 cells per field were quantified to define (A) average lipid droplets
(LDs) per THP-1 cell and (B) average area (µm2) for all groups using ImageJ software with a constant threshold. (C) A representative
visualization at 100X of one cell within each treatment group is shown. Oil red O (red) signifies LDs, α-Rickettsia (green) signifies R.
conorii, and DAPI (blue) signifies nuclei. White bar is indicative of 10µm. (D) Rickettsial survival in the presence of Orlistat or
DMSO was quantified by qPCR to analyze R. conorii (sca1) per host cell (actin) at 1 day post infection (dpi), 3 dpi, and 5 dpi. Data is
representative of three independent experiments with each condition performed in triplicate. Significance is represented by p≤0.05
determined by a one-way ANOVA followed by Bonferroni’s correction post hoc test. Statistical significance is defined by *p≤0.05,
**p≤0.005, ***p≤0.001.
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carnitine palmitoyltransferase 1a (CPTIa) that can then be transported across the mitochondrial
membrane for catabolism (Lodish et al. 2000). To define the role host FAO has on initiation of
LD alterations during infection the CPTIa inhibitor, Etomoxir, was used at a concentration
previously utilized to elucidate the role of FAO during infection with various intracellular
pathogens (Genoula et al. 2020; Chandra et al. 2020; Eisele et al. 2013; Jordan and Randall
2017). In addition, the dose of Etomoxir was used at a concentration that allowed THP-1
macrophages to remain viable (Figure A.2B) and has been shown to exhibit minimal “off-target”
effects in macrophages (Divakaruni et al. 2018). Uninfected and R. conorii-infected THP-1
macrophages treated with Etomoxir (10 µM) were processed to visualize changes in LDs at 1 hpi
(Figure 2.4A, B, & C). As expected, DMSO-treated R. conorii infected THP-1 macrophages
showed a significant increase in average LDs per host cell and decrease in average LD area
compared to uninfected DMSO treated cells at 1 hpi. Interestingly, treatment with Etomoxir
significantly reduced the average number of LDs in R. conorii infected cells comparable to the
DMSO infected control (Figure 2.4A & C) and restored the average area of LDs in R. conorii
infected cells to levels seen in uninfected cells (Figure 2.4B & C). These results suggest that
early in the infection process, CPTIa activation and FAO are involved in initiating the observed
alterations in host LDs. To determine if CPTIa and FAO are also important for bacterial survival
in THP-1 macrophages, host cells were treated with Etomoxir, and rickettsial survival overtime
was analyzed by qPCR. Indeed, pharmacological inhibition of CPTIa with Etomoxir prior to R.
conorii infection results in a significant decrease in rickettsial survival at 3 dpi and 5 dpi
compared to untreated controls (Figure 2.4D), suggesting a requirement for FAO to develop a
sustainable infection in THP-1 macrophages.
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Figure 2.4. Pharmacological inhibition of fatty acid β-oxidation (FAO) prevents lipid droplet modulation early in R. conorii THP-1
macrophage infection. THP-1 macrophages were treated with Etomoxir (10 µM) 24 hr before infection with R. conorii (MOI of 2).
Samples for LD analysis were collected at 1 hour post infection (hpi) before being stained with Oil Red O for visualization of LDs.
Ten fields of view from three independent experiements with 3-15 cells per field were quantified to define (A) average lipid droplets
(LDs) per THP-1 cell and (B) average area (µm2) for all groups using ImageJ software with a constant threshold. (C) A representative
visualization of one cell at 100X within each treatment group. Oil red O (red) signifies LDs, α-Rickettsia (green) signifies R. conorii,
and DAPI (blue) signifies nuclei. White bar is indicative of 10µm. (D) Rickettsial survival in the presence of Etomoxir or DMSO was
quantified by qPCR to analyze R. conorii (sca1) per host cell (actin) at 1 day post infection (dpi), 3 dpi, and 5 dpi. Data is
representative of three independent experiments with each condition performed in triplicate. Significance is represented by p≤0.05
determined by a one-way ANOVA followed by Bonferroni’s correction post hoc test. Statistical significance is defined by *p≤0.05,
**p≤0.005, ***p≤0.001.
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2.3.5. Host PPARα is not required for initial LD changes or sustainable R. conorii infection
of THP-1 macrophages
PPARα is a potent regulator of FAO, LD catabolism, and overall lipid modulation and
has been shown to play an important role in the macrophage shift to an M2 metabolic phenotype
seen during R. conorii infection of macrophages (Chawla 2010). C. pneumoniae and M.
tuberculosis are known modulators of macrophage polarization and specifically LD modulation
which have been linked to regulation of PPARα signaling during infection (Mei et al. 2009; Kim
et al. 2017). To investigate the role PPARα serves for the initiation of LD modulation early in R.
conorii infection, LDs were visualized in the presence of a PPARα inhibitory compound,
GW6471 (0.5 µM). GW6471 has been used previously for defining the requirement of FAO and
regulation of foam cell formation during C. pneumonia infection of macrophages (Mei et al.
2009). Pharmacological inhibition of PPARα with GW6471 (0.5 µM) was performed at a
concentration previously shown to inhibit PPARα activity (Yu et al. 2012; Xu et al. 2002) and at
a concentration that allowed THP-1 macrophages to remain viable (Figure A.2C). Interestingly,
treatment with GW6471 had no effect on host LD alterations that are stimulated early in
infection (Figure 2.5 A, B, & C), suggesting that PPARα-signaling is not required for early LD
modulation during R. conorii infection of THP-1 macrophages.
Other intracellular bacteria that require PPARα signaling have been shown to actively
modulate PPARα expression during infection (Mei et al. 2009; Crane et al. 2013; Cheng et al.
2014b; Kim et al. 2017). To determine if PPARα expression is altered during R. conorii infection
of THP-1 macrophages, alterations in pparα mRNA and PPARα protein expression at the initial
stage of infection were determined. As shown in Figure 2.5D & E, R. conorii infection does not
stimulate significant changes in pparα mRNA levels and PPARα protein expression at 1 hpi.
Similarly, PPARα protein expression remained significantly unaltered at the replicative stage of
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Figure 2.5. PPARα is not required for R. conorii infection of macrophages. Samples for LD
analysis were collected at 1 hour post infection (hpi) before being stained with Oil Red O for
visualization of LDs. Ten fields of view from three independent experiements with 3-15 cells per
field were quantified to define (A) average lipid droplets (LDs) per THP-1 cell and (B) average
area (µm2) for all groups using ImageJ software with a constant threshold. (C) A representative
visualization of one cell at 100X within each treatment group. Oil red O (red) signifies LDs, αRickettsia (green) signifies R. conorii, and DAPI (blue) signifies nuclei. White bar is indicative
of 10µm.
(fig. cont’d)
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Figure 2.5. (D) qRT-PCR analysis with total RNA from R. conorii infected (MOI of 2) THP-1
macrophages was employed to determine mRNA expression of pparα at 1 hpi. (E)
Immunoblotting was conducted with whole cell lysates for protein expression of PPARα at 1 hpi
in uninfected or R. conorii infected (MOI of 2) THP-1 macrophages. (F) DMSO or GW6471
qPCR analysis with gDNA from pre-treated THP-1 macrophages infected with R. conorii (MOI
= 2) in the presence of DMSO or GW6471 for inhibition of PPARα at 1 days post infection (dpi),
3 dpi and 5 dpi. All data is representative of three independent experiments with each condition
performed in triplicate. Significance is represented by p≤0.05 determined by a one-way ANOVA
followed by Bonferroni’s correction post hoc test. Statistical significance is defined by *p≤0.05,
**p≤0.005, *** p≤0.001.
infection (24 hpi) (Figure A.3A). Although mRNA and protein expression levels were unaltered,
PPARα activation and function could be modified during infection. To determine if functional
PPARα plays a role in R. conorii infection of THP-1 macrophages, GW6471 was utilized to
inhibit activation of PPARα. Interestingly inhibition of PPARα did not significantly affect R.
conorii survival compared to the vehicle control (Figure 2.5F) further indicating the absence of a
PPARα-signaling requirement during R. conorii infection.
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2.3.6. Pharmacological inhibition of host PPARɣ has a positive correlation with R. conorii
during THP-1 macrophage infection due to the inhibition of development of a foam celllike cellular response
PPARɣ is a potent regulator of lipid sequestering and accumulation into LDs and in
macrophages is associated with regulation of polarization (Chawla 2010). M. tuberculosis and C.
pneumoniae are heavily associated with the development of a foam cell phenotype characterized
by an increase in lipid scavenging and accumulation of lipids within LDs. The development of
this phenotype during infection requires PPARɣ expression and is important for bacterial
sustainability within the host cell (Leopold Wager, Arnett, and Schlesinger 2019; Arnett et al.
2018; Mei et al. 2009). To investigate the putative role PPARɣ serves for the initiation of LD
modulation early in R. conorii infection, LDs were visualized in the presence of a PPARɣ
inhibitory compound, GW9662 (10 µM). This concentration was chosen because it allowed
THP-1 macrophages to remain viable (Figure A.2D) and has been shown previously to inhibit
activation of PPARɣ in macrophages, including in studies with intracellular pathogens such as C.
pneumoniae and Brucella abortus (Zizzo and Cohen 2015; Mei et al. 2009; Xavier et al. 2013;
Han and Sidell 2002). Intriguingly, treatment with GW9662 had no effect on host LD
modulation initiated early in infection (Figure 2.6A, B, & C). Collectively, these results suggest
that PPAR signaling is likely not involved in R. conorii induced LD alterations on THP-1
macrophages.
To determine if PPARɣ expression is modulated during R. conorii infection of THP-1
macrophages, alterations in pparɣ mRNA and PPARɣ protein expression at early and replicative
stages of infection were analyzed. As shown in Figure 2.6D & E, R. conorii infection does not
stimulate differences in mRNA and protein expression levels at 1 hpi. Interestingly, PPARɣ
protein levels at 24 hpi also showed no significant changes (Figure A.3B). Inhibition of PPARɣ

76

Figure 2.6. Inhibition of PPARɣ is positively correlated with increased R. conorii infection of
macrophages. Samples for LD analysis were collected at 1 hour post infection (hpi) before being
stained with Oil Red O for visualization of LDs. Ten fields of view from three independent
experiements with 3-15 cells per field were quantified to define (A) average lipid droplets (LDs)
per THP-1 cell and (B) average area (µm2) for all groups using ImageJ software with a constant
threshold. (C) A representative visualization of one cell at 100X within each treatment group. Oil
red O (red) signifies LDs, α-Rickettsia (green) signifies R. conorii, and DAPI (blue) signifies
nuclei. White bar is indicative of 10µm.
(fig. cont’d)
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Figure 2.6. (D) qRT-PCR analysis with total RNA from R. conorii infected (MOI of 2) THP-1
macrophages to determine mRNA expression of pparɣ at 1 hour post infection (hpi). (E)
Immunoblotting with whole cell lysates for protein expression of PPARɣ at 1 hpi in uninfected
or R. conorii infected (MOI of 2) THP-1 macrophages. (F) qPCR analysis with gDNA from pretreated THP-1 macrophages infected with R. conorii (MOI of 2) in the presence of DMSO and
GW9662 for inhibition of PPARɣ at 1 days post infection (dpi) and 3 dpi. All data is
representative of three independent experiments with each condition performed in triplicate.
Significance is represented by p≤0.05 determined by a one-way ANOVA followed by
Bonferroni’s correction post hoc test. Statistical significance is defined by *p≤0.05, **p≤0.005,
*** p≤0.001.
significantly increased R. conorii growth at 3 dpi (Figure 2.6F), demonstrating that intracellular
survival in THP-1 macrophages is positively impacted by PPARɣ inhibition. At 5 dpi, we
observed a significant decrease in cell viability likely caused by continued R. conorii
proliferation (data not shown). Together, these results highlight the potential negative impact of
PPARɣ and subsequent accumulation of lipids and LDs within infected THP-1 macrophages
during R. conorii infection.
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To further describe the negative effects a PPARɣ signaling for lipid accumulation may
have during R. conorii infection of THP-1 macrophages, a foam cell-like phenotype was induced
by addition of oleic acid-albumin. The development and contribution of foam cell development
to pathogen intracellular survival has been well characterized for pathogens such as M.
tuberculosis and C. pneumoniae (Mei et al. 2009; Genoula et al. 2020; Cheng et al. 2014b; Reza
et al. 2009). Similarly, oleic acid-albumin was used at a concentration of 400µM as done
previously during M. tuberculosis infection (Agarwal et al. 2020). To confirm a significant
increase in LDs present during foam cell induction and to define the LD modulation initiated
during infection in foam-like cells, LD visualization and quantification was conducted as done
previously. The BSA controls showed similar results as those seen in previous experiments, with
a decrease in size of LDs and an increase in the number of LDs present during R. conorii
infection of macrophages (Figure 2.7A, B, & C). In contrast, THP-1 macrophages treated with
oleic acid-albumin resulted in a significant increase in LD size in uninfected and infected
samples, when compared to BSA controls, with little difference between uninfected and infected
oleic acid-albumin treated cells (Figure 2.7B & C). Interestingly, the number of LDs per host cell
in foam-like cells for uninfected and infected samples was comparable to that of the uninfected
control (Figure 2.7A & C). To determine if infection of oleic acid-albumin treated cells is
inhibitory for R. conorii infection of macrophages as predicted, R. conorii survival in THP-1
macrophages that present with a foam cell-like phenotype was determined. R. conorii survival
was significantly impaired in oleic acid-albumin treated cells after both 3 dpi and 5 dpi. Thus,
suggesting that the induction of a foam-like cell phenotype, correlated with a significant increase
in LD size, blocks R. conorii-induced early LD modulation and overall survivability in THP-1
macrophages.
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Figure 2.7. Formation of a foam cell-like phenotype in THP-1 macrophages results in a decrease
in R. conorii survival. THP-1 macrophages were treated with oleic acid-albumin (400 µM) 3 hr
before infection with R. conorii (MOI of 2). Samples for LD analysis were collected at 1 hour
post infection (hpi) before being stained with Oil Red O for visualization of LDs. Ten fields of
view from three independent experiements with 3-15 cells per field were quantified to define (A)
average lipid droplets (LDs) per THP-1 cell and (B) average area (µm2) for all groups using
ImageJ software with a constant threshold. (C) A representative visualization of one cell at 100X
within each treatment group. Oil red O (red) signifies LDs, α-Rickettsia (green) signifies R.
conorii, and DAPI (blue) signifies nuclei. White bar is indicative of 10µm.
(fig. cont’d)
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Figure 2.7. (D) Rickettsial survival in the presence of oleic acid-albumin or BSA was quantified
by qPCR to analyze R. conorii (sca1) per host cell (actin) at 1 day post infection (dpi), 3 dpi, and
5 dpi. Data is representative of three independent experiments with each condition performed in
triplicate. Significance is represented by p≤0.05 determined by a one-way ANOVA followed by
Bonferroni’s correction post hoc test. Statistical significance is defined by *p≤0.05, **p≤0.005,
***p≤0.001.
2.4. Discussion
Intracellular pathogens rely heavily on host cells to develop a niche required for efficient
infection and pathogen growth. Several studies have shed light on host processes important for
development of a niche for various vacuolar intracellular bacteria, while neglecting bacteria that
live and replicate within the nutrient-poor host cytosol. In macrophages, lipid metabolism has
more recently become a known key regulator of host cell homeostasis and polarization, which
has been associated with establishment of sustainable intracellular bacterial infections. As
previously mentioned, the intracellular bacteria that have defined alterations in host lipid
metabolic pathways are predominantly those that reside within a PCV upon infection of the host
cell. For example, modulation of various host lipid pathways has been shown to be involved in
providing nutrients and regulating host cell signaling to develop a replicative niche, and as
structural integrity for pathogens such as Mycobacterium tuberculosis, Chlamydia spp., dengue
virus and hepatitis C virus (Heaton et al. 2010; Heaton and Randall 2010; Yang et al. 2008;
Miyanari et al. 2007; Zhang et al. 2016; Allen and Martinez 2020). During macrophage

81

infection, pathogens, such as M. tuberculosis and C. pneumoniae, also manipulate host lipid
processes to initiate polarization of macrophages that is ideal for production of a favorable
bacterial niche (Cao et al. 2007; Buchacher et al. 2015; Toledo and Benach 2015). However, R.
conorii and other rickettsial species are cytosolic intracellular bacteria that lack the accessibility
of associating with host lipids within a pathogen containing vacuole. The requirement of lipid
synthesis for R. conorii macrophage infection by FASN suggests a need of lipids for a specific
function important for bacterial survival (Curto, Santa, et al. 2019); however, the role of host
lipid metabolism during intracellular infection by Rickettsia species remains unclear. The current
study focuses on further defining the importance of host LDs during R. conorii infection of THP1 macrophages by elucidating the initiation of LD structural alterations and lipid pathways
important for inducing these changes.
There are multiple fates that synthesized lipids during infection can meet including being
sequestered into lipid stores and catabolism by lipase-driven lipolysis or FAO. R. conorii
infection drives a dynamic shift in host LD phenotype early in infection with changes in both
size and number per host cell. However, these alterations are different at replicative stages of
infection, implying a temporal dynamic modulation of host LDs and lipid pathways throughout
the course of infection (Figure 2.8A). LDs are also a major source of lipids used for energy
production, structural integrity, and immune signaling (Olzmann and Carvalho 2019). Indeed,
pathogens have evolved mechanisms to sequester lipids from host LDs through lipid catabolic
pathways as a mechanism of providing substrates for modulation of signaling, structural lipids,
and energy (reviewed in (Allen and Martinez 2020)). Early studies with Rickettsia species
indicated the presence of membrane phospholipids, including phosphatidylcholine (PC), within
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the bacterial membrane. Genomic analyses revealed that Rickettsia species lack the machinery to
effectively produce certain membrane lipids including PC, suggesting a need to acquire these

Figure 2.8. Model of host lipid droplet modulation following R. conorii infection of THP-1
macrophages. (A) Lipid droplet (LD) number and size is dynamic during R. conorii infection,
depicted by an increase in average LD production early in infection with a decrease in average
LD area throughout infection. Purple circles represent host cells membrane containing nucleus
(blue) and R. conorii (green). (B) Host LD (red cluster of circles) alterations are shown to be
initated in the early stages of R. conorii infection of THP-1 macrophages. During early stages of
infection pharmacological inhibition of lipid catabolic pathways with Orlistat, which targets
triglyceride lipases, and Etomoxir, which targets the beginning steps of fatty acid oxiation (FAO)
by inhibiting carnitine-palmytol transferase (CPTIa), perturbs the significant LD alterations R.
conorii infection induces at 1 hpi (red symbols). This suggests that active FAO and triglyceride
lipases are involved in stimulating the LD modulation seen at early stages (dark green arrows).
Additionally, fatty acid synthase (FASN) is required for R. conroii infection of THP-1
macrophages (Curto, Santa, et al. 2019) and contributes to the production of free fatty acid and in
normal states produces lipids for storage in LDs (red cluster of circles); however, the
contribution of these free fatty acids to LDs or other pathways during infection remains
undetermined. Interestingly, a R. conorii (light green ovals) protein expressed early in infection
is necessary for initiation of host LD modulation (dark green arrows).
from host sources (Winkler and Miller 1978; Zezerov, Loginov, and Berezneva 1985; Driscoll et
al. 2017). Rickettsia species have also been shown to stimulate prostaglandin production during
infection indicating bacterial immune regulation through lipid metabolites (Rydkina et al. 2006).
These early studies defining lipid processes modulated during infection coincides with the
dynamic nature of LD alterations, including the likely release of lipids from LDs that may
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contribute to these phenotypes. Intriguingly, at early stages of R. conorii infection of THP-1
macrophages, there is an increase in average LD per host cell with a decrease in the average size
of the LDs. This phenotype could be due in part by an infection-induced stimulation of both
anabolic and catabolic lipid processes as seen in infections of host cells by other intracellular
pathogens, including M. tuberculosis, C. pneumoniae, and dengue virus (Heaton et al. 2010;
Daniel et al. 2011; Barisch and Soldati 2017; Walenna et al. 2018; Jordan and Randall 2017;
Heaton and Randall 2010; Genoula et al. 2020; Chandra et al. 2020). Similarly, Coxiella burnetii
infection induced an increase in LDs compared to uninfected controls, while requiring lipid
catabolism to regulate LD homeostasis necessary for efficient infection (Mulye, Zapata, and Gilk
2018). Additionally, this phenotype could also be produced through the stimulation of fission of
larger LDs into smaller LDs. Modulation of total lipid content and LD fission has been linked to
cell cycle progression with lack of LD catabolism negatively correlating with yeast cell growth
(Long et al. 2012; Kwok and Wong 2005). However, the mechanisms stimulating LD
fission/fusion dynamics in animal cells, and specifically macrophages, remains relatively
undefined.
Interestingly, R. conorii de novo protein synthesis in required for initiation of host LD
mobilization during infection, suggesting that a bacterial factor(s) is involved in modulating
these host lipid shifts important for development of a favorable replicative niche. Although the
host metabolic changes required for sustainable intracellular infections are being investigated,
the bacterial mechanisms involved in stimulating these responses have not yet been elucidated.
To date, very few intracellular bacteria have defined mechanisms that directly regulate host LDs,
and those that do are restricted to growth within a pathogen containing vacuole. For example, C.
trachomatis uses pathogen containing vacuole-associated bacterial proteins as a mechanism for
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recruitment of LDs and release of lipids from LDs during intracellular infection (Cocchiaro et al.
2008; Soupene, Wang, and Kuypers 2015). S. typhimurium also expresses a secreted effector
protein, SseL, that has been associated with direct regulation of host LD modulation to maintain
a viable niche for the bacteria (Arena et al. 2011). Unfortunately, BLAST analysis shows no
SseL homologues in the R. conorii genome. In terms of rickettsial infections, the secretome
components necessary for development of a desirable niche within the host cell are not well
elucidated (Gillespie et al. 2015). Rickettsia species including R. conorii encode for
phospholipases and putative effector proteins, which have a potential role in modulating host LD
responses to infection (Driskell et al. 2009; Rahman et al. 2010; Renesto et al. ; Walker, Feng,
and Popov 2001; Gillespie et al. 2015). Therefore, further work must be conducted to better
characterize the active bacterial mechanism required for modulation of host LDs and other
metabolic processes during infection.
M. tuberculosis has been shown to manipulate host lipid catabolic pathways and drive the
development of a foam cell phenotype required for bacterial sustainability (Genoula et al. 2020).
For M. tuberculosis, the formation of foam cells is necessary for development of chronic
infection, and when lipase-driven LD catabolism is inhibited with Orlistat, there is no effect on
bacterial growth (Jaisinghani et al. 2018). However, R. conorii infection does not result in the
formation of foam cells in macrophages. In addition, the pharmacological inhibition of lipasedriven triglyceride catabolism with Orlistat during R. conorii infection results in a significant
decrease in rickettsial survival and early LD modulation during infection (Figure 2.7B). Similar
to M. tuberculosis, R. conorii infection of THP-1 macrophages shifts the host cell towards a M2
macrophage phenotype (Mege, Mehraj, and Capo 2011; Curto, Santa, et al. 2019). This shift is
typically characterized by a decrease in the glycolytic pathways, suggesting that alternative
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molecules, such as lipids, are required to compensate (Curto, Santa, et al. 2019). The use of
lipids as an alternative carbon source relies on the upregulation of lipid catabolic processes such
as triglyceride specific lipase-driven lipolysis and FAO (Lodish et al. 2000). We demonstrated
that pharmacological inhibition of the host FAO initiation enzyme, CPTIa, causes a significant
decrease in rickettsial survival during THP-1 macrophage infection. Comparably, inhibition of
FAO by Etomoxir also reduced M. tuberculosis load during replicative stages in macrophages,
demonstrating the importance of FAO in establishing M2 macrophage polarization and
subsequent sustainable infection (Chandra et al. 2020). Separately, host FAO and LD modulation
have been associated with various intracellular infections predominantly for energy production
and regulation of the immune response (reviewed in (Allen and Martinez 2020)). However, LD
regulation as a source of lipids for FAO during the growth of intracellular non-vacuolar bacterial
pathogens has been largely unstudied. This study demonstrates that at early stages of infection,
inhibition of CPTIa activation leads to a dysfunction in initiation of LD modulation. Together
these data suggest a requirement of the lipid catabolic processes, triglyceride lipase driven
lipolysis and FAO, for initiation of LD alterations early in infection and bacterial survival in
THP-1 macrophages. (Figure 2.8B).
PPARs are key transcriptional modulators of host homeostasis by regulation of lipid
metabolism pathways (Hong et al. 2019). Previous studies have also identified PPARα and
PPARɣ as active regulators of the host immune response making these molecules viable targets
for therapeutic intervention (Crane et al. 2013; Leopold Wager, Arnett, and Schlesinger 2019).
Overall, PPARα upregulates lipid catabolism, predominantly through FAO, to maintain cell
homeostasis, and PPARɣ is traditionally associated with increases in lipid uptake and LD
formation (Hong et al. 2019). In macrophages, these transcription factors are drivers of cellular
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metabolism, typically shifting the response to a more M2 macrophage phenotype, like that seen
during R. conorii infection of macrophages (Chawla 2010; Curto, Santa, et al. 2019). Many other
intracellular pathogens, including M. tuberculosis and C. pneumoniae, regulate PPARα and
PPARɣ to mediate host metabolic processes required for establishment a hospitable niche (Mei
et al. 2009; Xavier et al. 2013; Arnett et al. 2018). However, the mechanisms for regulation of
PPARs throughout infection are largely not understood. Unlike M. tuberculosis and C.
pneumoniae, R. conorii infection of THP-1 macrophages does not require PPARα for the lipid
metabolic shifts necessary for bacterial survival. As mentioned previously, bacterial protein
synthesis is required for initiation of the LD phenotype seen early during infection. There is the
potential that instead of hijacking host PPARα to stimulate LD alterations, a R. conorii de novo
protein, like SseL in S. typhimurium, bypasses this host signaling pathway to stimulate the
desired response (Arena et al. 2011).
Surprisingly, PPARɣ inhibition significantly enhances R. conorii growth in THP-1
macrophages. A previous report indicated that inhibition of PPARɣ by GW9662 induces an antiinflammatory environment in macrophages, similar to that seen to be induced during R. conorii
infection (Zizzo and Cohen 2015; Curto, Riley, et al. 2019; Curto, Santa, et al. 2019). This would
suggest that prior treatment of macrophages with GW9662 likely provides a more favorable
niche upon infection with R. conorii that would allow for efficient bacterial growth. PPARɣ is
also heavily involved in increasing lipids sequestered into LDs to maintain cellular homeostasis
and is required for the foam cell formation observed during infections with M. tuberculosis and
Chlamydia pneumoniae (Mei et al. 2009; Leopold Wager, Arnett, and Schlesinger 2019). Our
results during PPARɣ inhibition suggest that the sequestering of lipids into LDs has a negative
impact on rickettsial growth and survival in macrophages. Incubation of mammalian cells with
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GW9662 at relevant concentrations to inhibit PPARɣ have also been shown to reduce lipids
sequestered within LDs in macrophage models, including THP-1 macrophages, strengthening
this notion (Yang et al. 2020; Souza-Moreira et al. 2019). In addition, we determine that the
stimulation of a foam cell-like phenotype before R. conorii infection negatively impact on
bacterial survival and early LD alterations in THP-1 macrophages and correlates with a decrease
in R. conorii survival within these cells. Additionally, previous reports define an importance of
LDs and subsequent lipid release during C. trachomatis infection of host cells (Saka et al. 2015;
Sharma et al. 2018; Cocchiaro et al. 2008; Kumar, Cocchiaro, and Valdivia 2006; Mulye, Zapata,
and Gilk 2018). Together, this suggests that an overabundance of LDs developed through
PPARɣ-driven lipid accumulation during R. conorii infection of THP-1 macrophages has a
detrimental effect on bacterial survival. As mentioned above, PPARɣ signaling and subsequent
lipid accumulation to, in some cases, form a foam cell-like phenotype have been associated with
activation of host inflammatory responses; therefore, inhibition of PPARɣ before infection could
have a positive effect on R. conorii growth by dampening inflammatory signals that Rickettsia
would otherwise have to avoid or regulate upon infection to provide the optimum replicative
niche (Shashkin, Dragulev, and Ley 2005; Curto, Riley, et al. 2019; Curto, Santa, et al. 2019).
There have been an increasing number of studies addressing the requirement for
regulation of host LDs to develop a hospitable niche for survival of various intracellular bacteria
(Allen and Martinez 2020; Walpole, Grinstein, and Westman 2018). Specifically, host lipids
derived from LDs are a key source of nutrients, metabolites, and structural and signaling
molecules, making it a common target for a variety of intracellular pathogens. We demonstrate
that average LDs per host cell are increased early in R. conorii-infected cells with a decrease in
average LD area throughout infection. Initiation of early LD alterations require host lipid
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catabolic processes, such as triglyceride lipases and FAO, as well as de novo bacterial protein
synthesis. These catabolic processes are independent of the upstream signaling molecule,
PPARα. However, inhibition of PPARɣ positively effects R. conorii growth in THP-1
macrophage. In addition, lipid accumulation to develop a foam cell-like phenotype is detrimental
to bacterial survival and LD modulation during THP-1 macrophage infection. Together, the data
generated from this study indicate that lipid catabolic processes that regulate host LD modulation
are an important understudied aspect of Rickettsia-host cell interactions and may shed further
insight into the mechanisms by which non-vacuolar facultative and obligate intracellular
bacterial pathogens regulate host cell processes to develop a favorable niche during the infection
of mammalian cells.
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CHAPTER III. DEVELOPMENT OF TOOLS FOR INVESTIGATION OF
RICKETTSIA RICKETTSII ANKYRIN-REPEAT PROTEINS
3.1. Introduction
Ankyrin repeat containing proteins (ARPs) are structural motifs that facilitate proteinprotein interactions in eukaryotic systems to regulate various functions including signaling
transduction to maintain host cell homeostasis and for cell survival. These proteins’ ability to
participate in various functions throughout the cell is attributed to the variability within the
structure and individual repeats that provide specificity and stable protein connections (Jernigan
and Bordenstein 2014; Al-Khodor et al. 2010a). Although, ARPs were discovered and are well
characterized within eukaryotic systems, they are not limited to eukaryotes. While less frequent,
the genome of several bacteria also contains genes encoding ARPs with high homology to those
found in eukaryotic systems. Specifically, bacteria that have a strong symbiotic relationship with
a eukaryotic host, like obligate intracellular bacteria, contain a higher number of ARPs. These
proteins are thought to have been evolutionarily acquired for facilitating specific interactions
with host molecules to establish and maintain infection (Jernigan and Bordenstein 2014). In fact,
a vast majority of the known intracellular bacterial ARPs are considered putative effector
proteins that are part of the pathogens secretome and facilitate infection of host cells by
interacting with and manipulating host molecules during infection (Gillespie et al. 2015; Rikihisa
and Lin 2010; Pan et al. 2008). Thus, it is important to better characterize the ARPs within
bacterial genomes, including R. rickettsii, to gain a better understanding of pathogenicity factors
for these intracellular organisms, which in turn will provide alternative targets and avenues for
development of effective treatment and preventative strategies against R. rickettsii and SFRs.
Although ARPs are found in high quantity in a variety of intracellular bacterial genomes,
there is little known about ARPs mechanisms of action and contribution to pathogenicity. Some
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intracellular species including Orientia tsutsugamushi, Coxiella burnetii, Legionella
pneumophila, Ehrlichia chaffeensis and Anaplasma phagocytophilum have experimental
evidence on the secretion and/or function of specific bacterial ARPs, including modulation of the
recycling pathway, transcription regulation, and nutrient acquisition (Pan et al. 2008; Rikihisa
and Lin 2010; Voth et al. 2011; Al-Khodor et al. 2010a; Jernigan and Bordenstein 2014;
VieBrock et al. 2014; Adcox et al. 2021). Conversely, little is known about ARPs present in the
genomes of Rickettsia species (Gillespie et al. 2015). An early study showed that a rickettsial
ARP, RARP-1, was found to be a secreted bacterial protein in Rickettsia typhi; however the
function(s) of RARP1 for R. typhi and other related species has yet to be elucidated (Kaur et al.
2012). Recently. another R. rickettsii protein, RARP2, was shown to regulate ER stability and
the recycling pathway, as well as to prevent MHC class I presentation on the infected host cell
(Lehman et al. 2018; Aistleitner et al. 2020). The limited information on rickettsial pathogenicity
factors and effector proteins supports the need to determine the function and vitality of ARPs
present within rickettsial genomes.
A recent report compared the transcriptomic expression of R. rickettsii strain Shelia
Smith genes while the bacteria infected a murine liver (in vivo model) to the overall expression
of R. rickettsii genes while the bacteria were grown in cell culture (in vitro model). Among the
genes that are highly transcribed in both conditions are rickettsial genes encoding for secretion
systems and the putative effector proteins, ARPs (Riley, Pruneau, and Martinez 2017). In this
study, tools necessary to investigate a putative R. rickettsii ARP, gene A1G_00070 (rarp3),
upregulated during in vivo infection with R. rickettsia were developed. Among these tools are
expression vectors containing rarp3 and polyclonal rabbit antibodies directed against RARP3.
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The vectors and protein were used to determine potential host protein:bacterial ARP interactions
that are occurring during R. rickettsii infection.
3.2. Materials and Methods
3.2.1. Bioinformatic analysis of RARP3
The protein sequence for RARP3 (protein ID: WP_012150237.1) was gathered from the
R. rickettsia strain Shelia Smith genome assembly
(https://www.ncbi.nlm.nih.gov/nuccore/NC_009882.1). The protein sequence was inputted in
NCBI Protein BLAST and the protein sequences with homology were aligned to the RARP3
protein sequence using MUSCLE Multiple Sequence Alignment software. Protein structure
prediction was determined by PHYRE2 Protein Fold Recognition Server with intensive
modelling mode. PSI-Blast Pseudo-Multiple Sequence Alignment was assessed in intensive
modelling mode to define proteins with potential structural homology. Alignment and
conservations were visualized using SnapGene.
3.2.2. Cell lines and bacterial strains
The African Green Monkey kidney epithelial cell line (Vero; ATCC CCL-81) and
Human embryonic kidney cell line (HEK 293T; ATCC CRL-3216) were cultured in DMEM
(Gibco-BRL) supplemented with 10% fetal bovine serum (FBS; Bio-Techne), 5% non-essential
amino acids, and 5% sodium pyruvate (complete DMEM) at 34°C with 5% CO2. Escherichia
coli Top10 and BL21 (DE3) were grown in LB Miller agar or broth supplemented with
carbenicillin (50 μg ml−1) or kanamycin sulfate (50 μg ml−1) at 37°C when necessary. Rickettsia
species were cultivated and purified from Vero cell cultures as described previously (Chan et al.
2009). Bacterial purification was performed by needle lysis and centrifugation with a 20%
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sucrose cushion as described in (Chan et al. 2011) and stored at -80°C in SPG buffer (218 mM
sucrose, 3.8 mM KH2PO4, 7.2 mM K2HPO4, 4.9 mM L-glutamate, pH 7.2).
3.2.3. Construction of Plasmid Constructs
The ARP of interest, RARP3 (Accession number/region: NC_009882.1:11702-11968)
was amplified from Rickettsia rickettsii strain Shelia Smith (Accession number: NC_009882.1)
genomic DNA utilizing the primers in Table 3.1. The primer sequences utilized allowed for
amplification of the whole RARP3 gene. The forward primer for pEGFP-C1 has an addition of
nucleotides before the gene start site to keep the gene in-frame and allow for production of the
RARP3 product.
Table 3.1. Primer sequences used for generation of each construct and sequencing.
Gene
A1G_00070
A1G_00070

Expression
Vector
pET28 Smt3
pET28 Smt3

Direction
Forward
Reverse

A1G_00070 pEGFP-C1
Forward
A1G_00070 pEGFP-C1
Reverse
** XhoI and BamHI sites are bold.

Primer Sequence
GGATCCATGTTTGAGGAAAATATTA
CTCGAGTAAAAAAGTTTTATTTAGAAA
CTCGAGAAATGTTTGAGGAAAAT
GGATCCTTATAAAAAAGTTTTATTTAGAAA

Standard PCR was performed using hot start taq DNA polymerase (Takara Bio)
following manufactures guidelines. Briefly, approximately 500 ng R. rickettsia gDNA was
combined with PCR mix and primers corresponding to specific genes with XhoI and BamHI
restriction sites. The PCR protocol was performed as follows: 30 cycles of 95℃ for 10s, 55℃
for 30 sec, and 72℃ for 1 min, followed by a 4℃ hold until further processing. Initial PCR
products were visualized by agarose gel electrophoresis and band at the predicted size (10 kDa)
was excised and processed by gel extraction (Qiagen). The extracted gene segments were
directionally cloned into the pCR4-TOPO vector (ThermoFisher Scientific) and sequence
confirmed. Sequencing was performed by the CEIDR Core Facilities and Services at Louisiana
State University School of Veterinary Medicine (LSU SVM). Unmutated inserts were then
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ligated into eukaryotic expression vector, pEGFP-C1 (Figure 3.1A), or E. coli expression vector,
pET28-smt3 (Figure 3.1B), using the XhoI and BamHI sites following manufacturers protocols
(New England Biolabs).
3.2.4. Ectopic protein expression in HEK293T cells
HEK293T cells were seeded (approximately 1x105 cells/mL) in 10cm2 cell-treated
culture dishes (Costar; 8 mL/dish) or onto sterile glass coverslips in 24-well plates (Costar).
After 24 hrs, cells were washed 3x with 1X phosphate buffer saline (PBS) before transfected
with 15 µg of RARP3:EGFP plasmid DNA using the Lipofectamine 2000 reagent following the
manufacturer’s protocol. Transfected cells were harvested at 48 hrs post-transfection.

Figure 3.1. Map of plasmid constructs used for production of RARP3 fusion proteins. (A) The
nucleotide sequence of Rickettsia rickettsii RARP3 (A1G_00070). (B) The eukaryotic expression
vector, pEGFP-C1, plasmid map with all features present in order with directionality and
indication of the XhoI and BamHI restriction sites depicting area of RARP3 nucleotide sequence
insertion with EGFP protein at the C-terminus of the fusion protein with RARP3 at the Nterminus. (C) The Escherichia coli expression vector, pET-23-smt3, plasmid map with all
features present in order with directionality illustrated. The XhoI and BamHI sites indicate area
where RARP3 nucleotide sequence was inserted with the 6x His tag present at the N-terminus
and the SUMO tag at the C-terminus to create the fusion protein.
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Transfected cells were investigated for GFP fusion protein expression by immunofluorescence
analysis (IFA) and western immunoblotting.
For IFA, HEK293T cells were grown and transfected as described above in 24-well
plates containing sterile glass coverslips. Transfected cells were 4% paraformaldehyde (PFA)
fixed for 20 min at 48 hrs post-transfection. Cells were permeabilized with 0.1% Triton X-100
for 5 min in 1x PBS with 2% BSA followed by DAPI (1:2000) for 1 hr before mounting on a
slide with Mowiol semi-permanent mounting media for visualization. Images were visualized
using a LEICA DM4000 B microscope at a final optical zoom of 63X oil immersion. Images
were processed using Image J software.
Western immunoblotting was also performed to confirm expression of the target protein
at the indicated time points. Briefly, transfected HEK293T cells were washed 3x with ice-cold
1X PBS then lysed in 200 µl 1% NP-40 lysis buffer (1% NP-40, 20 mM Tris, pH 8.0, 150 mM
NaCl, 10% glycerol, 20 mM NaF, 3 mM Na3VO4, 1X Complete Protease Inhibitor cocktail)
before addition of 6X SDS at each indicated time post-transfection. Lysates were resolved on
10% polyacrylamide gels before transfer to nitrocellulose. Membranes were incubated for 1 hr at
room temperature in 1X TBST (Tris buffer saline + 0.1% TWEEN 20 detergent) with 2% BSA
before addition of anti-GFP (1 µg/ml; Santa Cruz Biotechnology) incubated at 4℃ overnight.
Membrane was then washed with 1X TBST before addition of anti-mouse IgG-HRP (Sigma;
1:50000). Proteins were visualized with Super Signal WestPico enhanced chemiluminescence
system (Pierce) and exposure to film.
3.2.5. Protein Expression in E. coli and Protein Purification
The optimum isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration for induction
of RARP3:Sumo1 fusion protein production was determined by transformation of E. coli BL21
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(DE3) (Invitrogen) with the RARP3:Sumo1 plasmid as described previously. Transformed E.
coli was grown overnight. Overnight bacteria cultures were diluted to an OD600 = 0.2 in 50 mL
and grown for 1 hr at 37°C to reach mid-exponential phase (OD600 = 0.4-0.6). After midexponential phase was reached, individual cultures were incubated on ice for 30 min before
addition of IPTG at 0.1 µM, 0.25 µM, 0.5 µM, and 1 µM and incubated at 23°C overnight before
harvest. Total protein lysates were prepared using BPER-II protein extraction reagent with 1X
complete protease inhibitor cocktail before addition of 6X SDS. Anti-Sumo1 (1 µg/ml; Cell
Signaling) and anti-rabbit IgG-HRP (Sigma; 1:25000) were used as primary and secondary
antibodies for visualization of RARP3:Sumo1 fusion protein via western immunoblotting.
For RARP3:Sumo1 protein purification, overnight bacterial cultures of RARP3:Sumo1
plasmid in E. coli BL21 (DE3) (Invitrogen) (50ml) were diluted to an OD600 = 0.2 in 1.5 L of
fresh medium and grown to mid-exponential phase (OD600 = 0.4-0.6) at 37°C. Cultures were
cooled on ice for 30 min before induction with 0.5 µM isopropyl β-IPTG at 23°C overnight.
Cells were harvested by pelleting at 5000 xg for 15 min before resuspension in 30 mL binding
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole) with 1X complete protease inhibitor
cocktail (Pierce). Resuspended bacterial cells were lysed by passage through the French pressure
cell 3X (1,500 psi). Purification of the fusion proteins was preformed using the ÄKTA FPLC
(GE Healthcare) with a 5 mL HisTrap-HP column and elution was performed with a high
imidazole buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole). A portion (20 µl) of the
2 mL fractions were resolved on a 10% SDS-PAGE gel before analysis by PageBlue™ protein
staining solution (Thermo Scientific) as per manufactures protocol and western immunoblotting
as described previously. The gel band at appropriate size for fusion protein was excised and sent
to Taplin Biological Mass Spectrometry Facility for protein sequence confirmation.
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For mass spectrometry, gel pieces were then subjected to a modified in-gel trypsin
digestion procedure (Schevchenko 1996). After digestion, samples were prepared for analysis
through reverse-phase FPLC (Peng 2001). Peptides were detected, isolated, and fragmented to
produce a tandem mass spectrum of specific fragment ions for each peptide. Peptide sequences
(and hence protein identity) were determined by matching protein databases with the acquired
fragmentation pattern by the software program, Sequest (Thermo Fisher Scientific) (Eng 1994).
All databases include a reversed version of all the sequences and the data was filtered between a
1-2% peptide false discovery rate.
Fractions containing the confirmed RARP3: Sumo1 fusion protein were pooled and
dialyzed using the Slide-A-Lyzer® Dialysis Cassette kit (Thermo Scientific) into 1X PBS and
concentrated using an Amicon® Ultra centrifuge filter unit following manufacturers protocol
before being frozen in 20% glycerol and stored at 20°C until further use.
3.2.6. Antibody production and clean-up
Antibody production against the RARP3:Sumo1 fusion protein was preformed using a
New Zealand white rabbit that was immunized with antigen. This animal was housed in
accordance with the Animal Welfare Act and the Guide for the Care and Use of Laboratory
Animals. The NIH COBRE Phase III funded Protein Core Laboratory (PCL) at LSU-SVM was
utilized in part for the generation of the antibodies. Briefly, the rabbit was individually
immunized with 500 mg/animal of purified R. rickettsii RARP3:Sumo1 fusion antibodies in 1X
PBS mixed 1:1 with Freund’s Complete adjuvant. The rabbit was boosted approximately three
weeks post-immunization with an additional 500mg/animal of purified protein emulsified 1:1
with Freund’s Incomplete adjuvant. Blood and serum samples were collected three weeks post
boost and tested by western immunoblot analysis for reactivity against RARP3. The animal was
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anesthetized with isoflurane followed by cardiac puncture for the collection of blood and serum.
All procedures were performed in accordance with LSU standard operating procedures and
approved by the IACUC. The rabbit study was performed on animals housed at the LSU SVM.
All in vivo animal work performed at LSU is conducted within the AAALAC accredited
facilities.
IgG purification of serum collected from rabbits was performed with the ÄKTA FPLC
(GE Healthcare) on the appropriate 1 mL HiTrap Protein G HP column. The binding buffer
(20mM sodium phosphate, 150mM NaCl, pH 7.0) was utilized to equilibrate and wash the
column prior to and after sample loading. IgG were eluted with the elution buffer (100nM
glycine-HCl, pH 2.7) and fractions corresponding to the appropriate chromatographic peak were
pooled and neutralized to pH 7. Purified IgGs were then dialyzed into 1X PBS using a Slide-ALyzer® Dialysis Cassette kit (Thermo Fisher Scientific).
IgGs were further adsorbed with freshly prepared Vero cell acetone powders to reduce
non-specific binding to host cell proteins. Briefly, Vero cells were cultured to confluency in a
T175 cell culture flask. Once confluent, cells were trypsinized and centrifuged at 10,000 xg at
4°C for 5 min. The pellet was resuspended at a 1:1 ratio in 0.9% NaCl and transferred to a glass
centrifuge tube before addition of acetone at a ratio of 1:4. Cell suspension was then incubated
on ice for 10 min before centrifugation as done previously (Chan et al. 2009). Supernatant was
removed and pellet was spread on filter paper until no yellow was visible and left to dry at room
temperature. Once dry, acetone-powdered cells were added at approximately 1% W/V to diluted
(1:25) IgG purified antibody and incubated at room temperature for 30 min. After incubation,
solution was spun at max speed for 5 min and supernatant was collected.
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To further isolate RARP-3 specific polyclonal antibodies, we performed blot-affinity
purification (BAP) of IgGs against purified recombinant RARP-3 protein. 1 mg purified SUMORARP-3was resolved on a 4-20% SDS-PAGE gel and transferred to nitrocellulose as described
previously (Chan et al. 2009). 50uL of Vero cell-adsorbed antibody (see above) was diluted in
5mL of 1X TBST and incubated with the nitrocellulose membrane with RARP3 protein
overnight at 4°C. The membrane was then washed 3 times to remove unbound antibody before
bound antibody to the protein of interest was eluted by addition of 2 mL of glycine buffer (0.1M
glycine, 0.5M NaCl, 0.05% Tween-20, pH 2.8) for 3 min on ice. Elution solution was
immediately removed from membrane and transferred into 0.3 mL neutralization solution (1M
Tris pH 8.1). Elution with an additional 2 mL of elution solution to the membrane was performed
before combining with neutralization+1st round of elution. Eluted antibody was dialyzed and
concentrated into 1X PBS. Antibody clean-up was confirmed by western immunoblotting with a
R. rickettsii whole cell lysate as described above.
3.2.7. Pull-down analysis
For pull-down analysis, 25 ug of purified protein of interest (described above) was
incubate with 200 ug HEK293T cells solubilized in 1% NP40 lysis buffer (1% NP-40, 20 mM
Tris, pH 8.0, 150 mM NaCl, 10% glycerol, 20 mM NaF, 3 mM Na3VO4, 1X Complete Protease
Inhibitor cocktail) with agitation at 4℃ overnight. 50 uL of PerfectPro Ni-NTA MagBeads (5
Prime) in 1% NP40 lysis buffer (50:50) was added to the solution and incubated with agitation
for 1 hr. The resin was washed 3X with 1% NP-40 lysis buffer (1% NP-40, 20 mM Tris, pH 8.0,
150 mM NaCl, 10% glycerol, 20 mM NaF, 3 mM Na3VO4, 1X Complete Protease Inhibitor
cocktail) and protein was eluted in a high imidazole buffer (50mM NaH2PO4, 300mM NaCl,
250mM imidazole) before addition of 6X SDS and boiling for generation of lysates. The
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supernatant of lysates was analyzed by western immunoblotting for RARP3:Sumo1 as described
above as well as analyzed with PageBlue™ protein staining solution (Thermo Fisher Scientific)
and the Pierce™ Silver staining kit (Thermo Fisher Scientific) as per manufacturer’s protocol.
Host proteins that appear to specifically interact with SUMO-RARP-3, but not SUMO-1 were
excised from the gel and sent to the Taplin Biological Mass Spectrometry Facility for protein
identification. Proteins that contained 3 or more unique peptides were considered significant.
3.3. Results
3.3.1. Bioinformatic analysis of RARP3
Although, the topology of all ARPs is similar, with repeating α helices connected by βsheets forming a concaved supercoiled shape, the protein sequence and overall structure
homology is vastly different (Al-Khodor et al. 2010a; Jernigan and Bordenstein 2014; Mosavi,
Minor, and Peng 2002). RARP3 is a small protein that is approximately 10 kDa and consists of
only ankyrin repeats with no functional domain. When examining the presence of homologous
protein sequences to the R. rickettsii RARP3 sequence, other rickettsial species within the
spotted fever and transitional group showed sequence homology (Figure 3.2A). Interestingly,
sequences related to RARP3 are absent within species belonging to the typhus group of
Rickettsia. Analysis of the predicted protein structure using PHYRE2 show four α helices
making up two ankyrin-repeats with regions of predicted disorder connecting each α helix
(Figure 3.2B & C). PSI-Blast Pseudo-Multiple Sequence Alignment of the structural predictions
indicate that few undefined proteins are structurally similar to the protein of interest.
Intriguingly, an unknown protein within the transitional group species, Rickettsia felis, protein
RF_0011 (Q4JNU5) has 62.5% structural homology to RARP3 (Figure 3.2D & E). This R. felis
protein is larger (36 kDa) than the predicted RARP3 size (10 kDa). The homology present is
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Figure 3.2. Bioinformatic analysis of protein homologs and structure of RARP3. (A) A
MUSCLE multiple sequence alignment of all protein sequences with homolog to RARP3
according to BLAST analysis. The consensus sequence is the protein sequence of Rickettsia
rickettsii RARP3 (A1G_00070). Green shading of sequences corresponds to relatedness to
consensus sequence. Bars above multiple sequence alignment correspond to the conservation of
the area within the sequences. Red = very high levels, orange = high levels, yellow = moderate
levels, light blue = low levels, dark blue = very low levels. * signifies protein sequence that has
structural homology as well seen in (D, E) (B) A linear model representing the predicted
structure according to PHYRE2 analysis. Colors of rectangles representing α-helices correspond
with colors within the 3D model in (C). (D) Multiple sequence alignment of results from PSIBlast Pseudo-Multiple Sequence Alignment determined by PHYRE2 to define structural
homolgy. The consensus sequence is the protein sequence of Rickettsia rickettsii RARP3
(A1G_00070). Yellow shading or sequences represents relatedness to consensus sequence. Bars
above multiple sequence alignment correspond to the conservation of the area within the
sequences. Red = very high levels, orange = high levels, yellow = moderate levels, light blue =
low levels, dark blue = very low levels. (E) Values of structural alignment assessment of known
proteins performed in (D), including likelihood of random alignment (E-value), percentage and
residues relating to consensus sequence, region of homology within the protein, and protein size.
All values pertain to proteins deemed to have homology to RARP3.
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within the ARP region of these two proteins, suggesting there is a potential for similarities in
host binding sites. However, due to the size and domain differences, these two proteins functions
are likely different. Surprisingly, RF_0011 is the only protein found within the protein sequence
multiple alignment to have relatively high structural homology. The presence of RARP3
homology in rickettsial spotted fever and transitional groups with a lack of structural homology
suggest that though sequence homology within the ARP domains of these various proteins across
species is present, the proteins likely differ in protein folding, and potential host protein partners.
Thus, these proteins likely provide different functions for the rickettsial species.
3.3.2. Expression of eukaryotic expressing constructs in HEK293T cells
Transient expression of a protein of interest in a eukaryotic system can be used for a
variety of functions including analysis of protein:protein interactions and putative protein
localization within a host cell, complementation studies to determine the role in pathogenesis,
and overall function of the protein of interest. Here, HEK293T cells were used as a model to
assess the ability of the pEGFP-C1 plasmid with the RARP3 insert to be expressed in a
eukaryotic system. Expression of RARP3:EGFP fusion protein was assessed using both western
immunoblotting analysis and IFA. The fusion protein RARP3:EGFP migrates by western
immunoblotting analysis to approximately 37 kDa, which is consistent with the predictive size of
RAPR3 (10 kDa) fused to eGFP (27kDa) (Figure 3.3A). To confirm RARP3:GFP expression in
HEK293T cells, IFA was utilized to visualize GFP expression (Figure 3.3B). The data supports
the ability of RARP3:GFP to be expressed successfully within a eukaryotic system, which will
provide a valuable tool for defining the importance of RARP3 function(s) in a mammalian cell.
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3.3.3. Expression and purification of pET23-smt3 construct in E. coli
Expression of RARP3 in E. coli BL21 (DE3) allows for production of the protein to then
be used for an abundance of methods including protein purification, antibody production, and
pull-down analysis. The plasmid pET23-smt3 with the RARP3 insert was utilized to produce a
fusion RARP3:Sumo1 protein with a predicted molecular weight of 22-25 kDa in size. The
production of the fusion protein was induced at varying concentration of IPTG (0.1-1 µM)

Figure 3.3. Expression of RARP3:EGFP fusion protein in HEK293T cells. (A) Western
immunoblotting analysis of HEK293T cells expression fusion protein of interest or GFP
independently by α-GFP antibody. (B) Immunofluorescent analysis for GFP expression in
HEK293T cells expressing EGFP or RARP3:EGFP (green). Dapi (blue) was used to visualize
host cell nuclei.
and the normalized samples were analyzed by western immunoblotting analysis to determine the
optimum concentration of IPTG for mass protein production necessary for FPLC purification.
The optimum IPTG concentration was determined to be 0.5 µM, which we then used for larger
scale purification of RARP-3-SUMO (Figure 3.4A). Protein purification was carried out and 2
mL fractions were collected and analyzed by PageBlue™ protein staining solution to confirm
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purification. RARP3:Sumo1 was predicted based on size to be present in fractions 2-12
migrating to approximately 22 kDa (Figure 3.4B). The band within the red box depicted in
Figure 3.4B was analyzed by mass spectrometry and further confirmed to be the protein of
interest, RARP3. The fractions containing the protein of interest were pooled and concentrated
before being dialyzed. Clean-up and concentration of the RARP3:Sumo1 was assessed by
Coomassie (Figure 3.4C). The purification of RARP3:Sumo1 fusion protein provides a tool that

Figure 3.4. RARP3:Sumo1 fusion protein expression and purification in Escherichia coli. (A)
Western immunoblotting analysis of RARP3:Sumo1 fusion protein produced by Escherichia coli
induced with varying concentrations of IPTG. Fusion protein was detected by α-Sumo1
antibody. (B) PageBlue™ protein stained gel with fractions from FPLC protein purification that
contains protein of interest. Red box indicates region of PageBlue™ protein stained gel that was
analyzed by mass spectrometry for confirmation of protein identity. (C) PageBlue™ protein
stained gel of E. coli whole cell lysate expressing RARP3:Sumo1, the concentrate and flowthrough after being passed through the Amicon® Ultra centrifuge filter unit, and the concentrate
after dialysis with the Slide-A-Lyzer® Dialysis Cassette kit.
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can be used for antibody production against RARP3:Sumo1, analysis of protein:protein
interactions, and functional assays.
3.3.4. Antibody purification and confirmation
Once RARP3:Sumo1 was purified, cleaned-up, and concentrated, antibody against
RARP3 was generated by rabbit immunization. To confirm reactivity of rabbit serum immunized
with RARP3:Sumo1, the serum was tested against a HEK293T cell lysate expressing
RARP3:GFP and the purified RARP3:Sumo1. Figure 3.5A shows a confirmation of reactivity at
the correct sizes predicted for the fusion proteins. To determine if R. rickettsii produces RARP3,
a whole cell R. rickettsii lysate of purified bacteria was analyzed by SDS-PAGE and
immunoblotted using rabbit anti-RARP3 serum and a normal rabbit serum (NRS) as a control.
As shown in Figure 3.5B, western immunoblotting revealed a band at the predicted size for
RARP3 protein that is not present within the NRS control. Immunoblot analysis using purified
and Vero cell adsorbed RARP-3 antibody against whole cell R. rickettsii lysate showed reactivity
to the predicted protein of interest at 10 kDa remained and no non-specific signals (Figure 3.5C).
Together these data show the successful development of an antibody reactive to R. rickettsii
RARP3 protein.
3.3.5. Analysis of ARP interactions
To preliminarily assess the putative role of RARP-3 in host cells, we sought to determine
specific host cell proteins that can interact with RARP-3. Briefly, purified RARP-3-SUMO
protein was utilized to perform a pull-down analysis with HEK293T cells. Purified Sumo1 was
utilized as a control to rule out any host proteins that could be interacting with the Sumo1
domain of the fusion protein and not RARP-3. Affinity pull-down assays were performed,
reactions were resolved by SDS-PAGE and then stained with Coomassie blue. Bands that were
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Figure 3.5. Confirmation of RARP3 antibody identification of RARP3 and expression in
Rickettsia rickettsii. (A) Confirmation of antibody reactivity to RARP3 by analyzing a whole cell
lysate of HEK293T cells expressing the RARP3:GFP fusion protein and purified
RARP3:Sumo1 fusion protein through western immunoblotting with rabbit generated antibody
specific to RARP3. (B) Analysis of reactivity with RARP3 antibody in a purified Rickettsia
rickettsii lysate. Star indicates reaction with non-specific protein found in both α-RARP3 and the
normal rabbit serum control (NRS). Arrow indicates reactivity at the predicted size of the
untagged protein of interest. (C) The serum from the immunized rabbit was purified and tested
against the R. rickettsii lysate by western immunoblotting to show removal of the non-specific
reactivity seen in (B).
present in RARP3:Sumo1 samples that were not present in Sumo1 samples (red boxes) were
analyzed by mass spectrometry to identify possible host proteins that interact with RARP3. As
shown in Figure 3.6, several protein bands of approximately 250 kDa, 150 kDa and 15 kDa
appear to interact with RARP-3. These proteins were excised from the gel and prepared for
sequence identification using mass spectrometry.
Table 3.2 lists the proteins identified by mass spectrometry from the excised bands.
Unique peptides define the number of peptides identified throughout the reference protein
whereas the total number of peptides is the number of peptides identified overall, including those
that overlap the same part of the reference protein sequence. Proteins that only identified with 1-
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2 unique proteins were omitted from the table due to unlikelihood of being present at high
enough levels in the samples to be true interactions with RARP3:Sumo1. The percent protein
coverage defines the amount of sequence coverage the unique proteins span of the whole
reference protein sequence. Smaller reference proteins tend to have higher percent coverage with
lower unique peptides when compared to the higher molecular weight proteins, likely due to the
smaller sequence size requiring less peptides to cover the sequence. Among the identified

Figure 3.6. Pull-down analysis with purified RARP3 and HEK293T cell lysates to determine
protein:protein interactions. Pull-down analysis using purified RARP3 and Sumo protein control.
Red boxes depict regions of variation between RARP3 sample and Sumo control that were
analyzed by mass spectrometry for analysis of potential protein:protein interactions.
proteins are ribosomal or ribonuclear proteins (gene symbols beginning with RP, PRP or MRP,
NHP2 and SNRNP200). There is also a group that contain more structural and trafficking related
proteins, such a scaffolding protein that crosslinks with actin known as spectrin (SPTBN1 and
SPTBN2), a component of the cytoskeleton important for cell-to-cell contact (talin 1;TLN1),
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clathrin (CLTC) which is involved in uptake and vacuole formation, a protein required for
regulation of microtubule modulation (transforming protein RhoA precursor; RHOA), a protein
associated with cytoskeleton reorganization (leucine rich pentatricopeptide repeat containing;
LRPPRC), a golgi apparatus-to-endoplasmic reticulum (ER) vacuole trafficking protein
(transmembrane P24 trafficking protein 10; TMED10), nuclear transmembrane trafficking
protein, nucleoprotein (TRP), a protein that traffics vacuoles from the golgi apparatus to the
plasma membrane (NRAS proto-oncogene, GTPase; NRAS), and an early endosome antigen 1
(EEA1). Additionally, a protein required for the pyrimidine biosynthesis pathway (carbamoylphosphate synthetase 2; CAD), a protein necessary for glutathione homeostasis (gammaglutamylcyclotransferase; GGCT), a protein required for the mevalonate pathway
(phosphomevalonate kinase; PMVK), glyoxalase I (GLO1) which regulates glutathione levels
within the cell, deoxyuridine triphosphatase (DUT) that regulates the turnover of thymine
nucleotides, and a protein necessary for prostaglandin synthesis by prostaglandin E synthase 3
(PTGES3) were identified as potential RARP3 targets. Other proteins are commonly associated
with transcription, post-transcription, translation, and post-translational regulation and
processing, including pre-MRNA processing factor 8 (PRPF8), glutamyl-prolyl-tRNA synthetase
(EPRS), chromobox3 (CBX3), RNA binding motif protein 8A (RBM8A), signal peptidase
complex subunit 2 and 3 (SPCS2 & 3), eukaryotic translation initiation factor 3 subunit A
(EIF3A), ubiquitin conjugating enzyme E2 M (UBE2M), and calcyclin binding protein
(CACYBP). In addition, some proteins were found to be involved in regulating intracellular
signaling, such as sorcin (SRI), phosphatidylethanolamine binding protein 1 (PEPB1), dual
specificity phosphatase 3 (DUSP3), and a member of RAS oncogene family (RAP1A) (Table
5.2). Together, these putative RARP-3 interacting proteins provide additional areas of
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experimentation to define the contribution of RARP-3-target protein interactions to the Rickettsia
infection process.
Table 3.2. Mass spectrometry results from pull-down analysis with RARP-3 purified protein.
Unique Total
Reference
Gene
MWT
Protein
Peptides Peptides
Symbol
(kDa)
Coverage
15
17
sp|Q01082|SPTB2_HUMAN
SPTBN1
274.44
8.80%
14
14
sp|P27708|PYR1_HUMAN
CAD
242.83
6.70%
12
14
sp|Q9Y490|TLN1_HUMAN
TLN1
269.6
8.11%
12
12
sp|Q6P2Q9|PRP8_HUMAN
PRPF8
273.43
5.18%
11
11
sp|P12270|TPR_HUMAN
TPR
267.13
5.80%
10
13
sp|P07814|SYEP_HUMAN
EPRS
170.48
6.55%
7
8
sp|P46781|RS9_HUMAN
RPS9
22.58
25.26%
6
9
sp|Q07020|RL18_HUMAN
RPL18
21.62
34.57%
6
8
sp|Q9Y3B7|RM11_HUMAN
MRPL11
20.67
41.15%
4
8
sp|P49755|TMEDA_HUMAN TMED10
24.96
17.81%
4
8
sp|Q02543|RL18A_HUMAN
RPL18A
20.75
17.61%
7
7
sp|O15020|SPTN2_HUMAN
SPTBN2
271.16
3.22%
6
6
sp|Q13185|CBX3_HUMAN
CBX3
20.8
26.78%
6
6
sp|P01111|RASN_HUMAN
NRAS
21.22
36.51%
5
6
sp|O75643|U520_HUMAN
SNRNP200 244.35
3.23%
5
6
sp|P26373|RL13_HUMAN
RPL13
24.25
24.17%
5
6
sp|P18621|RL17_HUMAN
RPL17
21.38
25%
5
6
sp|Q9BYD1|RM13_HUMAN MRPL13
20.68
26.40%
4
6
sp|P62913|RL11_HUMAN
RPL11
20.24
20.79%
5
5
sp|Q9Y5S9|RBM8A_HUMAN RBM8A
19.88
26.44%
5
5
sp|Q15005|SPCS2_HUMAN
SPCS2
24.99
20.35%
4
5
sp|O75223|GGCT_HUMAN
GGCT
20.99
22.34%
4
5
sp|P62753|RS6_HUMAN
RPS6
28.66
16.47%
4
5
sp|Q15185|TEBP_HUMAN
PTGES3
18.69
19.38%
4
5
sp|P30626|SORCN_HUMAN SRI
21.66
21.21%
4
4
sp|Q14152|EIF3A_HUMAN
EIF3A
166.47
2.60%
4
4
sp|Q15075|EEA1_HUMAN
EEA1
162.37
3.05%
4
4
sp|P30086|PEBP1_HUMAN
PEBP1
21.04
30.48%
4
4
sp|P51452|DUS3_HUMAN
DUSP3
20.47
26.49%
4
5
sp|P30626|SORCN_HUMAN SRI
21.66
21.21%
4
4
sp|Q14152|EIF3A_HUMAN
EIF3A
166.47
2.60%
4
4
sp|Q15075|EEA1_HUMAN
EEA1
162.37
3.05%
(table cont’d)
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Unique Total
Reference
Peptides Peptides

Gene
Symbol

MWT
(kDa)

Protein
Coverage

4
4
4
4
4
4
4
4
3
3
3
3
3
3
3

PEBP1
DUSP3
UBE2M
RPS8
PMVK
MRPS23
RAP1A
GLO1
SPCS3
NHP2
RHOA
LRPPRC
DUT
CACYBP
RPL21

21.04
20.47
20.89
24.19
21.98
21.76
20.97
20.76
20.3
17.19
21.75
157.81
26.55
26.19
18.55

30.48%
26.49%
22.40%
19.23%
19.27%
21.05%
19.57%
17.93%
17.78%
31.37%
25.39%
2.30%
13.49%
21.93%
21.88%

4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

sp|P30086|PEBP1_HUMAN
sp|P51452|DUS3_HUMAN
sp|P61081|UBC12_HUMAN
sp|P62241|RS8_HUMAN
sp|Q15126|PMVK_HUMAN
sp|Q9Y3D9|RT23_HUMAN
sp|P62834|RAP1A_HUMAN
sp|Q04760|LGUL_HUMAN
sp|P61009|SPCS3_HUMAN
sp|Q9NX24|NHP2_HUMAN
sp|P61586|RHOA_HUMAN
sp|P42704|LPPRC_HUMAN
sp|P33316|DUT_HUMAN
sp|Q9HB71|CYBP_HUMAN
sp|P46778|RL21_HUMAN

3.4. Discussion
Effector proteins have been attributed for an increased level of pathogenesis for a variety
of intracellular bacteria. Structurally, effector proteins vary greatly and are grouped into packs
based on characteristic structural component. Predominantly proteins can be grouped due to the
presence of specific motifs, including leucine zipper, ankyrin-repeats, tandem repeats, or zinc
fingers. These domains are known facilitators of overall protein function and protein:protein
interactions (Ponting and Russel 2002). During infection, bacteria have taken advantage of these
protein domains to interact with host proteins and regulate host pathways to establish a
replicative niche (Nicod, Banaei-Esfahani, and Collins 2017). Here, tools for investigation of a
protein containing the ARP domain found to be upregulated during R. rickettsii in vivo infection
are developed. It is important to note that although this gene is transcriptionally upregulated in
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vivo, it is transcribed at high levels in vitro, indicating that an in vitro system can be used to
study RARP3 (Riley et al. 2017).
Compared to the effector proteins found in other intracellular bacteria, rickettsial effector
proteins and their respective functions are not well defined. However, there are a few that have
been more recently investigated. Among these is R. typhi, RalF, and has been shown to contain a
Sec7 domain that activates host Arf6 to regulate invasion (Folly-Klan et al. 2015; RennollBankert et al. 2016; Rennoll-Bankert, Rahman, et al. 2015). A Legionella pneumophila effector
protein was also used as a model for RalF due to heavy structural similarities (Folly-Klan et al.
2015). This protein, though present with structural and functional homology among Legionella
and Typhus group Rickettsia, is a pseudogene within the SFG genomes (Rennoll-Bankert,
Rahman, et al. 2015). Interestingly, the only other characterized rickettsial effector proteins are
ARPs. Among these is RARP1, which has been defined as a type I secretion system secreted
protein during in vitro infection with R. typhi; however, the function is still unknown (Kaur et al.
2012). The RARP1 homologue in R. rickettsii strain Shelia Smith was identified as being
upregulated in a transcriptomic analysis of R. rickettsii genes that are upregulated in an in vivo
system when compared to in vitro. Because R. ricketsii RARP1 shares homology to the secreted
R. typhi RARP1 and other secreted proteins it is likely also secreted during infection (Riley,
Pruneau, and Martinez 2017; Kaur et al. 2012). More recent work has focused on RARP2 present
in the virulent R. rickettsii strain Shelia Smith genome that is disrupted in the avirulent Iowa
strain indicating possible contribution to virulence; however, the complementation with the
complete RARP2 gene did not restore pathogenicity in the avirulent counterpart (Lehman et al.
2018). RARP-2 has been shown to disrupt the recycling pathway to prevent MHC-1 presentation
on the infected host cell. Interestingly, disruption of this gene does not fully perturb the host
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pathway disruptions suggesting a supporting or compensatory mechanism is present (Aistleitner
et al. 2020). Structurally, intracellular bacterial ARPs share similarities; however, on the level of
nucleotide and protein sequences, ARPs have diverging levels of variability. For example, O.
tsutsugamushi, shares redundancy in the sequence homology of various ARPs within the genome
that provide similar functions for the bacteria (Evans et al. 2018; Min et al. 2014; Rodino et al.
2018). Conversely, if redundancy is limited to the ARP region the ability to elucidate
protein:protein interactions and function from already defined ankyrin repeat containing proteins
becomes more difficult due to the addition of connecting protein domains and alternative
modifications that can facilitate differential folding and overall structure of the ankyrin repeat
containing protein. This in turn can cause proteins with homologous ARP regions to have vastly
different protein:protein interactions and functional roles during infection (Jernigan and
Bordenstein 2014; Li, Mahajan, and Tsai 2006; Voth 2011; Al-Khodor et al. 2010a). Therefore,
elucidating a potential target protein or function of the protein relies on the development of tools
specific to RARP3, so that the potential interactions and function can be determined.
Among some of the ARPs defined for other intracellular bacterial species are those
related to pathways/processes that were also shown to be potential targets for RARP3. For
example, R. rickettsii RARP2 regulates the golgi apparatus and ER trafficking important for
efficient infection. Similarly, O. tsutsugamushi Ank9 which is involved in regulation of the
recycling pathway and L. pneumophila AnkX that recruits golgi apparatus derived vacuoles to
the pathogen containing vacuole are essential for active growth and sustainable infection of
mammalian cells (Ernst et al. 2020; Allgood et al. 2017; Yu et al. 2018; Mukherjee et al. 2011;
Campanacci et al. 2013; Gavriljuk et al. 2016). In the study presented here, TMED10, a
trafficking protein that regulates vacuole travel between the golgi apparatus and the ER, was
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identified as a potential target for RARP3 providing a pathway similar to those defined for other
pathogens that could be regulated by a bacterial ARP. A previous proteomic analysis also
indicated that host ER proteins were heavily altered during macrophage infection with a similar
spotted fever group pathogen, Rickettsia conorii, providing evidence of a potential target
pathway for bacterial effector proteins (Curto, Santa, et al. 2019).
Nutrient acquisition has also been associated with bacterial ARPs, like L. pneumophila
AnkB that regulates the amino acid starvation pathway (Howell et al. 2000; Price, Al-Khodor, et
al. 2010; Price et al. 2009; Wong et al. 2017). Intriguingly, proteins involved in nucleotide
production, CAD and DUT, were defined as potential targets for RARP3, defining nutrient
acquisition, specifically nucleotide acquisition as a potential ARP regulated pathway during R.
rickettsii infection. An early study with a typhus group Rickettsia, Rickettsia prowazekii, showed
the requirement of host uracil production supporting the potential need for nutrient acquisition,
like nucleotides, from the host (Speed and Winkler 1991).
Most notably, bacterial ARPs are used during infection for regulation of host signaling
through transcriptional and translational alterations, such as O. tsutsugamushi which is has
various ARPs that containing F-box domains that act as nucleoproteins that are known regulators
of transcription (Min et al. 2014; Beyer et al. 2015; Evans et al. 2018; Adcox et al. 2021).
Similarly, RARP3 does not have a functional domain to mimic the host, however, a putative
target defined here is a host nucleoprotein, TRP, that may be sterically regulated by RARP3 to
perform functions like the O. tsutsugamushi mimicry ARPs. As mentioned, RARP3 is a small
protein containing only an ankyrin repeat domain and no other functional domain. To date,
ankyrin repeats alone do not have any known functional activity. However, a study of an
eukaryotic ARP was shown to require only two of the ankyrin repeats within the protein to
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interact with the protein target and facilitate the natural response indicating the protein:protein
interaction alone with a protein as small as RARP3 could sterically define the functionality of the
protein (Zhang and Peng 2000).
Although ARPs are well characterized proteins important for protein:protein interactions
in a eukaryotic host and are becoming more defined for host:bacterial protein relationships, more
work must be done to better understand the role these proteins play during infection. Thus, the
development of the tools, including plasmids with RARP3 protein, purified protein, and an
antibody, demonstrated here can be used to investigate RARP3 that is upregulated during in vivo
infection with R. rickettsii so that the rickettsial relationship with the host can be better
understood. An increase in the understand of the host:pathogen interactions will allow for
progression in development of prevention and therapeutic strategies against R. rickettsii and
other rickettsial disease.
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CHAPTER IV. DISSCUSSION OF RESULTS AND FUTURE DIRECTIONS
4.1. Introduction
The obligate intracellular nature of Rickettsia species requires a strong parasitic
relationship with the mammalian host to produce a sustainable infection. Human pathogenic
Rickettsia species have evolved to parasitize an array of mammalian cell types such as
endothelial cells, monocytes and macrophages. Previous studies in our lab have demonstrated a
differential protein expression in macrophages infected with the human pathogen, Rickettsia
conorii, compared to a non-human pathogen Rickettsia montanensis (Curto et al. 2016). We also
have shown that growth in macrophages is correlated with the ability of bona fide pathogenic
Rickettsia species to cause disease in humans and animals (Kristof et al. 2021). Proteomic
signatures of R. conorii infected THP-1 cells (macrophages) revealed that several host pathways
including those involved in lipid metabolism are modulated during infection (Curto, Santa, et al.
2019). Therefore, we hypothesize that if pathogenic Rickettsia species, such as R. conorii,
require host lipid metabolic processes, then inhibition of these pathways will negatively impact
rickettsial survival and host modulation during infection of macrophages. To address this
hypothesis, the work within this dissertation further investigated the contribution of lipid droplets
(LDs) and lipid catabolic pathways to rickettsial infection of mammalian cells. The data
presented here helps to further elucidate the molecular mechanisms that are important for
pathogenic Rickettsia infection and growth in phagocytic cells, such as macrophages, and how
these processes contribute to virulence.
Bacterial protein secretion/translocation systems and the substrates or effector proteins
that they export into an infected mammalian cell have been studied in a variety of intracellular
pathogens and play key roles in the establishment of infection and progression of disease
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(Jernigan and Bordenstein 2014); however, research on putative rickettsial effector proteins is
limited. Within this dissertation, we described the development and characterization of tools
necessary to investigate a putative R. rickettsii effector protein, RARP3, which is predicted to
play a role in the infection of mammalian cells.
4.2. Summary of Chapters
Lipid metabolism plays a role in regulation of host processes, such as immune signaling
and metabolism, to allow for maintenance of host homeostasis. Intracellular pathogens have
adapted mechanisms of hijacking host metabolic pathways required for survival and intracellular
replication. In this thesis, we determined that host LD modulation is initiated by an unknown
bacterial protein and host lipid catabolism early during R. conorii infection. The induction of
these host lipid catabolic processes is independent of upstream host peroxisome proliferatoractivated receptor-alpha (PPARα) signaling. Conversely, PPARɣ signaling and lipid droplet
accumulation in host cells has a negative correlation with LD modification and R.
conorii survival. Together, these results presented in Chapter II strongly suggest that the
modulation of LDs and host lipid catabolic pathways in macrophage cells infected by R. conorii
is an important and underappreciated aspect of the infection process.
Obligate intracellular pathogens have adapted mechanisms for establishing infection and
developing a hospitable niche. Among the factors attributed to the formation of an intracellular
niche are bacterial effector proteins. Effector proteins are widely studied among human
pathogenic intracellular bacterial species; however, the importance of these proteins in the
biology of Rickettsia species has not been well defined. A previous report investigating
rickettsial transcriptomic changes during in vivo infection with R. rickettsii revealed various
transcripts that code for putative effector proteins classified as ankyrin repeat proteins (ARPs)
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that are upregulated. Among these is a gene that is predicted to encode a small rickettsial ARP,
RARP3 (A1G_00070) (Riley, Pruneau, and Martinez 2017). BLAST analysis suggests that
RARP3 is homologous to proteins within a group of spotted fever (SFG) and translational group
(TRG) of Rickettsia. Furthermore, PHYRE2 structural analysis indicated that this protein is not
structurally conserved. One of the important aspects necessary for studying this putative effector
protein and others is the development and characterization of tools specific to the protein of
interest. The appropriate tools to ectopically express RARP3 in mammalian cells and purify
RARP3 recombinant protein in E. coli were developed. The use of these tools allowed for the
generation of a specific rabbit polyclonal antibody against RARP3 and expression of RARP3
was confirmed in R. rickettsii. Plasmid vectors containing RARP3 were developed for both
eukaryotic (pEGFP-C1) and Escherichia coli (pET23-smt3) expression. Expression of the
protein of interest utilizing these vectors was confirmed before antibody production and antibody
clean-up was performed. The antibody reactivity and specificity were used to confirm RARP3
expression in R. rickettsii. To define potential host:effector protein interactions, pull-down
analysis was performed which revealed a variety of host proteins that potentially serve as bona
fide RARP-3 binding partners. These results presented in Chapter III describe the generation of
tools required to further study the role RARP3 plays during R. rickettsii mammalian infection.
4.3. Conclusions and Future directions
The results discussed within this dissertation define aspects of host cell processes that are
important for mammalian infection with SFG Rickettsia’s, R. conorii and R. rickettsii, and
provide further insight into the mechanisms utilized by these bacteria to cause disease. Despite
the new discoveries discussed, future studies must be conducted to further explore the nature of
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the host-pathogen relationship and the role each feature plays in producing disease during
mammalian infection.
Recent evidence reveals that a human pathogen, R. conorii, and a non-human pathogen,
R. montanensis, differ in their ability to parasitize the human macrophage. Thus, suggesting that
the pathogenic R. conorii is able to manipulate the host cell to be advantageous for bacterial
growth, whereas R. montanensis cannot (Curto, Santa, et al. 2019). Therefore, the data presented
in Chapter II defining host pathways regulated during R. conorii and R. montanensis infection
must also be described for other pathogenic spotted fever group (SFG) and species in other
rickettsial groups to better differentiate overlapping host pathways and factors that contribute to
overall virulence of Rickettsia species and species/group specific pathogenicity factors.
Similarly, Chapter III predominantly focuses on SFG growth characteristics in macrophages and
endothelial cells, with R. bellii (ancestral group; AG) and R. akari (transitional group; TRG),
representing different groups. However, because the typhus group (TG) of Rickettsia are
transmitted differently and cause different diseases, this phenotype may not be broadly
applicable to this group. Conversely, a similar mechanism as defined here for the SFG could be
similar to that in TG Rickettsia. The addition of this knowledge in the future will provide an
increased understanding of Rickettsia diversity and the dynamic relationship with the host to
better understand virulence across the Rickettsia genus.
Chapter II of this dissertation presents data defining host lipid metabolic processes
regulated during R. conorii infection that are necessary for bacterial survival and stimulation of
LD modulation. The data described herein investigates the metabolism requirement for
pathogenic bacterial survival in human macrophages. However, other host cells, including
endothelial cells, are targeted during mammalian infection and invasion of these cell types may
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require a different metabolic response. Therefore, studies demonstrating R. conorii survival in
the endothelial cell line, EA.hy926, pre-treated with inhibitors of FASN, FAO, and triglyceride
lipases used in Chapter II were performed. Surprisingly, the inhibitors had no effect on R. conorii
growth, suggesting host requirements, specifically with lipid metabolic pathways, differs across
cell types (Figure 4.1). However, the lack of a requirement for lipids and lipid catabolism cannot
be ruled out in this cell type until alternative pathways such as sequestering of exogenous lipids

Figure 4.1. R. conorii survival in EA.hy926 cells treated with lipid metabolism inhibitors. (A)
EA.hy926 cells pre-treated with the fatty acid synthase inhibitor, Cerulenin, before R. conorii
infection and analysis of survival by qPCR at 1 day post infection (dpi), 3 dpi, and 5 dpi. (B) Pretreatment of EA.hy926 cells with a triglyceride lipase inhibitor, Orlistat, before infection with R.
conorii and analysis of survival. (C) Analysis of survival of R. conorii in EA.hy926 pre-treated
with a fatty acid β-acid inhibitor, Etomoxir. Data represents two experimental replicates each
with three technical replicates. Statistical analysis was performed using a one-way ANOVA with
Bonferroni’s correction with *p£0.05, **p£0.005, ***p£0.001.
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and lipophagy as a means of lipid catabolism during infection are investigated (Liu and Czaja
2013; Santos and Preta 2018; Ward et al. 2016; Han and Sidell 2002). Completion of more
rigorous studies in endothelial cells will provide a better understanding of the overall host lipid
dynamics induced during R. conorii mammalian infection.
Results presented in Chapter II also show that LDs and FASN are required during
infection of macrophages; however, the fate of lipids derived from LDs and FASN have yet to be
addressed. Similarly, lipid catabolic processes, like FAO and triglyceride lipase-driven
catabolism, were shown to be required during macrophage infection. Together, lipid
production/storage and catabolism have the potential to provide lipids for multiple functions
within the host cell (Haemmerle et al., 2011; Sathyanarayan et al., 2017; Schlaepfer et al., 2014).
For example, lipids from LDs and those produced by FASN can be used for pathways, including
processing by acetyl-CoA carboxylase (ACC) for production of membrane lipids such as
phospholipids (Jones et al. 2017). Preliminary results utilizing an inhibitor of ACC suggests that
this enzyme is important for R. conorii survival in THP-1 macrophages (Figure 4.2). Further
preliminary studies addressing phospholipid changes during infection indicate significant
increases in total phospholipids (Figure 4.3A) with significant changes in phosphatidylcholine
(PC), phosphatidylglycerol (PG), phosphatidylserine (PS), and phosphatidylinositol (PI). PC
increases indicate membrane production which can contribute to a variety of components within
the host cell such as vacuole formation, cell growth, and organelle generation, and even during
infection, bacterial membrane production, like seen in Chlamydia trachomatis infection
(Boncompain et al. 2014; Cox et al. 2016) (Figure 4.3B). Furthermore, early studies on
rickettsial metabolism indicated that host derived products, including PC, during infection with
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Figure 4.2. R. conorii survival in THP-1 macrophages treated with an acetyl-CoA carboxylase
inhibitor, TOFA. THP-1 macropahges were pre-treated TOFA before R. conorii infection and
analysis of survival by qPCR at 1 day post infection (dpi), 3 dpi, and 5 dpi. Data represents two
experimental replicates each with three technical replicates. Statistical analysis was performed
using a one-way ANOVA with Bonnferroni’s correction with *p£0.05, **p£0.005, ***p£0.001.
TG Rickettsia are required for production of bacterial progeny (Winkler and Miller 1978;
Winkler and Daugherty 1994; Frohlich et al. 2010). The modifications of PS, PG, and PI
composition in the host during infection of macrophages signifies an alteration of host cell
external and internal signaling likely required to establish an efficient and sustainable infection
(Wymann and Schneiter 2008). Indeed, R. typhi has a bacterial effector protein, RalF, that
regulates PI signaling necessary for infection supporting a likely modulation of host
phospholipids during infection (Rennoll-Bankert et al. 2016; Voss et al. 2020). Lipids released
from LDs and produced by FASN also play a role in regulating the host immune response.
Prostaglandins have been shown to be upregulated during infection with R. rickettsii, however
little is known about the role these lipids play and if other lipid species are modulated to
facilitate an ideal immune response for bacterial survival (Rydkina et al. 2006). Together,
evidence within this thesis and the described preliminary investigations indicate an
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Figure 4.3. Phospholipid changes after 12 hours of infection with R. conorii in THP-1
macrophages. (A) Total phospholipid alterations when comparing three biological replicates of
uninfected versus R. conorii infected samples. (B) Specific phospholipid classes and the
significant changes that are occurring in each group. The groups that showed significant species
being changed were phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidylglycerol
(PG), and phosphatidylserine (PS). Species with significant changes are indicated by red boxes
and red arrows on bar graph. The significant upregulation or downregulation of each specific
phospholipid species in each group is shown by the blue arrow.
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underappreciation of phospholipids and other lipid species, and a requirement of future studies to
further understand their role in rickettsial infection of mammalian cells and overall development
of disease. Interestingly, other processes not associated with host lipid modification were also
altered during infection that should be further investigated. This includes the elucidation of the
role of host energy and other mitochondrial processes during infection. In our previous study, it
was shown that host oxidative phosphorylation is increased during R. conorii infection of THP-1
macrophages suggesting that host ATP production is stimulated during infection (Curto, Santa, et
al. 2019). In Chapter II, it is also shown that FAO is a necessary component of rickettsial
infection of macrophages and has a role in the mobilization of lipids from LDs; however, the role
of these lipids processed by this pathway remains unknown. There are multiple avenues the
increase in ATP production through FAO and oxidative phosphorylation could take including
prolonging the life of the host cell by providing sustainable energy production that is derived
from a more anti-inflammatory process (Namgaladze and Brune 2016). Rickettsia could also
utilize bacterial ATP transporters to acquire host-derived energy rather than expending energy
producing ATP in less efficient manners. In fact, R. conorii, R. rickettsii, and R. prowazekii have
been shown to increase bacterial ATP transporters during infection suggesting a requirement of
the flux of ATP to or from the host cell cytosol (Riley, Pruneau, and Martinez 2017; Audia and
Winkler 2006; Curto, Riley, et al. 2019). The genomes of Rickettsia species also lack genes
encoding for key enzymes in efficient ATP generating processes, such as glycolysis, suggesting
that complementation with host ATP is possible to produce a more efficient, active infection
(Driscoll et al. 2017). However, little experimental evidence has been conducted to define the
requirement and subsequent fate of host FAO-derived ATP during rickettsial infection. Together,
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Chapter II of this dissertation demonstrates that further elucidation of the functions host lipids
have during infection is vital to understanding the pathogenicity of Rickettsia.
An alternative approach to defining rickettsial pathogenesis is better describing the
bacterial factors involved in initiating the ideal host responses. Chapter III demonstrates the
production of tools for defining a potentially important bacterial ARP (RARP3). However, more
work must be done to elucidate the host targets and function for RARP3 as well as the functional
benefit this protein has during infection. Known rickettsial factors, especially putative secreted
effector proteins, that contribute to bacterial pathogenesis are limited. Furthermore, according to
our earlier study where RARP3 was upregulated in vivo, various other R. rickettsii ARPs were
determined to be upregulated as well and warrant further investigation (Riley, Pruneau, and
Martinez 2017). Among these is an ARP that is homologous to RARP1 described to be a TISS
effector protein in Rickettsia typhi. In R. typhi, RARP1 is transcribed within a polycistronic
operon with a TolC domain upstream of the ARP domain (Kaur et al. 2012). Similarly, the
homologue of RARP1, A1G_01760, found in R. rickettsii also has a TolC upstream and a three
ankyrin ARP domain implying a likelihood of this protein to act as a putative secreted protein,
similar to the R. typhi protein. Unfortunately, the host protein pair and the function of RARP1 for
R. typhi has yet to be elucidated. However, tools like those described in Chapter III are being
developed to further characterize the RARP1 homologue to define the contribution of RARP1 to
the virulence of human pathogenic Rickettsia across rickettsial groups. Indeed, expression of
A1G_01760 in a eukaryotic expression vector, pEGFP-C1 has been achieved (Figure 4.4).
The major findings presented here provide further elucidation of the innerworkings of the
host:pathogen relationship. Here, we show that host lipid metabolism and other host pathways
are essential in allowing for survival within these phagocytic cells. Manipulation of LDs
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Figure 4.4. Expression of A1G_01760:EGFP fusion protein in HEK293T cells. (A) Western
immunoblotting analysis of HEK293T cells expression fusion protein of interest or GFP
independently by α-GFP antibody. (B) Immunofluorescent analysis for GFP expression in
HEK293T cells expressing GFP or RARP3:EGFP (green). Dapi (blue) was used to visualize host
cell nuclei.
specifically requires bacterial protein synthesis, indicating a putative effector protein is likely
involved in stimulating a favorable response during infection. Therefore, tools were also
developed to describe the role of putative effector protein RARPs in manipulating the host cell.
This work not only provides host targets for directed therapeutics to treat against SFG rickettsial
diseases, but also displays the beginning data required for understanding the
macrophage:Rickettsia relationship and rickettsial virulence determinants.

125

APPENDIX A. SUPPORTING MATERIAL FOR CHAPTER II

Figure A.1. Colocalization of R. conorii and host lipid droplets (LDs) during THP-1 macrophage
infection. (A) THP-1 macrophages were infected with R. conorii (MOI of 2) for 1 hr and 24 hrs
before visualization (using 63X objective) of LDs in infected cells and colocalization analysis.
Inset shows area of analysis of fluorescent intensity and yellow lines indicate objects being
analyzed. (B) ImageJ software was used to determine the the fluorescent intensity of objects
along the yellow lines indicated in (A). Overlapping peaks indicate colocalization of respective
objects. Red signifies LDs, green signifies R. conorii, and blue signifies nuclei.
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Figure A.2. Analysis of THP-1 macrophage viability in the presence of inhibitors. MTT cell
viability analysis of THP-1 macrophages treated with varying concentrations of Orlistat (50 µM
– 0.08125 µM) (A), Etomoxir (200 µM – 0.325 µM) (B), GW6471 (14.8 µM – 0.029 µM) (C),
or GW9662 (50 µM – 1.30 µM). Cell survival is plotted as percent of DMSO control.

Figure A.3. PPARα and ɣ protein levels at early and replicative stages of infection.(A)
Immunoblotting with whole cell lysates for protein expression of PPARα at 1 hpi and 24 hpi in
uninfected or R. conorii infected (MOI of 2) THP-1 macrophages. (B) Immunoblotting with
whole cell lysates for protein expression of PPARɣ at 1 hpi and 24 hpi in uninfected or R.
conorii infected (MOI of 2) THP-1 macrophages.
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